Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Parkinson Disease: HELP
Erwan Bezard
Based on 89 articles published since 2010
(Why 89 articles?)
||||
Expertise Level
The expertise of Erwan Bezard ranks in the
  • Top 0.045%
  • ... of 91,190 published authors worldwide on Parkinson Disease
  • ... from 2010 through 2020
  • ... based on contributions to 89 articles on the topic.
Graphical view (beta)
Get your prestigious
World Expert badge
similar to this:
 
Aliases Bézard, Erwan   ·   Bezard, Erwan   ·   Bezard, E
Work Locations
Details
Most likely:    Centre National de la Recherche Scientifique      
2020
  • Univ. de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France. · CNRS, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France. · Pubmed 32138193
  • Centre National de la Recherche Scientifique, Université de Strasbourg, Institut des Neurosciences Cellulaires et Intégratives, F-67000 Strasbourg, France. · Centre National de la Recherche Scientifique, Université de Strasbourg, Institut des Neurosciences Cellulaires et Intégratives, F-67000 Strasbourg, France; Unitat Predepartemental de Medicina, Universitat Jaume I Castelló de la Plana, Spain. · Université de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France; Centre National de la Recherche Scientifique, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France. · Centre National de la Recherche Scientifique, Université de Strasbourg, Institut des Neurosciences Cellulaires et Intégratives, F-67000 Strasbourg, France; Department of Endocrinology and Metabolism, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, Netherlands. · Centre National de la Recherche Scientifique, Université de Strasbourg, Institut des Neurosciences Cellulaires et Intégratives, F-67000 Strasbourg, France. Electronic address: · Pubmed 32087289
  • Medical Mass Spectrometry Imaging, Department of Pharmaceutical Biosciences, Uppsala University, Uppsala, Sweden; Science for Life Laboratory, National Resource for Mass Spectrometry Imaging, Uppsala University, Uppsala, Sweden. · Medical Mass Spectrometry Imaging, Department of Pharmaceutical Biosciences, Uppsala University, Uppsala, Sweden. · Section of Neurology, Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden. · Université de Bordeaux, Institut des Maladies Neurodégénératives, Bordeaux, France; Centre National de la Recherche Scientifique, Institut des Maladies Neurodégénératives, Bordeaux, France. · Medical Mass Spectrometry Imaging, Department of Pharmaceutical Biosciences, Uppsala University, Uppsala, Sweden; Science for Life Laboratory, National Resource for Mass Spectrometry Imaging, Uppsala University, Uppsala, Sweden. Electronic address: · Pubmed 31927144
2019
  • Centre National de la Recherche Scientifique, Université de Strasbourg, Institut des Neurosciences Cellulaires et Intégratives, F-67000 Strasbourg, France. · Université de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France; Centre National de la Recherche Scientifique, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France. · Centre National de la Recherche Scientifique, Université de Strasbourg, Institut des Neurosciences Cellulaires et Intégratives, F-67000 Strasbourg, France. Electronic address: · Pubmed 30365972
  • Medical Mass Spectrometry Imaging, Department of Pharmaceutical Biosciences, Uppsala University, Uppsala, Sweden. · Science for Life Laboratory, National Resource for Mass Spectrometry Imaging, Uppsala University, Uppsala, Sweden. · Department of Medicinal Chemistry, Uppsala University, Uppsala, Sweden. · Section of Neurology, Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden. · Institut des Maladies Neurodégénératives, Université de Bordeaux, Bordeaux, France. · Institut des Maladies Neurodégénératives, CNRS, Bordeaux, France. · Department of Medicinal Chemistry, Uppsala University, Uppsala, Sweden. · Medical Mass Spectrometry Imaging, Department of Pharmaceutical Biosciences, Uppsala University, Uppsala, Sweden. · Science for Life Laboratory, National Resource for Mass Spectrometry Imaging, Uppsala University, Uppsala, Sweden. · Pubmed 31548706
  • Université de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France. · CNRS, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France. · Telethon Institute of Genetics and Medicine (TIGEM), Pozzuoli (Naples), Italy. · Department of Translational Medicine, Federico II University, Naples, Italy. · Department of Molecular and Human Genetics, Ian and Dan Duncan Neurological Research Institute, Baylor College of Medicine, Houston, Texas, USA. · Laboratoire de Neurosciences Expérimentales et Cliniques, INSERM U-1084, Université de Poitiers, Poitiers, France. · Service de Neurologie, Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France. · Pubmed 31434803
  • Département des Sciences de l'Activité Physique, Université du Québec à Montréal, Montréal, QC, Canada. · Centre de Recherche de l'Institut Universitaire de Gériatrie de Montréal, Montréal, QC, Canada. · Département de Stomatologie, Faculté de Médecine Dentaire, Université de Montréal, Montréal, QC, Canada. · Département de Médecine, CHU Montréal, Montréal, QC, Canada. · Laboratoire de Neurophysiologie, Université de Bordeaux, Institut des Maladies Neurodégénératives, Bordeaux, France. · Unité Mixte de Recherche 5293, Centre National de la Recherche Scientifique, Institut des Maladies Neurodégénératives, Bordeaux, France. · Département de Réadaptation, Faculté de Médecine, Université Laval, Quebec, QC, Canada. · Department of Clinical Neurosciences, Hotchkiss Brain Institute, University of Calgary, Calgary, AB, Canada. · Pubmed 30967832
  • Dipartimento di Scienze Farmacologiche e Biomolecolari (DiSFeB), Università degli Studi di Milano - La Statale, 20133 Milano, Italy. · Laboratory of Neurophysiology, Santa Lucia Foundation, IRCCS, 00100 Rome, Italy. · Laboratory of Neurophysiology, Santa Lucia Foundation, IRCCS, 00100 Rome, Italy; Department of Philosophy, Human, Social and Educational Sciences, University of Perugia, 06100 Perugia, Italy. · Université de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France; CNRS, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France. · Motac Neuroscience Ltd, Manchester, United Kingdom; Institute of Laboratory Animal Sciences, China Academy of Medical Sciences, Beijing, China. · Laboratory of Neurophysiology, Santa Lucia Foundation, IRCCS, 00100 Rome, Italy; Clinica Neurologica, Università degli studi di Perugia, Ospedale Santa Maria della Misericordia, S. Andrea delle Fratte, 06156 Perugia, Italy. · Université de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France; CNRS, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France; Motac Neuroscience Ltd, Manchester, United Kingdom; Institute of Laboratory Animal Sciences, China Academy of Medical Sciences, Beijing, China. · Experimental Neurophysiology Laboratory, IRCCS San Raffaele Pisana, University San Raffaele, Rome, Italy. · Dipartimento di Scienze Farmacologiche e Biomolecolari (DiSFeB), Università degli Studi di Milano - La Statale, 20133 Milano, Italy. Electronic address: · Pubmed 30261285
2018
  • Research Statistics, Pfizer Worldwide Research and Development, Cambridge, United Kingdom. · Motac Neuroscience, Manchester, United Kingdom. · Internal Medicine Research Unit, Pfizer Worldwide Research and Development, Cambridge, Massachusetts, USA. · Université de Bordeaux, Institut des Maladies Neurodégénératives, Bordeaux, France. · Centre National de la Recherche Scientifique Unité Mixte de Recherche 5293, Institut des Maladies Neurodégénératives, Bordeaux, France. · Pubmed 30288778
  • Department of Medical Sciences, Section of Pharmacology, University of Ferrara, National Institute of Neuroscience, Ferrara, Italy. · Université de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France; CNRS, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France. · Department of Neuroscience, Novartis Institutes for BioMedical Research, Novartis Pharma AG, 4002 Basel, Switzerland. · Department of Medical Sciences, Section of Pharmacology, University of Ferrara, National Institute of Neuroscience, Ferrara, Italy. Electronic address: · Pubmed 30172844
  • Universidad de Navarra, Facultad de Ciencias, Departamento de Bioquímica y Genética, Avenida Pío XII, 31008 Pamplona, Spain; Universidad de Navarra, CIMA, Programa de Neurociencias, Avenida Pío XII, 31008 Pamplona, Spain. · Servicio de Neurología, Complejo Hospitalario de Navarra, Pamplona, Spain; IdiSNA, Instituto de Investigación Sanitaria de Navarra, Spain. · Univ. de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France; CNRS, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France. · Motac Neuroscience Ltd, Manchester, United Kingdom; Institute of Laboratory Animal Sciences, China Academy of Medical Sciences, Beijing, China. · Universidad de Navarra, CIMA, Programa de Neurociencias, Avenida Pío XII, 31008 Pamplona, Spain; IdiSNA, Instituto de Investigación Sanitaria de Navarra, Spain; Clínica Universidad de Navarra, Servicio de Neurología, Avenida Pío XII, 31008 Pamplona, Spain. · Univ. de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France; CNRS, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France; Motac Neuroscience Ltd, Manchester, United Kingdom; Institute of Laboratory Animal Sciences, China Academy of Medical Sciences, Beijing, China. · Universidad de Navarra, Facultad de Ciencias, Departamento de Bioquímica y Genética, Avenida Pío XII, 31008 Pamplona, Spain; Universidad de Navarra, CIMA, Programa de Neurociencias, Avenida Pío XII, 31008 Pamplona, Spain; IdiSNA, Instituto de Investigación Sanitaria de Navarra, Spain. Electronic address: · Pubmed 29936234
  • Département des Sciences de l'activité physique, Université du Québec à Montréal, Montréal, Québec, Canada. · Centre de Recherche de l'Institut universitaire de gériatrie de Montréal, Montréal, Québec, Canada. · Département de stomatologie, Faculté de médecine dentaire, Université de Montréal, Montréal, QC, Canada. · Département de médecine, CHU Montréal, Montréal, QC, Canada. · Université de Bordeaux, Institut des Maladies Neurodégénératives, F-33000 Bordeaux, France. · Centre National de la Recherche Scientifique Unité Mixte de Recherche 5293, Institut des Maladies Neurodégénératives, F-33000 Bordeaux, France. · Département de réadaptation, Faculté de médecine, Université Laval, Québec, Québec, Canada. · Département de médecine, Faculté de médecine, Université Laval, Québec, Québec, Canada. · Pubmed 29843253
2017
  • HM CINAC, Hospital Universitario HM Puerta del Sur, Mostoles, Madrid, Spain. · Universidad CEU San Pablo, Madrid, Spain. · CIBERNED, Madrid, Spain. · Department of Neurology, Philipps University, Marburg, Germany. · Parkinson's Disease and Movement Disorders Department, HYGEIA Hospital and Attikon Hospital, University of Athens, Athens, Greece. · Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois, USA. · Department of Neurology, Medical University Innsbruck, Innsbruck, Austria. · Morton and Gloria Shulman Movement Disorders Clinic and the Edmond J Safra Program in Parkinson's Disease, Toronto Western Hospital, Toronto, Canada. · Department of Medicine, University of Toronto, Toronto, Canada. · Department of Psychiatry, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA. · Parkinson's Disease and Mental Illness Research, Education and Clinical Centers (PADRECC and MIRECC), Corporal Michael J. Crescenz Veteran's Affairs Medical Center, Philadelphia, Pennsylvania, USA. · Medical Sciences, Newcastle University, Newcastle, UK. · Brain and Mind Centre, Sydney Medical School, The University of Sydney, Sydney, Australia. · School of Medical Sciences, University of New South Wales and Neuroscience Research Australia, Sydney, Australia. · Université de Bordeaux, Institut des Maladies Neurodégénératives, Centre National de la Recherche Scientifique Unité Mixte de Recherche 5293, Institut des Maladies Neurodégénératives, Bordeaux, France. · China Academy of Medical Sciences, Institute of Lab Animal Sciences, Beijing, China. · Departments of Neurology, Pathology, and Cell Biology, the Center for Motor Neuron Biology and Disease, Columbia University, New York, New York, USA. · Columbia Translational Neuroscience Initiative, Columbia University, New York, New York, USA. · Institut du Cerveau et de la Moelle épinière - ICM, Centre de NeuroImagerie de Recherche - CENIR, Sorbonne Universités, UPMC Univ Paris 06, Inserm U1127, CNRS UMR 7225, Paris, France. · Groupe Hospitalier Pitié-Salpêtrière, Paris, France. · Clinical Sciences Department, Newcastle University, Newcastle, UK. · Department of Nuclear Medicine, Aarhus University, Aarhus, Denmark. · Human Neurophysiology, Sobell Department, UCL Institute of Neurology, London, UK. · Human Motor Control Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland, USA. · Department of Neurology, Emory University School of Medicine, Atlanta, Georgia, USA. · Morton and Gloria Shulman Movement Disorders Centre and the Edmond J Safra Program in Parkinson's disease, Toronto Western Hospital, University of Toronto, Toronto, Canada. · Movement Disorders and Neuromodulation Center, Department of Neurology, University of California-San Francisco, San Francisco, California, USA. · Parkinson's Disease Research, Education and Clinical Center, San Francisco Veterans Affairs Medical Center, San Francisco, California, USA. · Veterans Affairs Pacific Islands Health Care System, Honolulu, Hawaii, USA. · Parkinson's Institute, Sunnyvale, California, USA. · Institute of Neurogenetics, University of Luebeck, Luebeck, Germany. · Department of Clinical Genetics, Erasmus University Medical Center, Rotterdam, The Netherlands. · Parkinson's Disease Center and Movement Disorders Clinic, Department of Neurology, Baylor College of Medicine, Houston, Texas, USA. · Department of Neurosurgery, Toronto Western Hospital, University of Toronto, Toronto, Canada. · Department of Neurology, Universitätsklinikum Schleswig-Holstein, Christian Albrechts University Kiel, Kiel, Germany. · Department of Medical Neurobiology, Institute of Medical Research Israel-Canada, Jerusalem, Israel. · Edmond and Lily Safra Center for Brain Sciences, The Hebrew University, Jerusalem, Israel. · Department of Neurosurgery, Hadassah University Hospital, Jerusalem, Israel. · Parkinson's Disease and Movement Disorders Unit, Neurology Service, Institut Clínic de Neurociències, Hospital Clínic de Barcelona, Barcelona, Spain. · Department of Medicine, Universitat de Barcelona, IDIBAPS, Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED) Barcelona, Spain. · Movement Disorders Clinic, Clinical Neurodegenerative Research Unit, Mexico City, Mexico. · Instituto Nacional de Neurología y Neurocirugía, Mexico City, Mexico. · Department of Neurology, Columbia University Medical Center, New York, New York, USA. · Department of Neurology, McGill University, Montreal General Hospital, Montreal, Quebec, Canada. · Klinik für Neurologie, UKSH, Campus Kiel, Christian-Albrechts-Universität, Kiel, Germany. · Institute for Neurodegenerative Disorders, New Haven, Connecticut, USA. · Department of Neurology, University of Alabama at Birmingham, Birmingham, Alabama, USA. · Department of Physiology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA. · Departments of Neurology and Neuroscience, Mount Sinai School of Medicine, New York, New York, USA. · Research Center for Brain Repair, Rush University Medical Center, Chicago, Illinois, USA. · Neuroscience Graduate Program, Rush University Medical Center, Chicago, Illinois, USA. · Neurological Clinic, Department of Medicine, Hospital Santa Maria della Misericordia, University of Perugia, Perugia, Italy. · Laboratory of Neurophysiology, Santa Lucia Foundation, IRCCS, Rome, Italy. · University Department of Clinical Neurosciences, UCL Institute of Neurology, University College London, London, UK. · Pacific Parkinson's Research Centre, Division of Neurology & Djavadf Mowafaghian Centre for Brain Health, University of British Columbia, British Columbia, Canada. · Vancouver Coastal Health, Vancouver, British Columbia, Canada. · Pubmed 28887905
  • Motac Neuroscience Ltd, Manchester, United Kingdom. Electronic address: · Motac Neuroscience Ltd, Manchester, United Kingdom; Univ. de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France; CNRS, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France. · Pubmed 28764902
  • Department of Psychiatry and Behavioural and Clinical Neurosciences Institute, University of Cambridge, Cambridge, UK; Cambridgeshire and Peterborough NHS Foundation Trust, Cambridge, UK. Electronic address: · Departments of Pharmacology and Psychiatry, Center for Compulsive Behavior and Addiction, Rush University Medical Center, Chicago, IL, USA. · Department of Cognitive, Linguistic and Psychological Sciences and Department of Psychiatry and Human Behavior, Brown Institute for Brain Science, Providence, RI, USA. · Institut des Sciences Cognitives Marc Jeannerod, CNRS, Bron, France; Université Claude Bernard Lyon 1, Villeurbanne, France. · Departments of Neuroscience, Psychiatry and Psychology, University of Pittsburgh, Pittsburgh, PA, USA. · Biodonostia Health Research Institute, University Hospital Donostia, and Basque Center on Cognition, Brain and Language, San Sebastián, Spain; Ikerbasque-Basque Foundation for Science, Bilbao, Spain; Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas, Instituto Carlos III, Spain. · Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas, Instituto Carlos III, Spain; HM Centro Integral de Neurociencias, HM Puerta del Sur, Mostoles and Centro de Estudios Universitarios-San Pablo University, Madrid, Spain. · Université de Bordeaux, Institut des Maladies Neurodégénératives, Bordeaux, France; Centre National de la Recherche Scientifique, Institut des Maladies Neurodégénératives, Bordeaux, France. · Pubmed 28229895
  • Université de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, Bordeaux, France; CNRS, Institut des Maladies Neurodégénératives, UMR 5293, Bordeaux, France. · GAIA Research Center, Bioanalytical Department, The Goulandris Natural History Museum, Kifissia 14562, Greece. · National and Kapodistrian University of Athens Medical School, Department of Internal Medicine, 75 Mikras Asias Street, Athens 11527, Greece. · Université de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, Bordeaux, France; CNRS, Institut des Maladies Neurodégénératives, UMR 5293, Bordeaux, France. Electronic address: · GAIA Research Center, Bioanalytical Department, The Goulandris Natural History Museum, Kifissia 14562, Greece; National and Kapodistrian University of Athens Medical School, Department of Pharmacology, 75 Mikras Asias Street, Athens 11527, Greece. Electronic address: · Pubmed 26209472
  • University de Bordeaux, Institut des Maladies Neurodégénératives Bordeaux, France. · CNRS, Institut des Maladies Neurodégénératives, Bordeaux, France. · CHU Bordeaux, Service de Biologie de la reproduction-CECOS, Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France. · University de Bordeaux, Interdisciplinary Institute for Neuroscience, Bordeaux, France. · CNRS, Institut Interdisciplinaire de Neurosciences, Bordeaux, France. · Pubmed 28853717
  • Motac Neuroscience Ltd, Manchester, United Kingdom. Electronic address: · Motac Neuroscience Ltd, Manchester, United Kingdom; Institute of Laboratory Animal Sciences, China Academy of Medical Sciences, Beijing, China. · Department of Biomedical Sciences, Section of Toxicology, University of Cagliari, University Campus, SS554 km 4.5, 09042 Monserrato, Italy. · Department of Biomedical Sciences, Section of Physiology, University of Cagliari, University Campus, SS554 km 4.5, 09042 Monserrato, Italy. · Motac Neuroscience Ltd, Manchester, United Kingdom; Institute of Laboratory Animal Sciences, China Academy of Medical Sciences, Beijing, China; Univ. de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France; CNRS, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France. · Pubmed 28739086
  • Department of Anatomy and Neurosciences, VU University Medical Center, Amsterdam Neuroscience, 1081 BT Amsterdam, The Netherlands. · Ernst Strüngmann Institut for Neuroscience in Cooperation with Max Planck Society, 60528 Frankfurt am Main, Germany. · Université de Bordeaux, Institut des Maladies Neurodégénératives, Unité Mixte de Recherche 5293, F-33000 Bordeaux, France. · Centre National de la Recherche Scientifique, Institut des Maladies Neurodégénératives, Unité Mixte de Recherche 5293, F-33000 Bordeaux, France, and. · Department of Neurology, VU University Medical Center, Amsterdam Neuroscience, 1081 HV Amsterdam, The Netherlands. · Department of Anatomy and Neurosciences, VU University Medical Center, Amsterdam Neuroscience, 1081 BT Amsterdam, The Netherlands, · Pubmed 28687605
  • Univ. de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, F-33000, Bordeaux, France. · CNRS, Institut des Maladies Neurodégénératives, UMR 5293, F-33000, Bordeaux, France. · Motac neuroscience Ltd, Manchester, UK. · Institute of Lab Animal Sciences, China Academy of Medical Sciences, Beijing, China. · Department of Biomedical and Molecular Sciences, Queen's University, Kingston, Canada. · Univ. de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, F-33000, Bordeaux, France. · CNRS, Institut des Maladies Neurodégénératives, UMR 5293, F-33000, Bordeaux, France. · Motac neuroscience Ltd, Manchester, UK. · Institute of Lab Animal Sciences, China Academy of Medical Sciences, Beijing, China. · Pubmed 28539659
  • UMR 5293, Institut des Maladies Neurodégénératives, Université de Bordeaux, 33076 Bordeaux, France. · CNRS, UMR 5293, Institut des Maladies Neurodégénératives, 33076 Bordeaux, France. · Vall d'Hebron Research Institute, CIBERNED and Catalan Institution for Research and Advanced Studies (ICREA), Autonomous University of Barcelona (UAB), Barcelona, Spain. · UMR 5297, Interdisciplinary Institute of Neurosciences, Université de Bordeaux, 33076 Bordeaux, France. · CNRS, UMR 5297, Interdisciplinary Institute of Neurosciences, 33076 Bordeaux, France. · Neurodegenerative Disease Department, Merck Serono Institute, Geneva, Switzerland. · Pubmed 28520872
  • Departamento de Neurociencias, Achucarro Basque Center for Neuroscience, Universidad del País Vasco (UPV/EHU) and Centro de Investigación Biomédica en Red en Enfermedades Neurodegenerativas (CIBERNED), S-48940 Leioa, Spain. · ImmuSmol, F-33600 Pessac, France. · Univ. de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France; CNRS, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France. · Univ. de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France; CNRS, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France; INSERM U1084 Laboratoire de Neurosciences Experimentales et Cliniques, F-86000 Poitiers, France. · HM Centro Integral de Neurociencias A.C. (CINAC), HM Puerta del Sur and CIBERNED and CEU-San Pablo University Madrid, E-28938 Mostoles, Spain. · Univ. de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France; CNRS, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France; Motac Neuroscience, UK-M15 6WE Manchester, UK. Electronic address: · Pubmed 28411117
  • Neuroscience Therapeutic Area, New Medicines, UCB Biopharma SPRL, 1420 Braine l'Alleud, Belgium. · Univ. de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, Bordeaux, 33000, France. · CNRS, Institut des Maladies Neurodégénératives, UMR 5293, Bordeaux, 33000, France. · Pubmed 28407359
  • Univ. de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France. · CNRS, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France. · Pubmed 28374864
  • Department of Medicinal Chemistry and Molecular Pharmacology, Purdue University, West Lafayette, IN, USA. · Purdue Institute for Integrative Neuroscience, Purdue University, West Lafayette, IN, USA. · Université de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, Bordeaux, France. · CNRS, Institut des Maladies Neurodégénératives, UMR 5293, Bordeaux, France. · Department of Neurology, Massachusetts Alzheimer's Disease Research Center, Massachusetts General Hospital, Charlestown, MA, USA. · Department of Statistics, Purdue University, West Lafayette, IN, USA. · Department of Biological and Experimental Psychology, School of Biological and Chemical Sciences, Queen Mary University of London, London, UK. · Department of Medicinal Chemistry and Molecular Pharmacology, Purdue University, West Lafayette, IN, USA. · Purdue Institute for Integrative Neuroscience, Purdue University, West Lafayette, IN, USA. · Pubmed 28069058
2016
  • Université de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, Bordeaux, France. · CNRS, Institut des Maladies Neurodégénératives, UMR 5293, Bordeaux, France. · Telethon Institute of Genetics and Medicine, Pozzuoli, Italy. · Department of Neurology, University Hospital Bordeaux, Bordeaux, France. · Pubmed 26926119
  • Université de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, Bordeaux, France. · CNRS, Institut des Maladies Neurodégénératives, UMR 5293, Bordeaux, France. · Neurodegenerative Diseases Research Group, Vall d'Hebron Research Institute, Centro Investigación Biomédica en Red Enfermedades Neurodegenerativas, Barcelona, Spain. · Department of Biochemistry and Molecular Biology, Autonomous University of Barcelona, Bellaterra, Barcelona, Spain. · Catalan Institution for Research and Advanced Studies, Barcelona, Spain. · Laboratory for Translational Parkinson's Disease Research, Center for Neurodegenerative Science, Van Andel Research Institute, Grand Rapids, Michigan, USA. · Department of Neurological Sciences, The Graduate College, Rush University, Chicago, Illinois, USA. · Pubmed 26347034
  • Université de Bordeaux, Institut des Maladies Neurodégénératives, Bordeaux, France. · CNRS, Institut des Maladies Neurodégénératives, UMR 5293, Bordeaux, France. · Service de Neurologie, CHU de Bordeaux, Bordeaux, France. · NS-Park/FCRIN Network, UMS 015, Toulouse, France. · Addex Pharma SA, Plan Les Ouates, Switzerland. · NS-Park/FCRIN Network, UMS 015, Toulouse, France. · Neurology Service, A, Hôpital Gabriel Montpied, Clermont Ferrand, France. · Sorbonne Universités and UPMC Univ Paris 06, INSERM UMRS-1127 and CIC-1422; CNRS UMR-7225; AP-HP; and ICM, Hôpital Pitié-Salpêtrière, Paris, France. · Universitätsklinikum Giessen und Marburg, Klinik für Neurologie, Marburg, Germany. · Department of Neurology USC/Keck School of Medicine, Los Angeles, California, USA. · Parkinson's Disease and Movement Disorders Center of Boca Raton, Boca Raton, Florida, USA. · Université de Bordeaux, Institut des Maladies Neurodégénératives, Bordeaux, France. · CNRS, Institut des Maladies Neurodégénératives, UMR 5293, Bordeaux, France. · Rush University Medical Center, Dept. of Neurological Sciences, Movement Disorder Section, Chicago, Illinois, USA. · Paracelsus Elena Klinik, centre for Parkinson's Disease & Movement Disorders, Kassel, Germany. · CIC9302, Departments of Clinical Pharmacology and Neurosciences and NeuroToul COEN Center; INSERM, University Hospital of Toulouse and University of Toulouse 3, Toulouse, France. · Pubmed 27214664
  • Motac Neuroscience Ltd, Manchester, United Kingdom. Electronic address: · Motac Neuroscience Ltd, Manchester, United Kingdom. · Motac Neuroscience Ltd, Manchester, United Kingdom; Univ. de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France; CNRS, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France. · Pubmed 27424102
  • Univ. de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, F-33000, Bordeaux, France; CNRS, Institut des Maladies Neurodégénératives, UMR 5293, F-33000, Bordeaux, France. · Service de neurologie de l'hôpital de Poitiers, F-86021, Poitiers, France; Université de Poitiers, F-86000, Poitiers, France; CIC INSERM 1402, CHU de Poitiers, Poitiers, France. · Université de Poitiers, F-86000, Poitiers, France; CIC INSERM 1402, CHU de Poitiers, Poitiers, France; INSERM U1084 Laboratoire de Neurosciences Experimentales et Cliniques, F-86000, Poitiers, France. · INSERM U1084 Laboratoire de Neurosciences Experimentales et Cliniques, F-86000, Poitiers, France; Department of Pharmacology, University of Cambridge, CB2 1PD, Cambridge, UK; Behavioural and Clinical Neuroscience Institute of the University of Cambridge, CB2 3ED, Cambridge, UK. · Univ. de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, F-33000, Bordeaux, France; CNRS, Institut des Maladies Neurodégénératives, UMR 5293, F-33000, Bordeaux, France. Electronic address: · Pubmed 27216859
  • Department of Medical Sciences, Section of Pharmacology, University of Ferrara, via Fossato di Mortara 17-19, 44121 Ferrara, Italy; Neuroscience Center and National Institute of Neuroscience, University of Ferrara, via Fossato di Mortara 17-19, 44121 Ferrara, Italy. · Department of Biomedical and Specialty Surgical Sciences, Section of Human Physiology, University of Ferrara, via Fossato di Mortara 19, 44121 Ferrara, Italy. · Université de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France; CNRS, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France. · Astraea Therapeutics, 320 Logue Avenue, Mountain View, CA 94040, USA. · Department of Medical Sciences, Section of Pharmacology, University of Ferrara, via Fossato di Mortara 17-19, 44121 Ferrara, Italy; Neuroscience Center and National Institute of Neuroscience, University of Ferrara, via Fossato di Mortara 17-19, 44121 Ferrara, Italy. Electronic address: · Pubmed 26804029
  • Cynbiose, Marcy l'Etoile, France. · Univ. de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, 33000, Bordeaux, France. · CNRS, Institut des Maladies Neurodégénératives, UMR 5293, 33000, Bordeaux, France. · Institute of Materia Medica, Chinese Academy of Medical Sciences, Beijing, People's Republic of China, 100050. · Motac Neuroscience, Manchester, United Kingdom. · Institute of Laboratory Animal Sciences, China Academy of Medical Sciences, Beijing, People's Republic of China. · Pubmed 26799359
  • a University de Bordeaux, Institut des Maladies Neurodégénératives , UMR 5293, Bordeaux , France. · b CNRS, Institut des Maladies Neurodégénératives , UMR 5293, Bordeaux , France. · c University de Bordeaux, Institut des Sciences Moléculaires , UMR 5255, Talence , France. · Pubmed 26761717
  • Neuroscience Therapeutic Area, New Medicines, UCB Biopharma SPRL, 1420 Braine L'alleud, Belgium. · University De Bordeaux, Institut Des Maladies Neurodégénératives, UMR 5293, Bordeaux, 33000, France. · CNRS, Institut Des Maladies Neurodégénératives, UMR 5293, Bordeaux, 33000, France. · Pubmed 26695835
  • Univ. De Bordeaux, Institut Des Maladies Neurodégénératives, Bordeaux, France. · Institut Des Maladies Neurodégénératives, CNRS, Bordeaux, France. · Pubmed 26583879
  • Univ. de Bordeaux, Institut des Maladies Neurodégénératives,UMR 5293,33000 Bordeaux,France; CNRS,Institut des Maladies Neurodégénératives,UMR 5293,33000 Bordeaux,France. · Pubmed 26480869
2015
  • Univ. de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, 33000 Bordeaux, France; CNRS, Institut des Maladies Neurodégénératives, UMR 5293, 33000 Bordeaux, France. · Univ. de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, 33000 Bordeaux, France; CNRS, Institut des Maladies Neurodégénératives, UMR 5293, 33000 Bordeaux, France; Department of Neurology, University Hospital Bordeaux, France. · Laboratory of Neurophysiology, Fondazione Santa Lucia, IRCCS, Rome, Italy. · Division of Neuroscience, Institute of Experimental Neurology, San Raffaele Scientific Institute, 20132 Milan, Italy. · Department of Neuroscience, Karolinska Institutet, Stockholm, Sweden. · Basal Ganglia Pathophysiology Unit, Department of Experimental Medical Science, Lund University, Lund, Sweden. · Department of Neurology, Columbia University, New York, USA. · Pacific Parkinson's Research Centre and National Parkinson Foundation Centre of Excellence, University of British Columbia, Vancouver, Canada. · Department of Biomedical Sciences, Section of Neuropsychopharmacology, Cagliari University, 09124 Cagliari, Italy. · Univ. de Bordeaux, Institut Interdisciplinaire de neurosciences, UMR 5297, 33000 Bordeaux, France; CNRS, Institut Interdisciplinaire de neurosciences, UMR 5297, 33000 Bordeaux, France. · Department of Neurology, Hospital Universitario Donostia and Neuroscience Unit, Bio Donostia Research Institute, San Sebastian, Spain. · Department of Pharmacology, Vanderbilt University Medical Center, Nashville, TN 37232, USA. · Center for Health Sciences, SRI International, CA 94025, USA. · Department of Medical Sciences, Section of Pharmacology, University of Ferrara, Ferrara, Italy. · Dipartimento di Scienze Farmacologiche e Biomolecolari, Università degli Studi di Milano, 20133 Milano, Italy. · Department of Biomedical Sciences, Physiology Section, Cagliari University, Cagliari, Italy. · Motac Neuroscience Ltd, Manchester, UK. · Michigan State University, College of Human Medicine, Department of Translational Science and Molecular Medicine & The Udall Center of Excellence in Parkinson's Disease Research, 333 Bostwick Ave NE, Grand Rapids, MI 49503, USA. · Morton & Gloria Shulman Movement Disorders Center, Toronto Western Hospital, Toronto, Ontario M4T 2S8, Canada. · Univ. de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, 33000 Bordeaux, France; CNRS, Institut des Maladies Neurodégénératives, UMR 5293, 33000 Bordeaux, France; Motac Neuroscience Ltd, Manchester, UK. Electronic address: · Pubmed 26209473
  • Motac Neuroscience Ltd, Manchester, United Kingdom. · Motac Neuroscience Ltd, Manchester, United Kingdom; Univ. de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France; CNRS, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France. · Pubmed 26135120
  • Institute of Neurodegenerative Diseases, University of Bordeaux, Centre National de la Recherche Scientifique Unité Mixte de Recherche 5293, 33076 Bordeaux, France. · Research Unit of Theoretical & Applied Economics, University of Bordeaux, Centre National de la Recherche Scientifique Unité Mixte de Recherche 5113, 33608 Pessac, France. · Departments of Neurology, Pathology and Cell Biology, and the Center for Motor Neuron Biology and Disease, Columbia University, New York, NY 10032, USA. · Neurodegenerative Diseases Research Group, Vall d'Hebron Research Institute, Centro Investigación Biomédica en Red Enfermedades Neurodegenerativas, 08035 Barcelona, Spain. · Department of Biochemistry and Molecular Biology, Autonomous University of Barcelona, 08193 Bellaterra, Barcelona, Spain. · Catalan Institution for Research and Advanced Studies, 08010 Barcelona, Spain. · ICM, Paris, France; Sorbonne Universités. · UPMC Université Paris 06, UM 75, ICM, Paris, France. · CNRS, UMR 7225, ICM, Paris, France. · Inserm, U 1127, ICM, Paris, France. · Molecular Genetics Section and Laboratory of Neurogenetics, NIA, NIH, Bethesda, MD20892, USA. · Departments of Neurology and Neuroscience, Mount Sinai School of Medicine, New York, NY 10032, USA. · TransThera Consulting Co., Zionsville, IN, 46077, USA. · Department of Neurology and Feil Family Brain and Mind research Institute, Weill Cornell Medical College, New York NY 10021, USA. · Pubmed 26050140
  • Departments of Cell Biology, · Institut des Maladies Neurodégénératives, UMR 5293, Université de Bordeaux, 33000 Bordeaux, France; Institut des Maladies Neurodégénératives, UMR 5293, CNRS, 33000 Bordeaux, France; · Departments of Cell Biology. · Department of Pharmacology and Toxicology, University at Buffalo, The State Uiversity of New York, Buffalo, NY 14260; and. · Departments of Cell Biology, Institute of Translational Biomedicine, St. Petersburg State University, St. Petersburg, 199034, Russia. · Departments of Cell Biology, Medicine, and Neurobiology, Duke University Medical Center, Durham NC 27710; · Pubmed 25918399
  • Department of Biomedical Sciences, Section of Physiology, University of Cagliari, University Campus, SS554 km 4.5, 09042 Monserrato, Italy. · Univ. de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France; CNRS, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France; Motac Neuroscience, Manchester, UK. · Motac Neuroscience, Manchester, UK; Institute of Lab Animal Sciences, China Academy of Medical Sciences, Beijing, China. · Institute of Lab Animal Sciences, China Academy of Medical Sciences, Beijing, China. · Univ. de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France; CNRS, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France; Motac Neuroscience, Manchester, UK; Institute of Lab Animal Sciences, China Academy of Medical Sciences, Beijing, China. · Department of Biomedical Sciences, Section of Physiology, University of Cagliari, University Campus, SS554 km 4.5, 09042 Monserrato, Italy. Electronic address: · Pubmed 25907446
  • 1 Univ. de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France 2 CNRS, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France · 3 Department of Biomedical Sciences, Section of Physiology, University of Cagliari, University Campus, SS554 km 4.5, 09042 Monserrato, Italy. · Pubmed 25669729
  • Univ. de Bordeaux, UMR 5293, F-33000 Bordeaux, France CNRS, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France. · Institute of Lab Animal Sciences, China Academy of Medical Sciences, Beijing 100101, China. · Univ. de Bordeaux, UMR 5293, F-33000 Bordeaux, France CNRS, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France Institute of Lab Animal Sciences, China Academy of Medical Sciences, Beijing 100101, China. · Pubmed 24770706
2014
  • Institut des Maladies Neurodégénératives, Université de Bordeaux, UMR 5293 Bordeaux, France ; CNRS, Institut des Maladies Neurodégénératives, UMR 5293 Bordeaux, France. · Pubmed 25177278
  • Department of Clinical Neurosciences, UCL Institute of Neurology, London, UK. Electronic address: · Departments of Neurology and Neuroscience, Mount Sinai School of Medicine, New York, NY, USA. · Pittsburgh Institute for Neurodegenerative Diseases, University of Pittsburgh, Pittsburgh, PA 15260, USA. · Université de Bordeaux, Institut des Maladies Neurodégénératives, 33000 Bordeaux, France; CNRS, Institut des Maladies Neurodégénératives, 33000 Bordeaux, France. · Pubmed 24954676
  • Univ. de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France; CNRS, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France. · CHU de Bordeaux, Unité de Soutien Méthodologique à la Recherche Clinique (USMR), Pôle de santé publique, Bordeaux, France. · Univ. de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France; CNRS, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France; Service de Neurologie, CHU de Bordeaux, F-33604 Pessac, France. · Centre de référence atrophie multisystématisée, CHU de Toulouse, Toulouse, France. · Centre de référence atrophie multisystématisée, CHU de Toulouse, Toulouse, France; Department of Clinical Pharmacology, University Hospital and University of Toulouse 3, Toulouse, France; Department of Neurosciences, University Hospital and University of Toulouse 3, Toulouse, France; INSERM UMR825 and CIC9302, Toulouse, France. · Univ. de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France; CNRS, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France; Service de Neurologie, CHU de Bordeaux, F-33604 Pessac, France; Centre de référence atrophie multisystématisée, CHU de Bordeaux, Pessac, France. · Univ. de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France; CNRS, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France; Service de Neurologie, CHU de Bordeaux, F-33604 Pessac, France; Centre de référence atrophie multisystématisée, CHU de Bordeaux, Pessac, France. Electronic address: · Pubmed 24727096
  • Faculty of Life Sciences, University of Manchester, Manchester, UK; Univ. de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France; CNRS, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France. Electronic address: · Univ. de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France; CNRS, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France. · Faculty of Life Sciences, University of Manchester, Manchester, UK. · Pubmed 24969021
  • Motac Neuroscience Ltd., Manchester, United Kingdom; Université de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, Bordeaux F-33000, France; CNRS, Institut des Maladies Neurodégénératives, UMR 5293, Bordeaux F-33000, France. · Institute of Laboratory Animal Sciences, China Academy of Medical Sciences, Beijing, China. · Motac Neuroscience Ltd., Manchester, United Kingdom; Université de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, Bordeaux F-33000, France; CNRS, Institut des Maladies Neurodégénératives, UMR 5293, Bordeaux F-33000, France; Institute of Laboratory Animal Sciences, China Academy of Medical Sciences, Beijing, China. Electronic address: · Pubmed 24572591
  • 1] Univ. de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, 33000 Bordeaux, France [2] CNRS, Institut des Maladies Neurodégénératives, UMR 5293, 33000 Bordeaux, France [3] Motac neuroscience, Manchester, UK. · 1] Univ. de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, 33000 Bordeaux, France [2] CNRS, Institut des Maladies Neurodégénératives, UMR 5293, 33000 Bordeaux, France. · 1] Motac neuroscience, Manchester, UK [2] Institute of Laboratory Animal Sciences, China Academy of Medical Sciences, Beijing, China. · Department of Life Sciences and Biotechnology (SVeB), University of Ferrara, Ferrara, Italy. · Institute of Pharmacology and Toxicology, Charité Campus Mitte, Humboldt University, 10117 Berlin, Germany. · 1] Univ. de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, 33000 Bordeaux, France [2] CNRS, Institut des Maladies Neurodégénératives, UMR 5293, 33000 Bordeaux, France [3] Motac neuroscience, Manchester, UK [4] Institute of Laboratory Animal Sciences, China Academy of Medical Sciences, Beijing, China [5] Service de Neurologie, Centre Expert Parkinson, CHU de Bordeaux, 33076 Bordeaux, France. · Department of Medical Sciences, Section of Pharmacology, University of Ferrara, Ferrara, Italy. · 1] Univ. de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, 33000 Bordeaux, France [2] CNRS, Institut des Maladies Neurodégénératives, UMR 5293, 33000 Bordeaux, France [3] Service de Neurologie, Centre Expert Parkinson, CHU de Bordeaux, 33076 Bordeaux, France [4] Centre de référence AMS, CHU de Bordeaux, 33076 Bordeaux, France. · Pubmed 24429495
  • Université de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, Bordeaux, France; CNRS, Institut des Maladies Neurodégénératives, UMR 5293, Bordeaux, France. Electronic address: · Université de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, Bordeaux, France; CNRS, Institut des Maladies Neurodégénératives, UMR 5293, Bordeaux, France. Electronic address: · Université de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, Bordeaux, France; CNRS, Institut des Maladies Neurodégénératives, UMR 5293, Bordeaux, France; Service de Neurologie, CHU de Bordeaux Haut-Lévêque, Pessac, France. Electronic address: · Université de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, Bordeaux, France; CNRS, Institut des Maladies Neurodégénératives, UMR 5293, Bordeaux, France; Institute of Laboratory Animal Sciences, China Academy of Medical Sciences, Beijing, China. Electronic address: · Université de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, Bordeaux, France; CNRS, Institut des Maladies Neurodégénératives, UMR 5293, Bordeaux, France; Département de Neurophysiologie Clinique, CHU de Bordeaux Pellegrin, Bordeaux, France. Electronic address: · Pubmed 24211719
  • Université de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, Bordeaux, France; CNRS, Institut des Maladies Neurodégénératives, UMR 5293, Bordeaux, France. · Department of Pharmaceutical Biosciences, Biomolecular Imaging and Proteomics, Uppsala University, Box 591, SE-75124 Uppsala, Sweden. · Motac Neuroscience, Manchester, UK; Institute of Laboratory Animal Sciences, China Academy of Medical Sciences, Beijing, China. · Motac Neuroscience, Manchester, UK. · Université de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, Bordeaux, France; CNRS, Institut des Maladies Neurodégénératives, UMR 5293, Bordeaux, France; Motac Neuroscience, Manchester, UK; Institute of Laboratory Animal Sciences, China Academy of Medical Sciences, Beijing, China. Electronic address: · Pubmed 24148855
2013
  • Univ. de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France; CNRS, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France; Institute of Lab Animal Sciences, China Academy of Medical Sciences, Beijing, China. · Pubmed 24135129
  • Univ. de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France; CNRS, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France. · Univ. de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France; CNRS, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France; Service de Neurologie, CHU de Bordeaux, F-33604 Pessac, France. · Univ. de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France; CNRS, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France. Electronic address: · Pubmed 22940424
2011
  • Insitute of Neurodegenerative Diseases, Université Victor Ségalen-Bordeaux II, Centre National de la Recherche Scientifique, Bordeaux, France. · Pubmed 21626544
2010
  • Universite Victor Segalen-Bordeaux 2, Centre National de la Recherche Scientifique, Bordeaux Institute of Neuroscience, UMR 5227 Bordeaux, France. · Pubmed 20105227
2019
  • Service de Neurologie, Hôpital Pellegrin, CHU de Bordeaux, 33000, Bordeaux, France. · Institut des Maladies Neurodégénératives, Université de Bordeaux, UMR 5293, 146 rue Léo Saignat, 33000, Bordeaux Cedex, France. · CNRS, Institut des Maladies Neurodégénératives, UMR 5293, 33000, Bordeaux, France. · Institute of Laboratory Animal Sciences, China Academy of Medical Sciences, Beijing, China. · Motac Neuroscience, Manchester, UK. · CIC Toulouse, Toulouse, France. · Départements de Pharmacologie Clinique et Neurosciences, INSERM CIC9302, CHU de Toulouse, Toulouse, France. · Service de Pharmacologie, Faculté de Médecine, CHU de Toulouse, Université de Toulouse, Toulouse, France. · Service de Neurologie, Hôpital Pellegrin, CHU de Bordeaux, 33000, Bordeaux, France. · Institut des Maladies Neurodégénératives, Université de Bordeaux, UMR 5293, 146 rue Léo Saignat, 33000, Bordeaux Cedex, France. · CNRS, Institut des Maladies Neurodégénératives, UMR 5293, 33000, Bordeaux, France. · Department Medicine, University of Otago, Christchurch, New Zealand. · New Zealand Brain Research Institute, Christchurch, New Zealand. · Pubmed 31098725
2017
  • Ceinge Biotecnologie Avanzate, Naples, Italy. · Department of Molecular Medicine and Medical Biotechnology, University of Naples Federico II, Naples, Italy. · Department of Pharmacology, Vanderbilt University, Nashville, TN, United States of America. · Department of Biology Unit of Cell and Developmental Biology, University of Pisa, Pisa, Italy. · Department of Environmental, Biological and Pharmaceutical Sciences and Technologies, University of Campania, Luigi Vanvitelli, Italy. · Motac Neuroscience, UK-M15 6WE, Manchester, United Kingdom. · Institute of Lab Animal Sciences, China Academy of Medical Sciences, Beijing, China. · Université de Bordeaux, Institut des Maladies Neurodégénératives,Bordeaux, France. · Centre National de la Recherche Scientifique Unité Mixte de Recherche 5293, Institut des Maladies Neurodégénératives, Bordeaux, France. · IRCSS Casa Sollievo della Sofferenza, ISBReMIT-Institute for Stem Cell Biology, Regenerative Medicine and Innovative Therapies, San Giovanni Rotondo, Italy. · Department of Medicine, University of Perugia and Clinica Neurologica, Santa Maria della Misericordia Hospital, Perugia, Italy. · National Research Council of Italy (CNR), Neuroscience Institute, Cagliari, Italy. · Department of Biomedical Sciences, section of Neuropsychopharmacology, University of Cagliari, Cagliari, Italy. · Center for Neuroscience and Cognitive Systems, Istituto Italiano di Tecnologia, Rovereto, TN, Italy. · Neuroscience Institute, National Research Council (CNR), Pisa, Italy. · Pubmed 28742811
  • Department of Clinical Neurosciences, Institute of Neurology, University College London, NW3 2PF, United Kingdom. · Motac Neuroscience, Manchester, United Kingdom. · Institute of Laboratory Animal Sciences, China Academy of Medical Sciences, Beijing City, People's Republic of China. · University de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, Bordeaux, F-33000, France. · CNRS, Institut des Maladies Neurodégénératives, UMR 5293, Bordeaux, F-33000, France. · Pubmed 28295625
2016
  • National Research Council of Italy, Neuroscience Institute, Cagliari, Italy. · Motac Neuroscience Ltd, Manchester, UK. · Institute of Laboratory Animal Sciences, China Academy of Medical Sciences, Beijing, China. · Department of Biomedical Sciences, section of Neuropsychopharmacology, University of Cagliari, Cagliari, Italy. · Department of Biomedical Sciences, section of Physiology, University of Cagliari, Cagliari, Italy. · Department of Chemical and Pharmaceutical Sciences, University of Ferrara, Ferrara, Italy. · Université de Bordeaux, Institut des Maladies Neurodégénératives, Bordeaux, France. · CNRS, Institut des Maladies Neurodégénératives, Bordeaux, France. · Pubmed 26871939
2014
  • Institute of Neurodegenerative Diseases, University of Bordeaux, Centre National de la Recherche Scientifique Unité Mixte de Recherche, Bordeaux, France. · Pubmed 25214445
  • Université Bordeaux; CNRS, Institut des Maladies Neurodégénératives, Bordeaux, France; Department of Pathology, Bordeaux University Hospital, Bordeaux, France. · Pubmed 24494664
2012
  • Institut des Maladies Neurodégénératives, Université de Bordeaux, CNRS UMR 5293, Bordeaux, France. · Pubmed 22885599
  • Insitute of Neurodegenerative Diseases, University of Bordeaux Segalen, Centre National de la Recherche Scientifique Unité Mixte de Recherche 5293, 33076 Bordeaux, France. · Pubmed 22647602
  • University de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293 Bordeaux, France; CNRS, Institut des Maladiesw Neurodégénératives, UMR 5293 Bordeaux, France. · Pubmed 22393538
2011
  • Université Victor Ségalen-Bordeaux II, Centre National de la Recherche Scientifique, Institute of Neurodegenerative Diseases, Bordeaux, France. · Pubmed 22046592
2010
  • Centre National de la Recherche Scientifique UMR 5227, Bordeaux Institute of Neuroscience, Université Victor-Segalen Bordeaux 2 Bordeaux, France. · Pubmed 20890450
Probable:    Universite de Bordeaux      
2020
  • Centre National de la Recherche Scientifique, Université de Strasbourg, Institut des Neurosciences Cellulaires et Intégratives, F-67000 Strasbourg, France. · Centre National de la Recherche Scientifique, Université de Strasbourg, Institut des Neurosciences Cellulaires et Intégratives, F-67000 Strasbourg, France; Unitat Predepartemental de Medicina, Universitat Jaume I Castelló de la Plana, Spain. · Université de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France; Centre National de la Recherche Scientifique, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France. · Centre National de la Recherche Scientifique, Université de Strasbourg, Institut des Neurosciences Cellulaires et Intégratives, F-67000 Strasbourg, France; Department of Endocrinology and Metabolism, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, Netherlands. · Centre National de la Recherche Scientifique, Université de Strasbourg, Institut des Neurosciences Cellulaires et Intégratives, F-67000 Strasbourg, France. Electronic address: · Pubmed 32087289
  • Medical Mass Spectrometry Imaging, Department of Pharmaceutical Biosciences, Uppsala University, Uppsala, Sweden; Science for Life Laboratory, National Resource for Mass Spectrometry Imaging, Uppsala University, Uppsala, Sweden. · Medical Mass Spectrometry Imaging, Department of Pharmaceutical Biosciences, Uppsala University, Uppsala, Sweden. · Section of Neurology, Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden. · Université de Bordeaux, Institut des Maladies Neurodégénératives, Bordeaux, France; Centre National de la Recherche Scientifique, Institut des Maladies Neurodégénératives, Bordeaux, France. · Medical Mass Spectrometry Imaging, Department of Pharmaceutical Biosciences, Uppsala University, Uppsala, Sweden; Science for Life Laboratory, National Resource for Mass Spectrometry Imaging, Uppsala University, Uppsala, Sweden. Electronic address: · Pubmed 31927144
2019
  • Centre National de la Recherche Scientifique, Université de Strasbourg, Institut des Neurosciences Cellulaires et Intégratives, F-67000 Strasbourg, France. · Université de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France; Centre National de la Recherche Scientifique, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France. · Centre National de la Recherche Scientifique, Université de Strasbourg, Institut des Neurosciences Cellulaires et Intégratives, F-67000 Strasbourg, France. Electronic address: · Pubmed 30365972
  • Medical Mass Spectrometry Imaging, Department of Pharmaceutical Biosciences, Uppsala University, Uppsala, Sweden. · Science for Life Laboratory, National Resource for Mass Spectrometry Imaging, Uppsala University, Uppsala, Sweden. · Department of Medicinal Chemistry, Uppsala University, Uppsala, Sweden. · Section of Neurology, Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden. · Institut des Maladies Neurodégénératives, Université de Bordeaux, Bordeaux, France. · Institut des Maladies Neurodégénératives, CNRS, Bordeaux, France. · Department of Medicinal Chemistry, Uppsala University, Uppsala, Sweden. · Medical Mass Spectrometry Imaging, Department of Pharmaceutical Biosciences, Uppsala University, Uppsala, Sweden. · Science for Life Laboratory, National Resource for Mass Spectrometry Imaging, Uppsala University, Uppsala, Sweden. · Pubmed 31548706
  • Université de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France. · CNRS, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France. · Telethon Institute of Genetics and Medicine (TIGEM), Pozzuoli (Naples), Italy. · Department of Translational Medicine, Federico II University, Naples, Italy. · Department of Molecular and Human Genetics, Ian and Dan Duncan Neurological Research Institute, Baylor College of Medicine, Houston, Texas, USA. · Laboratoire de Neurosciences Expérimentales et Cliniques, INSERM U-1084, Université de Poitiers, Poitiers, France. · Service de Neurologie, Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France. · Pubmed 31434803
  • Département des Sciences de l'Activité Physique, Université du Québec à Montréal, Montréal, QC, Canada. · Centre de Recherche de l'Institut Universitaire de Gériatrie de Montréal, Montréal, QC, Canada. · Département de Stomatologie, Faculté de Médecine Dentaire, Université de Montréal, Montréal, QC, Canada. · Département de Médecine, CHU Montréal, Montréal, QC, Canada. · Laboratoire de Neurophysiologie, Université de Bordeaux, Institut des Maladies Neurodégénératives, Bordeaux, France. · Unité Mixte de Recherche 5293, Centre National de la Recherche Scientifique, Institut des Maladies Neurodégénératives, Bordeaux, France. · Département de Réadaptation, Faculté de Médecine, Université Laval, Quebec, QC, Canada. · Department of Clinical Neurosciences, Hotchkiss Brain Institute, University of Calgary, Calgary, AB, Canada. · Pubmed 30967832
  • Dipartimento di Scienze Farmacologiche e Biomolecolari (DiSFeB), Università degli Studi di Milano - La Statale, 20133 Milano, Italy. · Laboratory of Neurophysiology, Santa Lucia Foundation, IRCCS, 00100 Rome, Italy. · Laboratory of Neurophysiology, Santa Lucia Foundation, IRCCS, 00100 Rome, Italy; Department of Philosophy, Human, Social and Educational Sciences, University of Perugia, 06100 Perugia, Italy. · Université de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France; CNRS, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France. · Motac Neuroscience Ltd, Manchester, United Kingdom; Institute of Laboratory Animal Sciences, China Academy of Medical Sciences, Beijing, China. · Laboratory of Neurophysiology, Santa Lucia Foundation, IRCCS, 00100 Rome, Italy; Clinica Neurologica, Università degli studi di Perugia, Ospedale Santa Maria della Misericordia, S. Andrea delle Fratte, 06156 Perugia, Italy. · Université de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France; CNRS, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France; Motac Neuroscience Ltd, Manchester, United Kingdom; Institute of Laboratory Animal Sciences, China Academy of Medical Sciences, Beijing, China. · Experimental Neurophysiology Laboratory, IRCCS San Raffaele Pisana, University San Raffaele, Rome, Italy. · Dipartimento di Scienze Farmacologiche e Biomolecolari (DiSFeB), Università degli Studi di Milano - La Statale, 20133 Milano, Italy. Electronic address: · Pubmed 30261285
2018
  • UC Gardner Neuroscience Institute and Gardner Family Center for Parkinson's Disease and Movement Disorders, Department of Neurology, University of Cincinnati, Cincinnati, OH. · Institute of Molecular and Clinical Sciences, St George's University of London, London, United Kingdom. · Edmond J. Safra Program in Parkinson's Disease, Morton and Gloria Shulman Movement Disorders Clinic, Toronto Western Hospital, University Health Network, Division of Neurology, University of Toronto, Toronto, Ontario, Canada. · Krembil Brain Institute, Toronto, Ontario, Canada. · University of Bordeaux, Institute of Neurodegenerative Diseases, Bordeaux, France. · National Center for Scientific Research, Institute of Neurodegenerative Diseases, Bordeaux, France. · Experimental Neurophysiology Laboratory, IRCCS University San Raffaele Pisana, University San Raffaele, Rome, Italy. · Neurological Clinic, University of Perugia, Santa Maria della Misericordia Hospital, Perugia, Italy. · Pubmed 30357892
  • Research Statistics, Pfizer Worldwide Research and Development, Cambridge, United Kingdom. · Motac Neuroscience, Manchester, United Kingdom. · Internal Medicine Research Unit, Pfizer Worldwide Research and Development, Cambridge, Massachusetts, USA. · Université de Bordeaux, Institut des Maladies Neurodégénératives, Bordeaux, France. · Centre National de la Recherche Scientifique Unité Mixte de Recherche 5293, Institut des Maladies Neurodégénératives, Bordeaux, France. · Pubmed 30288778
  • Department of Medical Sciences, Section of Pharmacology, University of Ferrara, National Institute of Neuroscience, Ferrara, Italy. · Université de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France; CNRS, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France. · Department of Neuroscience, Novartis Institutes for BioMedical Research, Novartis Pharma AG, 4002 Basel, Switzerland. · Department of Medical Sciences, Section of Pharmacology, University of Ferrara, National Institute of Neuroscience, Ferrara, Italy. Electronic address: · Pubmed 30172844
  • Département des Sciences de l'activité physique, Université du Québec à Montréal, Montréal, Québec, Canada. · Centre de Recherche de l'Institut universitaire de gériatrie de Montréal, Montréal, Québec, Canada. · Département de stomatologie, Faculté de médecine dentaire, Université de Montréal, Montréal, QC, Canada. · Département de médecine, CHU Montréal, Montréal, QC, Canada. · Université de Bordeaux, Institut des Maladies Neurodégénératives, F-33000 Bordeaux, France. · Centre National de la Recherche Scientifique Unité Mixte de Recherche 5293, Institut des Maladies Neurodégénératives, F-33000 Bordeaux, France. · Département de réadaptation, Faculté de médecine, Université Laval, Québec, Québec, Canada. · Département de médecine, Faculté de médecine, Université Laval, Québec, Québec, Canada. · Pubmed 29843253
  • Division of Neuroscience, San Raffaele Scientific Institute, 20132 Milan, Italy. · Molecular Neurogenetics Unit, IRCCS Foundation C. Besta Neurological Institute, 20126 Milan, Italy. · IRCCS Institute of Neurological Sciences of Bologna, Bellaria Hospital, Bologna, Italy. · University of Milano-Bicocca, Department of Medicine and Surgery, Monza, Italy. · Division of Neuroscience, San Raffaele Scientific Institute, 20132 Milan, Italy; National Research Council (CNR), Institute of Neuroscience, 20129 Milan, Italy. · Division of Neuroscience, San Raffaele Scientific Institute, 20132 Milan, Italy; University of Milano-Bicocca, Milan, Italy. · Department of Neuroscience, University of Messina, Messina, Italy. · Division of Clinical Haematology-Oncology, European Institute of Oncology, Milan, Italy. · Université de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France. · IRCCS Institute of Neurological Sciences of Bologna, Bellaria Hospital, Bologna, Italy; Neurology Unit, Department of Biomedical and Neuromotor Sciences, University of Bologna, Bologna, Italy. · Division of Neuroscience, San Raffaele Scientific Institute, 20132 Milan, Italy; National Research Council (CNR), Institute of Neuroscience, 20129 Milan, Italy. Electronic address: · Pubmed 29466734
2017
  • HM CINAC, Hospital Universitario HM Puerta del Sur, Mostoles, Madrid, Spain. · Universidad CEU San Pablo, Madrid, Spain. · CIBERNED, Madrid, Spain. · Department of Neurology, Philipps University, Marburg, Germany. · Parkinson's Disease and Movement Disorders Department, HYGEIA Hospital and Attikon Hospital, University of Athens, Athens, Greece. · Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois, USA. · Department of Neurology, Medical University Innsbruck, Innsbruck, Austria. · Morton and Gloria Shulman Movement Disorders Clinic and the Edmond J Safra Program in Parkinson's Disease, Toronto Western Hospital, Toronto, Canada. · Department of Medicine, University of Toronto, Toronto, Canada. · Department of Psychiatry, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA. · Parkinson's Disease and Mental Illness Research, Education and Clinical Centers (PADRECC and MIRECC), Corporal Michael J. Crescenz Veteran's Affairs Medical Center, Philadelphia, Pennsylvania, USA. · Medical Sciences, Newcastle University, Newcastle, UK. · Brain and Mind Centre, Sydney Medical School, The University of Sydney, Sydney, Australia. · School of Medical Sciences, University of New South Wales and Neuroscience Research Australia, Sydney, Australia. · Université de Bordeaux, Institut des Maladies Neurodégénératives, Centre National de la Recherche Scientifique Unité Mixte de Recherche 5293, Institut des Maladies Neurodégénératives, Bordeaux, France. · China Academy of Medical Sciences, Institute of Lab Animal Sciences, Beijing, China. · Departments of Neurology, Pathology, and Cell Biology, the Center for Motor Neuron Biology and Disease, Columbia University, New York, New York, USA. · Columbia Translational Neuroscience Initiative, Columbia University, New York, New York, USA. · Institut du Cerveau et de la Moelle épinière - ICM, Centre de NeuroImagerie de Recherche - CENIR, Sorbonne Universités, UPMC Univ Paris 06, Inserm U1127, CNRS UMR 7225, Paris, France. · Groupe Hospitalier Pitié-Salpêtrière, Paris, France. · Clinical Sciences Department, Newcastle University, Newcastle, UK. · Department of Nuclear Medicine, Aarhus University, Aarhus, Denmark. · Human Neurophysiology, Sobell Department, UCL Institute of Neurology, London, UK. · Human Motor Control Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland, USA. · Department of Neurology, Emory University School of Medicine, Atlanta, Georgia, USA. · Morton and Gloria Shulman Movement Disorders Centre and the Edmond J Safra Program in Parkinson's disease, Toronto Western Hospital, University of Toronto, Toronto, Canada. · Movement Disorders and Neuromodulation Center, Department of Neurology, University of California-San Francisco, San Francisco, California, USA. · Parkinson's Disease Research, Education and Clinical Center, San Francisco Veterans Affairs Medical Center, San Francisco, California, USA. · Veterans Affairs Pacific Islands Health Care System, Honolulu, Hawaii, USA. · Parkinson's Institute, Sunnyvale, California, USA. · Institute of Neurogenetics, University of Luebeck, Luebeck, Germany. · Department of Clinical Genetics, Erasmus University Medical Center, Rotterdam, The Netherlands. · Parkinson's Disease Center and Movement Disorders Clinic, Department of Neurology, Baylor College of Medicine, Houston, Texas, USA. · Department of Neurosurgery, Toronto Western Hospital, University of Toronto, Toronto, Canada. · Department of Neurology, Universitätsklinikum Schleswig-Holstein, Christian Albrechts University Kiel, Kiel, Germany. · Department of Medical Neurobiology, Institute of Medical Research Israel-Canada, Jerusalem, Israel. · Edmond and Lily Safra Center for Brain Sciences, The Hebrew University, Jerusalem, Israel. · Department of Neurosurgery, Hadassah University Hospital, Jerusalem, Israel. · Parkinson's Disease and Movement Disorders Unit, Neurology Service, Institut Clínic de Neurociències, Hospital Clínic de Barcelona, Barcelona, Spain. · Department of Medicine, Universitat de Barcelona, IDIBAPS, Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED) Barcelona, Spain. · Movement Disorders Clinic, Clinical Neurodegenerative Research Unit, Mexico City, Mexico. · Instituto Nacional de Neurología y Neurocirugía, Mexico City, Mexico. · Department of Neurology, Columbia University Medical Center, New York, New York, USA. · Department of Neurology, McGill University, Montreal General Hospital, Montreal, Quebec, Canada. · Klinik für Neurologie, UKSH, Campus Kiel, Christian-Albrechts-Universität, Kiel, Germany. · Institute for Neurodegenerative Disorders, New Haven, Connecticut, USA. · Department of Neurology, University of Alabama at Birmingham, Birmingham, Alabama, USA. · Department of Physiology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA. · Departments of Neurology and Neuroscience, Mount Sinai School of Medicine, New York, New York, USA. · Research Center for Brain Repair, Rush University Medical Center, Chicago, Illinois, USA. · Neuroscience Graduate Program, Rush University Medical Center, Chicago, Illinois, USA. · Neurological Clinic, Department of Medicine, Hospital Santa Maria della Misericordia, University of Perugia, Perugia, Italy. · Laboratory of Neurophysiology, Santa Lucia Foundation, IRCCS, Rome, Italy. · University Department of Clinical Neurosciences, UCL Institute of Neurology, University College London, London, UK. · Pacific Parkinson's Research Centre, Division of Neurology & Djavadf Mowafaghian Centre for Brain Health, University of British Columbia, British Columbia, Canada. · Vancouver Coastal Health, Vancouver, British Columbia, Canada. · Pubmed 28887905
  • Department of Psychiatry and Behavioural and Clinical Neurosciences Institute, University of Cambridge, Cambridge, UK; Cambridgeshire and Peterborough NHS Foundation Trust, Cambridge, UK. Electronic address: · Departments of Pharmacology and Psychiatry, Center for Compulsive Behavior and Addiction, Rush University Medical Center, Chicago, IL, USA. · Department of Cognitive, Linguistic and Psychological Sciences and Department of Psychiatry and Human Behavior, Brown Institute for Brain Science, Providence, RI, USA. · Institut des Sciences Cognitives Marc Jeannerod, CNRS, Bron, France; Université Claude Bernard Lyon 1, Villeurbanne, France. · Departments of Neuroscience, Psychiatry and Psychology, University of Pittsburgh, Pittsburgh, PA, USA. · Biodonostia Health Research Institute, University Hospital Donostia, and Basque Center on Cognition, Brain and Language, San Sebastián, Spain; Ikerbasque-Basque Foundation for Science, Bilbao, Spain; Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas, Instituto Carlos III, Spain. · Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas, Instituto Carlos III, Spain; HM Centro Integral de Neurociencias, HM Puerta del Sur, Mostoles and Centro de Estudios Universitarios-San Pablo University, Madrid, Spain. · Université de Bordeaux, Institut des Maladies Neurodégénératives, Bordeaux, France; Centre National de la Recherche Scientifique, Institut des Maladies Neurodégénératives, Bordeaux, France. · Pubmed 28229895
  • Université de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, Bordeaux, France; CNRS, Institut des Maladies Neurodégénératives, UMR 5293, Bordeaux, France. · GAIA Research Center, Bioanalytical Department, The Goulandris Natural History Museum, Kifissia 14562, Greece. · National and Kapodistrian University of Athens Medical School, Department of Internal Medicine, 75 Mikras Asias Street, Athens 11527, Greece. · Université de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, Bordeaux, France; CNRS, Institut des Maladies Neurodégénératives, UMR 5293, Bordeaux, France. Electronic address: · GAIA Research Center, Bioanalytical Department, The Goulandris Natural History Museum, Kifissia 14562, Greece; National and Kapodistrian University of Athens Medical School, Department of Pharmacology, 75 Mikras Asias Street, Athens 11527, Greece. Electronic address: · Pubmed 26209472
  • Department of Anatomy and Neurosciences, VU University Medical Center, Amsterdam Neuroscience, 1081 BT Amsterdam, The Netherlands. · Ernst Strüngmann Institut for Neuroscience in Cooperation with Max Planck Society, 60528 Frankfurt am Main, Germany. · Université de Bordeaux, Institut des Maladies Neurodégénératives, Unité Mixte de Recherche 5293, F-33000 Bordeaux, France. · Centre National de la Recherche Scientifique, Institut des Maladies Neurodégénératives, Unité Mixte de Recherche 5293, F-33000 Bordeaux, France, and. · Department of Neurology, VU University Medical Center, Amsterdam Neuroscience, 1081 HV Amsterdam, The Netherlands. · Department of Anatomy and Neurosciences, VU University Medical Center, Amsterdam Neuroscience, 1081 BT Amsterdam, The Netherlands, · Pubmed 28687605
  • Univ. de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, F-33000, Bordeaux, France. · CNRS, Institut des Maladies Neurodégénératives, UMR 5293, F-33000, Bordeaux, France. · Motac neuroscience Ltd, Manchester, UK. · Institute of Lab Animal Sciences, China Academy of Medical Sciences, Beijing, China. · Department of Biomedical and Molecular Sciences, Queen's University, Kingston, Canada. · Univ. de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, F-33000, Bordeaux, France. · CNRS, Institut des Maladies Neurodégénératives, UMR 5293, F-33000, Bordeaux, France. · Motac neuroscience Ltd, Manchester, UK. · Institute of Lab Animal Sciences, China Academy of Medical Sciences, Beijing, China. · Pubmed 28539659
  • UMR 5293, Institut des Maladies Neurodégénératives, Université de Bordeaux, 33076 Bordeaux, France. · CNRS, UMR 5293, Institut des Maladies Neurodégénératives, 33076 Bordeaux, France. · Vall d'Hebron Research Institute, CIBERNED and Catalan Institution for Research and Advanced Studies (ICREA), Autonomous University of Barcelona (UAB), Barcelona, Spain. · UMR 5297, Interdisciplinary Institute of Neurosciences, Université de Bordeaux, 33076 Bordeaux, France. · CNRS, UMR 5297, Interdisciplinary Institute of Neurosciences, 33076 Bordeaux, France. · Neurodegenerative Disease Department, Merck Serono Institute, Geneva, Switzerland. · Pubmed 28520872
  • Departamento de Neurociencias, Achucarro Basque Center for Neuroscience, Universidad del País Vasco (UPV/EHU) and Centro de Investigación Biomédica en Red en Enfermedades Neurodegenerativas (CIBERNED), S-48940 Leioa, Spain. · ImmuSmol, F-33600 Pessac, France. · Univ. de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France; CNRS, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France. · Univ. de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France; CNRS, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France; INSERM U1084 Laboratoire de Neurosciences Experimentales et Cliniques, F-86000 Poitiers, France. · HM Centro Integral de Neurociencias A.C. (CINAC), HM Puerta del Sur and CIBERNED and CEU-San Pablo University Madrid, E-28938 Mostoles, Spain. · Univ. de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France; CNRS, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France; Motac Neuroscience, UK-M15 6WE Manchester, UK. Electronic address: · Pubmed 28411117
  • Department of Medicinal Chemistry and Molecular Pharmacology, Purdue University, West Lafayette, IN, USA. · Purdue Institute for Integrative Neuroscience, Purdue University, West Lafayette, IN, USA. · Université de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, Bordeaux, France. · CNRS, Institut des Maladies Neurodégénératives, UMR 5293, Bordeaux, France. · Department of Neurology, Massachusetts Alzheimer's Disease Research Center, Massachusetts General Hospital, Charlestown, MA, USA. · Department of Statistics, Purdue University, West Lafayette, IN, USA. · Department of Biological and Experimental Psychology, School of Biological and Chemical Sciences, Queen Mary University of London, London, UK. · Department of Medicinal Chemistry and Molecular Pharmacology, Purdue University, West Lafayette, IN, USA. · Purdue Institute for Integrative Neuroscience, Purdue University, West Lafayette, IN, USA. · Pubmed 28069058
2016
  • Université de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, Bordeaux, France. · CNRS, Institut des Maladies Neurodégénératives, UMR 5293, Bordeaux, France. · Telethon Institute of Genetics and Medicine, Pozzuoli, Italy. · Department of Neurology, University Hospital Bordeaux, Bordeaux, France. · Pubmed 26926119
  • Université de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, Bordeaux, France. · CNRS, Institut des Maladies Neurodégénératives, UMR 5293, Bordeaux, France. · Neurodegenerative Diseases Research Group, Vall d'Hebron Research Institute, Centro Investigación Biomédica en Red Enfermedades Neurodegenerativas, Barcelona, Spain. · Department of Biochemistry and Molecular Biology, Autonomous University of Barcelona, Bellaterra, Barcelona, Spain. · Catalan Institution for Research and Advanced Studies, Barcelona, Spain. · Laboratory for Translational Parkinson's Disease Research, Center for Neurodegenerative Science, Van Andel Research Institute, Grand Rapids, Michigan, USA. · Department of Neurological Sciences, The Graduate College, Rush University, Chicago, Illinois, USA. · Pubmed 26347034
  • Université de Bordeaux, Institut des Maladies Neurodégénératives, Bordeaux, France. · CNRS, Institut des Maladies Neurodégénératives, UMR 5293, Bordeaux, France. · Service de Neurologie, CHU de Bordeaux, Bordeaux, France. · NS-Park/FCRIN Network, UMS 015, Toulouse, France. · Addex Pharma SA, Plan Les Ouates, Switzerland. · NS-Park/FCRIN Network, UMS 015, Toulouse, France. · Neurology Service, A, Hôpital Gabriel Montpied, Clermont Ferrand, France. · Sorbonne Universités and UPMC Univ Paris 06, INSERM UMRS-1127 and CIC-1422; CNRS UMR-7225; AP-HP; and ICM, Hôpital Pitié-Salpêtrière, Paris, France. · Universitätsklinikum Giessen und Marburg, Klinik für Neurologie, Marburg, Germany. · Department of Neurology USC/Keck School of Medicine, Los Angeles, California, USA. · Parkinson's Disease and Movement Disorders Center of Boca Raton, Boca Raton, Florida, USA. · Université de Bordeaux, Institut des Maladies Neurodégénératives, Bordeaux, France. · CNRS, Institut des Maladies Neurodégénératives, UMR 5293, Bordeaux, France. · Rush University Medical Center, Dept. of Neurological Sciences, Movement Disorder Section, Chicago, Illinois, USA. · Paracelsus Elena Klinik, centre for Parkinson's Disease & Movement Disorders, Kassel, Germany. · CIC9302, Departments of Clinical Pharmacology and Neurosciences and NeuroToul COEN Center; INSERM, University Hospital of Toulouse and University of Toulouse 3, Toulouse, France. · Pubmed 27214664
  • Department of Clinical Neurosciences, Institute of Neurology, University College London, London, United Kingdom. · Neurodegenerative Diseases Institute, University of Bordeaux, Mixed Unit of Research 5293, Bordeaux, France. · Neurodegenerative Diseases Institute, National Center for Scientific Research, Mixed Unit of Research 5293, Bordeaux, France. · Pubmed 27859541
  • Department of Medical Sciences, Section of Pharmacology, University of Ferrara, via Fossato di Mortara 17-19, 44121 Ferrara, Italy; Neuroscience Center and National Institute of Neuroscience, University of Ferrara, via Fossato di Mortara 17-19, 44121 Ferrara, Italy. · Department of Biomedical and Specialty Surgical Sciences, Section of Human Physiology, University of Ferrara, via Fossato di Mortara 19, 44121 Ferrara, Italy. · Université de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France; CNRS, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France. · Astraea Therapeutics, 320 Logue Avenue, Mountain View, CA 94040, USA. · Department of Medical Sciences, Section of Pharmacology, University of Ferrara, via Fossato di Mortara 17-19, 44121 Ferrara, Italy; Neuroscience Center and National Institute of Neuroscience, University of Ferrara, via Fossato di Mortara 17-19, 44121 Ferrara, Italy. Electronic address: · Pubmed 26804029
  • Université de Bordeaux, Institut des Maladies Neurodégénératives, Bordeaux, France; National Centre for Scientific Research, Institut des Maladies Neurodégénératives, Bordeaux, France. · Université de Bordeaux, Institut des Maladies Neurodégénératives, Bordeaux, France; National Centre for Scientific Research, Institut des Maladies Neurodégénératives, Bordeaux, France; Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France. · Université de Bordeaux, Institut des Maladies Neurodégénératives, Bordeaux, France; National Centre for Scientific Research, Institut des Maladies Neurodégénératives, Bordeaux, France. Electronic address: · Pubmed 25442003
  • Institute of Neurodegenerative Diseases, University of Bordeaux and National Center for Scientific Research, Bordeaux, France. · Pubmed 27273753
2015
  • Univ. de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, 33000 Bordeaux, France; CNRS, Institut des Maladies Neurodégénératives, UMR 5293, 33000 Bordeaux, France. · Univ. de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, 33000 Bordeaux, France; CNRS, Institut des Maladies Neurodégénératives, UMR 5293, 33000 Bordeaux, France; Department of Neurology, University Hospital Bordeaux, France. · Laboratory of Neurophysiology, Fondazione Santa Lucia, IRCCS, Rome, Italy. · Division of Neuroscience, Institute of Experimental Neurology, San Raffaele Scientific Institute, 20132 Milan, Italy. · Department of Neuroscience, Karolinska Institutet, Stockholm, Sweden. · Basal Ganglia Pathophysiology Unit, Department of Experimental Medical Science, Lund University, Lund, Sweden. · Department of Neurology, Columbia University, New York, USA. · Pacific Parkinson's Research Centre and National Parkinson Foundation Centre of Excellence, University of British Columbia, Vancouver, Canada. · Department of Biomedical Sciences, Section of Neuropsychopharmacology, Cagliari University, 09124 Cagliari, Italy. · Univ. de Bordeaux, Institut Interdisciplinaire de neurosciences, UMR 5297, 33000 Bordeaux, France; CNRS, Institut Interdisciplinaire de neurosciences, UMR 5297, 33000 Bordeaux, France. · Department of Neurology, Hospital Universitario Donostia and Neuroscience Unit, Bio Donostia Research Institute, San Sebastian, Spain. · Department of Pharmacology, Vanderbilt University Medical Center, Nashville, TN 37232, USA. · Center for Health Sciences, SRI International, CA 94025, USA. · Department of Medical Sciences, Section of Pharmacology, University of Ferrara, Ferrara, Italy. · Dipartimento di Scienze Farmacologiche e Biomolecolari, Università degli Studi di Milano, 20133 Milano, Italy. · Department of Biomedical Sciences, Physiology Section, Cagliari University, Cagliari, Italy. · Motac Neuroscience Ltd, Manchester, UK. · Michigan State University, College of Human Medicine, Department of Translational Science and Molecular Medicine & The Udall Center of Excellence in Parkinson's Disease Research, 333 Bostwick Ave NE, Grand Rapids, MI 49503, USA. · Morton & Gloria Shulman Movement Disorders Center, Toronto Western Hospital, Toronto, Ontario M4T 2S8, Canada. · Univ. de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, 33000 Bordeaux, France; CNRS, Institut des Maladies Neurodégénératives, UMR 5293, 33000 Bordeaux, France; Motac Neuroscience Ltd, Manchester, UK. Electronic address: · Pubmed 26209473
  • Institute of Neurodegenerative Diseases, University of Bordeaux, Centre National de la Recherche Scientifique Unité Mixte de Recherche 5293, 33076 Bordeaux, France. · Research Unit of Theoretical & Applied Economics, University of Bordeaux, Centre National de la Recherche Scientifique Unité Mixte de Recherche 5113, 33608 Pessac, France. · Departments of Neurology, Pathology and Cell Biology, and the Center for Motor Neuron Biology and Disease, Columbia University, New York, NY 10032, USA. · Neurodegenerative Diseases Research Group, Vall d'Hebron Research Institute, Centro Investigación Biomédica en Red Enfermedades Neurodegenerativas, 08035 Barcelona, Spain. · Department of Biochemistry and Molecular Biology, Autonomous University of Barcelona, 08193 Bellaterra, Barcelona, Spain. · Catalan Institution for Research and Advanced Studies, 08010 Barcelona, Spain. · ICM, Paris, France; Sorbonne Universités. · UPMC Université Paris 06, UM 75, ICM, Paris, France. · CNRS, UMR 7225, ICM, Paris, France. · Inserm, U 1127, ICM, Paris, France. · Molecular Genetics Section and Laboratory of Neurogenetics, NIA, NIH, Bethesda, MD20892, USA. · Departments of Neurology and Neuroscience, Mount Sinai School of Medicine, New York, NY 10032, USA. · TransThera Consulting Co., Zionsville, IN, 46077, USA. · Department of Neurology and Feil Family Brain and Mind research Institute, Weill Cornell Medical College, New York NY 10021, USA. · Pubmed 26050140
  • Departments of Cell Biology, · Institut des Maladies Neurodégénératives, UMR 5293, Université de Bordeaux, 33000 Bordeaux, France; Institut des Maladies Neurodégénératives, UMR 5293, CNRS, 33000 Bordeaux, France; · Departments of Cell Biology. · Department of Pharmacology and Toxicology, University at Buffalo, The State Uiversity of New York, Buffalo, NY 14260; and. · Departments of Cell Biology, Institute of Translational Biomedicine, St. Petersburg State University, St. Petersburg, 199034, Russia. · Departments of Cell Biology, Medicine, and Neurobiology, Duke University Medical Center, Durham NC 27710; · Pubmed 25918399
  • 1 Univ. de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France 2 CNRS, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France · 3 Department of Biomedical Sciences, Section of Physiology, University of Cagliari, University Campus, SS554 km 4.5, 09042 Monserrato, Italy. · Pubmed 25669729
2014
  • Institut des Maladies Neurodégénératives, Université de Bordeaux, UMR 5293 Bordeaux, France ; CNRS, Institut des Maladies Neurodégénératives, UMR 5293 Bordeaux, France. · Pubmed 25177278
  • Department of Clinical Neurosciences, UCL Institute of Neurology, London, UK. Electronic address: · Departments of Neurology and Neuroscience, Mount Sinai School of Medicine, New York, NY, USA. · Pittsburgh Institute for Neurodegenerative Diseases, University of Pittsburgh, Pittsburgh, PA 15260, USA. · Université de Bordeaux, Institut des Maladies Neurodégénératives, 33000 Bordeaux, France; CNRS, Institut des Maladies Neurodégénératives, 33000 Bordeaux, France. · Pubmed 24954676
  • Motac Neuroscience Ltd., Manchester, United Kingdom; Université de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, Bordeaux F-33000, France; CNRS, Institut des Maladies Neurodégénératives, UMR 5293, Bordeaux F-33000, France. · Institute of Laboratory Animal Sciences, China Academy of Medical Sciences, Beijing, China. · Motac Neuroscience Ltd., Manchester, United Kingdom; Université de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, Bordeaux F-33000, France; CNRS, Institut des Maladies Neurodégénératives, UMR 5293, Bordeaux F-33000, France; Institute of Laboratory Animal Sciences, China Academy of Medical Sciences, Beijing, China. Electronic address: · Pubmed 24572591
  • Université de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, Bordeaux, France; CNRS, Institut des Maladies Neurodégénératives, UMR 5293, Bordeaux, France. Electronic address: · Université de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, Bordeaux, France; CNRS, Institut des Maladies Neurodégénératives, UMR 5293, Bordeaux, France. Electronic address: · Université de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, Bordeaux, France; CNRS, Institut des Maladies Neurodégénératives, UMR 5293, Bordeaux, France; Service de Neurologie, CHU de Bordeaux Haut-Lévêque, Pessac, France. Electronic address: · Université de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, Bordeaux, France; CNRS, Institut des Maladies Neurodégénératives, UMR 5293, Bordeaux, France; Institute of Laboratory Animal Sciences, China Academy of Medical Sciences, Beijing, China. Electronic address: · Université de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, Bordeaux, France; CNRS, Institut des Maladies Neurodégénératives, UMR 5293, Bordeaux, France; Département de Neurophysiologie Clinique, CHU de Bordeaux Pellegrin, Bordeaux, France. Electronic address: · Pubmed 24211719
  • Université de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, Bordeaux, France; CNRS, Institut des Maladies Neurodégénératives, UMR 5293, Bordeaux, France. · Department of Pharmaceutical Biosciences, Biomolecular Imaging and Proteomics, Uppsala University, Box 591, SE-75124 Uppsala, Sweden. · Motac Neuroscience, Manchester, UK; Institute of Laboratory Animal Sciences, China Academy of Medical Sciences, Beijing, China. · Motac Neuroscience, Manchester, UK. · Université de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, Bordeaux, France; CNRS, Institut des Maladies Neurodégénératives, UMR 5293, Bordeaux, France; Motac Neuroscience, Manchester, UK; Institute of Laboratory Animal Sciences, China Academy of Medical Sciences, Beijing, China. Electronic address: · Pubmed 24148855
2013
  • University de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, Bordeaux, France. · Pubmed 22753348
2011
  • Insitute of Neurodegenerative Diseases, Université Victor Ségalen-Bordeaux II, Centre National de la Recherche Scientifique, Bordeaux, France. · Pubmed 21626544
2010
  • Universite Victor Segalen-Bordeaux 2, Centre National de la Recherche Scientifique, Bordeaux Institute of Neuroscience, UMR 5227 Bordeaux, France. · Pubmed 20105227
2019
  • Service de Neurologie, Hôpital Pellegrin, CHU de Bordeaux, 33000, Bordeaux, France. · Institut des Maladies Neurodégénératives, Université de Bordeaux, UMR 5293, 146 rue Léo Saignat, 33000, Bordeaux Cedex, France. · CNRS, Institut des Maladies Neurodégénératives, UMR 5293, 33000, Bordeaux, France. · Institute of Laboratory Animal Sciences, China Academy of Medical Sciences, Beijing, China. · Motac Neuroscience, Manchester, UK. · CIC Toulouse, Toulouse, France. · Départements de Pharmacologie Clinique et Neurosciences, INSERM CIC9302, CHU de Toulouse, Toulouse, France. · Service de Pharmacologie, Faculté de Médecine, CHU de Toulouse, Université de Toulouse, Toulouse, France. · Service de Neurologie, Hôpital Pellegrin, CHU de Bordeaux, 33000, Bordeaux, France. · Institut des Maladies Neurodégénératives, Université de Bordeaux, UMR 5293, 146 rue Léo Saignat, 33000, Bordeaux Cedex, France. · CNRS, Institut des Maladies Neurodégénératives, UMR 5293, 33000, Bordeaux, France. · Department Medicine, University of Otago, Christchurch, New Zealand. · New Zealand Brain Research Institute, Christchurch, New Zealand. · Pubmed 31098725
2017
  • Ceinge Biotecnologie Avanzate, Naples, Italy. · Department of Molecular Medicine and Medical Biotechnology, University of Naples Federico II, Naples, Italy. · Department of Pharmacology, Vanderbilt University, Nashville, TN, United States of America. · Department of Biology Unit of Cell and Developmental Biology, University of Pisa, Pisa, Italy. · Department of Environmental, Biological and Pharmaceutical Sciences and Technologies, University of Campania, Luigi Vanvitelli, Italy. · Motac Neuroscience, UK-M15 6WE, Manchester, United Kingdom. · Institute of Lab Animal Sciences, China Academy of Medical Sciences, Beijing, China. · Université de Bordeaux, Institut des Maladies Neurodégénératives,Bordeaux, France. · Centre National de la Recherche Scientifique Unité Mixte de Recherche 5293, Institut des Maladies Neurodégénératives, Bordeaux, France. · IRCSS Casa Sollievo della Sofferenza, ISBReMIT-Institute for Stem Cell Biology, Regenerative Medicine and Innovative Therapies, San Giovanni Rotondo, Italy. · Department of Medicine, University of Perugia and Clinica Neurologica, Santa Maria della Misericordia Hospital, Perugia, Italy. · National Research Council of Italy (CNR), Neuroscience Institute, Cagliari, Italy. · Department of Biomedical Sciences, section of Neuropsychopharmacology, University of Cagliari, Cagliari, Italy. · Center for Neuroscience and Cognitive Systems, Istituto Italiano di Tecnologia, Rovereto, TN, Italy. · Neuroscience Institute, National Research Council (CNR), Pisa, Italy. · Pubmed 28742811
2016
  • National Research Council of Italy, Neuroscience Institute, Cagliari, Italy. · Motac Neuroscience Ltd, Manchester, UK. · Institute of Laboratory Animal Sciences, China Academy of Medical Sciences, Beijing, China. · Department of Biomedical Sciences, section of Neuropsychopharmacology, University of Cagliari, Cagliari, Italy. · Department of Biomedical Sciences, section of Physiology, University of Cagliari, Cagliari, Italy. · Department of Chemical and Pharmaceutical Sciences, University of Ferrara, Ferrara, Italy. · Université de Bordeaux, Institut des Maladies Neurodégénératives, Bordeaux, France. · CNRS, Institut des Maladies Neurodégénératives, Bordeaux, France. · Pubmed 26871939
2014
  • Institute of Neurodegenerative Diseases, University of Bordeaux, Centre National de la Recherche Scientifique Unité Mixte de Recherche, Bordeaux, France. · Pubmed 25214445
2013
  • Institute of Neurodegenerative Diseases, University of Bordeaux Segalen, Centre National de Recherche Scientifique Unité Mixte de Recherche 5293, Bordeaux, France. · Pubmed 23580333
  • Institute of Neurodegenerative Diseases, UMR 5293, F-33000 Bordeaux, France, University of Bordeaux, Bordeaux, France; Institute of Neurodegenerative Diseases, UMR 5293, F-33000 Bordeaux, France, National Center for Scientific Research, Bordeaux, France. · Pubmed 23494678
  • Université de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, Bordeaux, France. · Pubmed 23283428
2012
  • Université de Bordeaux, Institut des Maladies Neurodégénératives, Bordeaux, France. · Pubmed 23041629
  • Institut des Maladies Neurodégénératives, Université de Bordeaux, CNRS UMR 5293, Bordeaux, France. · Pubmed 22885599
  • Insitute of Neurodegenerative Diseases, University of Bordeaux Segalen, Centre National de la Recherche Scientifique Unité Mixte de Recherche 5293, 33076 Bordeaux, France. · Pubmed 22647602
2011
  • Université Victor Ségalen-Bordeaux II, Centre National de la Recherche Scientifique, Institute of Neurodegenerative Diseases, Bordeaux, France. · Pubmed 22046592
2010
  • Centre National de la Recherche Scientifique UMR 5227, Bordeaux Institute of Neuroscience, Université Victor-Segalen Bordeaux 2 Bordeaux, France. · Pubmed 20890450
Probable:    Miscellaneous institutions in Bordeaux      
2020
  • Univ. de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France. · CNRS, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France. · Pubmed 32138193
2018
  • UC Gardner Neuroscience Institute and Gardner Family Center for Parkinson's Disease and Movement Disorders, Department of Neurology, University of Cincinnati, Cincinnati, OH. · Institute of Molecular and Clinical Sciences, St George's University of London, London, United Kingdom. · Edmond J. Safra Program in Parkinson's Disease, Morton and Gloria Shulman Movement Disorders Clinic, Toronto Western Hospital, University Health Network, Division of Neurology, University of Toronto, Toronto, Ontario, Canada. · Krembil Brain Institute, Toronto, Ontario, Canada. · University of Bordeaux, Institute of Neurodegenerative Diseases, Bordeaux, France. · National Center for Scientific Research, Institute of Neurodegenerative Diseases, Bordeaux, France. · Experimental Neurophysiology Laboratory, IRCCS University San Raffaele Pisana, University San Raffaele, Rome, Italy. · Neurological Clinic, University of Perugia, Santa Maria della Misericordia Hospital, Perugia, Italy. · Pubmed 30357892
2017
  • University de Bordeaux, Institut des Maladies Neurodégénératives Bordeaux, France. · CNRS, Institut des Maladies Neurodégénératives, Bordeaux, France. · CHU Bordeaux, Service de Biologie de la reproduction-CECOS, Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France. · University de Bordeaux, Interdisciplinary Institute for Neuroscience, Bordeaux, France. · CNRS, Institut Interdisciplinaire de Neurosciences, Bordeaux, France. · Pubmed 28853717
  • Neuroscience Therapeutic Area, New Medicines, UCB Biopharma SPRL, 1420 Braine l'Alleud, Belgium. · Univ. de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, Bordeaux, 33000, France. · CNRS, Institut des Maladies Neurodégénératives, UMR 5293, Bordeaux, 33000, France. · Pubmed 28407359
  • Univ. de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France. · CNRS, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France. · Pubmed 28374864
2016
  • Department of Clinical Neurosciences, Institute of Neurology, University College London, London, United Kingdom. · Neurodegenerative Diseases Institute, University of Bordeaux, Mixed Unit of Research 5293, Bordeaux, France. · Neurodegenerative Diseases Institute, National Center for Scientific Research, Mixed Unit of Research 5293, Bordeaux, France. · Pubmed 27859541
  • Cynbiose, Marcy l'Etoile, France. · Univ. de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, 33000, Bordeaux, France. · CNRS, Institut des Maladies Neurodégénératives, UMR 5293, 33000, Bordeaux, France. · Institute of Materia Medica, Chinese Academy of Medical Sciences, Beijing, People's Republic of China, 100050. · Motac Neuroscience, Manchester, United Kingdom. · Institute of Laboratory Animal Sciences, China Academy of Medical Sciences, Beijing, People's Republic of China. · Pubmed 26799359
  • a University de Bordeaux, Institut des Maladies Neurodégénératives , UMR 5293, Bordeaux , France. · b CNRS, Institut des Maladies Neurodégénératives , UMR 5293, Bordeaux , France. · c University de Bordeaux, Institut des Sciences Moléculaires , UMR 5255, Talence , France. · Pubmed 26761717
  • Neuroscience Therapeutic Area, New Medicines, UCB Biopharma SPRL, 1420 Braine L'alleud, Belgium. · University De Bordeaux, Institut Des Maladies Neurodégénératives, UMR 5293, Bordeaux, 33000, France. · CNRS, Institut Des Maladies Neurodégénératives, UMR 5293, Bordeaux, 33000, France. · Pubmed 26695835
  • Univ. De Bordeaux, Institut Des Maladies Neurodégénératives, Bordeaux, France. · Institut Des Maladies Neurodégénératives, CNRS, Bordeaux, France. · Pubmed 26583879
  • University de Bordeaux, Institut des Maladies Neurodégénératives, Bordeaux, France; National Centre for Scientific Research, Institut des Maladies Neurodégénératives, Bordeaux, France. · China Academy of Medical Sciences, Institute of Laboratory Animal Sciences, Beijing, China. · Laboratory of Neurophysiology and Plasticity, Fondazione Santa Lucia, Istituto di Ricovero e Cura a Carattere Scientifico, Rome, Italy. · University de Bordeaux, Institut des Maladies Neurodégénératives, Bordeaux, France; National Centre for Scientific Research, Institut des Maladies Neurodégénératives, Bordeaux, France. Electronic address: · Pubmed 25146322
2013
  • Institute for Neurodegenerative Diseases, Bordeaux University, Bordeaux, France. · Pubmed 23389842
2017
  • Department of Clinical Neurosciences, Institute of Neurology, University College London, NW3 2PF, United Kingdom. · Motac Neuroscience, Manchester, United Kingdom. · Institute of Laboratory Animal Sciences, China Academy of Medical Sciences, Beijing City, People's Republic of China. · University de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, Bordeaux, F-33000, France. · CNRS, Institut des Maladies Neurodégénératives, UMR 5293, Bordeaux, F-33000, France. · Pubmed 28295625
2012
  • Univ. de Bordeaux, Institut des Maladies Neurodégénératives , UMR 5293, F-33000 Bordeaux, France. · Pubmed 23205271
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 89 total) written by Erwan Bezard about Parkinson Disease:

  • Targeting α-synuclein for PD Therapeutics: A Pursuit on All Fronts. 2020
  • Ablation of the tail of the ventral tegmental area compensates symptoms in an experimental model of Parkinson's disease. 2020
  • Simultaneous mass spectrometry imaging of multiple neuropeptides in the brain and alterations induced by experimental parkinsonism and L-DOPA therapy. 2020
  • The hidden side of Parkinson's disease: Studying pain, anxiety and depression in animal models. 2019
  • Comprehensive mapping of neurotransmitter networks by MALDI-MS imaging. 2019
  • Transcription factor EB overexpression prevents neurodegeneration in experimental synucleinopathies. 2019
  • Assessment of plasma creatine kinase as biomarker for levodopa-induced dyskinesia in Parkinson's disease. 2019
  • Remnants of Cardinal Symptoms of Parkinson's Disease, Not Dyskinesia, Are Problematic for Dyskinetic Patients Performing Activities of Daily Living. 2019
  • NMDA receptor GluN2D subunit participates to levodopa-induced dyskinesia pathophysiology. 2019
  • Levodopa-induced dyskinesia in Parkinson disease: Current and evolving concepts. 2018
Show List of Full Article Records
Google Searches

Learn more about Erwan Bezard using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
Centre National de la Recherche Scientifique
Universite de Bordeaux
Miscellaneous institutions in Bordeaux
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
Centre National de la Recherche Scientifique
2020
  • Univ. de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France. · CNRS, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France. · Pubmed 32138193
  • Centre National de la Recherche Scientifique, Université de Strasbourg, Institut des Neurosciences Cellulaires et Intégratives, F-67000 Strasbourg, France. · Centre National de la Recherche Scientifique, Université de Strasbourg, Institut des Neurosciences Cellulaires et Intégratives, F-67000 Strasbourg, France; Unitat Predepartemental de Medicina, Universitat Jaume I Castelló de la Plana, Spain. · Université de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France; Centre National de la Recherche Scientifique, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France. · Centre National de la Recherche Scientifique, Université de Strasbourg, Institut des Neurosciences Cellulaires et Intégratives, F-67000 Strasbourg, France; Department of Endocrinology and Metabolism, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, Netherlands. · Centre National de la Recherche Scientifique, Université de Strasbourg, Institut des Neurosciences Cellulaires et Intégratives, F-67000 Strasbourg, France. Electronic address: · Pubmed 32087289
  • Medical Mass Spectrometry Imaging, Department of Pharmaceutical Biosciences, Uppsala University, Uppsala, Sweden; Science for Life Laboratory, National Resource for Mass Spectrometry Imaging, Uppsala University, Uppsala, Sweden. · Medical Mass Spectrometry Imaging, Department of Pharmaceutical Biosciences, Uppsala University, Uppsala, Sweden. · Section of Neurology, Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden. · Université de Bordeaux, Institut des Maladies Neurodégénératives, Bordeaux, France; Centre National de la Recherche Scientifique, Institut des Maladies Neurodégénératives, Bordeaux, France. · Medical Mass Spectrometry Imaging, Department of Pharmaceutical Biosciences, Uppsala University, Uppsala, Sweden; Science for Life Laboratory, National Resource for Mass Spectrometry Imaging, Uppsala University, Uppsala, Sweden. Electronic address: · Pubmed 31927144
2019
  • Centre National de la Recherche Scientifique, Université de Strasbourg, Institut des Neurosciences Cellulaires et Intégratives, F-67000 Strasbourg, France. · Université de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France; Centre National de la Recherche Scientifique, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France. · Centre National de la Recherche Scientifique, Université de Strasbourg, Institut des Neurosciences Cellulaires et Intégratives, F-67000 Strasbourg, France. Electronic address: · Pubmed 30365972
  • Medical Mass Spectrometry Imaging, Department of Pharmaceutical Biosciences, Uppsala University, Uppsala, Sweden. · Science for Life Laboratory, National Resource for Mass Spectrometry Imaging, Uppsala University, Uppsala, Sweden. · Department of Medicinal Chemistry, Uppsala University, Uppsala, Sweden. · Section of Neurology, Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden. · Institut des Maladies Neurodégénératives, Université de Bordeaux, Bordeaux, France. · Institut des Maladies Neurodégénératives, CNRS, Bordeaux, France. · Department of Medicinal Chemistry, Uppsala University, Uppsala, Sweden. · Medical Mass Spectrometry Imaging, Department of Pharmaceutical Biosciences, Uppsala University, Uppsala, Sweden. · Science for Life Laboratory, National Resource for Mass Spectrometry Imaging, Uppsala University, Uppsala, Sweden. · Pubmed 31548706
  • Université de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France. · CNRS, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France. · Telethon Institute of Genetics and Medicine (TIGEM), Pozzuoli (Naples), Italy. · Department of Translational Medicine, Federico II University, Naples, Italy. · Department of Molecular and Human Genetics, Ian and Dan Duncan Neurological Research Institute, Baylor College of Medicine, Houston, Texas, USA. · Laboratoire de Neurosciences Expérimentales et Cliniques, INSERM U-1084, Université de Poitiers, Poitiers, France. · Service de Neurologie, Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France. · Pubmed 31434803
  • Département des Sciences de l'Activité Physique, Université du Québec à Montréal, Montréal, QC, Canada. · Centre de Recherche de l'Institut Universitaire de Gériatrie de Montréal, Montréal, QC, Canada. · Département de Stomatologie, Faculté de Médecine Dentaire, Université de Montréal, Montréal, QC, Canada. · Département de Médecine, CHU Montréal, Montréal, QC, Canada. · Laboratoire de Neurophysiologie, Université de Bordeaux, Institut des Maladies Neurodégénératives, Bordeaux, France. · Unité Mixte de Recherche 5293, Centre National de la Recherche Scientifique, Institut des Maladies Neurodégénératives, Bordeaux, France. · Département de Réadaptation, Faculté de Médecine, Université Laval, Quebec, QC, Canada. · Department of Clinical Neurosciences, Hotchkiss Brain Institute, University of Calgary, Calgary, AB, Canada. · Pubmed 30967832
  • Dipartimento di Scienze Farmacologiche e Biomolecolari (DiSFeB), Università degli Studi di Milano - La Statale, 20133 Milano, Italy. · Laboratory of Neurophysiology, Santa Lucia Foundation, IRCCS, 00100 Rome, Italy. · Laboratory of Neurophysiology, Santa Lucia Foundation, IRCCS, 00100 Rome, Italy; Department of Philosophy, Human, Social and Educational Sciences, University of Perugia, 06100 Perugia, Italy. · Université de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France; CNRS, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France. · Motac Neuroscience Ltd, Manchester, United Kingdom; Institute of Laboratory Animal Sciences, China Academy of Medical Sciences, Beijing, China. · Laboratory of Neurophysiology, Santa Lucia Foundation, IRCCS, 00100 Rome, Italy; Clinica Neurologica, Università degli studi di Perugia, Ospedale Santa Maria della Misericordia, S. Andrea delle Fratte, 06156 Perugia, Italy. · Université de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France; CNRS, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France; Motac Neuroscience Ltd, Manchester, United Kingdom; Institute of Laboratory Animal Sciences, China Academy of Medical Sciences, Beijing, China. · Experimental Neurophysiology Laboratory, IRCCS San Raffaele Pisana, University San Raffaele, Rome, Italy. · Dipartimento di Scienze Farmacologiche e Biomolecolari (DiSFeB), Università degli Studi di Milano - La Statale, 20133 Milano, Italy. Electronic address: · Pubmed 30261285
2018
  • Research Statistics, Pfizer Worldwide Research and Development, Cambridge, United Kingdom. · Motac Neuroscience, Manchester, United Kingdom. · Internal Medicine Research Unit, Pfizer Worldwide Research and Development, Cambridge, Massachusetts, USA. · Université de Bordeaux, Institut des Maladies Neurodégénératives, Bordeaux, France. · Centre National de la Recherche Scientifique Unité Mixte de Recherche 5293, Institut des Maladies Neurodégénératives, Bordeaux, France. · Pubmed 30288778
  • Department of Medical Sciences, Section of Pharmacology, University of Ferrara, National Institute of Neuroscience, Ferrara, Italy. · Université de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France; CNRS, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France. · Department of Neuroscience, Novartis Institutes for BioMedical Research, Novartis Pharma AG, 4002 Basel, Switzerland. · Department of Medical Sciences, Section of Pharmacology, University of Ferrara, National Institute of Neuroscience, Ferrara, Italy. Electronic address: · Pubmed 30172844
  • Universidad de Navarra, Facultad de Ciencias, Departamento de Bioquímica y Genética, Avenida Pío XII, 31008 Pamplona, Spain; Universidad de Navarra, CIMA, Programa de Neurociencias, Avenida Pío XII, 31008 Pamplona, Spain. · Servicio de Neurología, Complejo Hospitalario de Navarra, Pamplona, Spain; IdiSNA, Instituto de Investigación Sanitaria de Navarra, Spain. · Univ. de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France; CNRS, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France. · Motac Neuroscience Ltd, Manchester, United Kingdom; Institute of Laboratory Animal Sciences, China Academy of Medical Sciences, Beijing, China. · Universidad de Navarra, CIMA, Programa de Neurociencias, Avenida Pío XII, 31008 Pamplona, Spain; IdiSNA, Instituto de Investigación Sanitaria de Navarra, Spain; Clínica Universidad de Navarra, Servicio de Neurología, Avenida Pío XII, 31008 Pamplona, Spain. · Univ. de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France; CNRS, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France; Motac Neuroscience Ltd, Manchester, United Kingdom; Institute of Laboratory Animal Sciences, China Academy of Medical Sciences, Beijing, China. · Universidad de Navarra, Facultad de Ciencias, Departamento de Bioquímica y Genética, Avenida Pío XII, 31008 Pamplona, Spain; Universidad de Navarra, CIMA, Programa de Neurociencias, Avenida Pío XII, 31008 Pamplona, Spain; IdiSNA, Instituto de Investigación Sanitaria de Navarra, Spain. Electronic address: · Pubmed 29936234
  • Département des Sciences de l'activité physique, Université du Québec à Montréal, Montréal, Québec, Canada. · Centre de Recherche de l'Institut universitaire de gériatrie de Montréal, Montréal, Québec, Canada. · Département de stomatologie, Faculté de médecine dentaire, Université de Montréal, Montréal, QC, Canada. · Département de médecine, CHU Montréal, Montréal, QC, Canada. · Université de Bordeaux, Institut des Maladies Neurodégénératives, F-33000 Bordeaux, France. · Centre National de la Recherche Scientifique Unité Mixte de Recherche 5293, Institut des Maladies Neurodégénératives, F-33000 Bordeaux, France. · Département de réadaptation, Faculté de médecine, Université Laval, Québec, Québec, Canada. · Département de médecine, Faculté de médecine, Université Laval, Québec, Québec, Canada. · Pubmed 29843253
2017
  • HM CINAC, Hospital Universitario HM Puerta del Sur, Mostoles, Madrid, Spain. · Universidad CEU San Pablo, Madrid, Spain. · CIBERNED, Madrid, Spain. · Department of Neurology, Philipps University, Marburg, Germany. · Parkinson's Disease and Movement Disorders Department, HYGEIA Hospital and Attikon Hospital, University of Athens, Athens, Greece. · Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois, USA. · Department of Neurology, Medical University Innsbruck, Innsbruck, Austria. · Morton and Gloria Shulman Movement Disorders Clinic and the Edmond J Safra Program in Parkinson's Disease, Toronto Western Hospital, Toronto, Canada. · Department of Medicine, University of Toronto, Toronto, Canada. · Department of Psychiatry, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA. · Parkinson's Disease and Mental Illness Research, Education and Clinical Centers (PADRECC and MIRECC), Corporal Michael J. Crescenz Veteran's Affairs Medical Center, Philadelphia, Pennsylvania, USA. · Medical Sciences, Newcastle University, Newcastle, UK. · Brain and Mind Centre, Sydney Medical School, The University of Sydney, Sydney, Australia. · School of Medical Sciences, University of New South Wales and Neuroscience Research Australia, Sydney, Australia. · Université de Bordeaux, Institut des Maladies Neurodégénératives, Centre National de la Recherche Scientifique Unité Mixte de Recherche 5293, Institut des Maladies Neurodégénératives, Bordeaux, France. · China Academy of Medical Sciences, Institute of Lab Animal Sciences, Beijing, China. · Departments of Neurology, Pathology, and Cell Biology, the Center for Motor Neuron Biology and Disease, Columbia University, New York, New York, USA. · Columbia Translational Neuroscience Initiative, Columbia University, New York, New York, USA. · Institut du Cerveau et de la Moelle épinière - ICM, Centre de NeuroImagerie de Recherche - CENIR, Sorbonne Universités, UPMC Univ Paris 06, Inserm U1127, CNRS UMR 7225, Paris, France. · Groupe Hospitalier Pitié-Salpêtrière, Paris, France. · Clinical Sciences Department, Newcastle University, Newcastle, UK. · Department of Nuclear Medicine, Aarhus University, Aarhus, Denmark. · Human Neurophysiology, Sobell Department, UCL Institute of Neurology, London, UK. · Human Motor Control Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland, USA. · Department of Neurology, Emory University School of Medicine, Atlanta, Georgia, USA. · Morton and Gloria Shulman Movement Disorders Centre and the Edmond J Safra Program in Parkinson's disease, Toronto Western Hospital, University of Toronto, Toronto, Canada. · Movement Disorders and Neuromodulation Center, Department of Neurology, University of California-San Francisco, San Francisco, California, USA. · Parkinson's Disease Research, Education and Clinical Center, San Francisco Veterans Affairs Medical Center, San Francisco, California, USA. · Veterans Affairs Pacific Islands Health Care System, Honolulu, Hawaii, USA. · Parkinson's Institute, Sunnyvale, California, USA. · Institute of Neurogenetics, University of Luebeck, Luebeck, Germany. · Department of Clinical Genetics, Erasmus University Medical Center, Rotterdam, The Netherlands. · Parkinson's Disease Center and Movement Disorders Clinic, Department of Neurology, Baylor College of Medicine, Houston, Texas, USA. · Department of Neurosurgery, Toronto Western Hospital, University of Toronto, Toronto, Canada. · Department of Neurology, Universitätsklinikum Schleswig-Holstein, Christian Albrechts University Kiel, Kiel, Germany. · Department of Medical Neurobiology, Institute of Medical Research Israel-Canada, Jerusalem, Israel. · Edmond and Lily Safra Center for Brain Sciences, The Hebrew University, Jerusalem, Israel. · Department of Neurosurgery, Hadassah University Hospital, Jerusalem, Israel. · Parkinson's Disease and Movement Disorders Unit, Neurology Service, Institut Clínic de Neurociències, Hospital Clínic de Barcelona, Barcelona, Spain. · Department of Medicine, Universitat de Barcelona, IDIBAPS, Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED) Barcelona, Spain. · Movement Disorders Clinic, Clinical Neurodegenerative Research Unit, Mexico City, Mexico. · Instituto Nacional de Neurología y Neurocirugía, Mexico City, Mexico. · Department of Neurology, Columbia University Medical Center, New York, New York, USA. · Department of Neurology, McGill University, Montreal General Hospital, Montreal, Quebec, Canada. · Klinik für Neurologie, UKSH, Campus Kiel, Christian-Albrechts-Universität, Kiel, Germany. · Institute for Neurodegenerative Disorders, New Haven, Connecticut, USA. · Department of Neurology, University of Alabama at Birmingham, Birmingham, Alabama, USA. · Department of Physiology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA. · Departments of Neurology and Neuroscience, Mount Sinai School of Medicine, New York, New York, USA. · Research Center for Brain Repair, Rush University Medical Center, Chicago, Illinois, USA. · Neuroscience Graduate Program, Rush University Medical Center, Chicago, Illinois, USA. · Neurological Clinic, Department of Medicine, Hospital Santa Maria della Misericordia, University of Perugia, Perugia, Italy. · Laboratory of Neurophysiology, Santa Lucia Foundation, IRCCS, Rome, Italy. · University Department of Clinical Neurosciences, UCL Institute of Neurology, University College London, London, UK. · Pacific Parkinson's Research Centre, Division of Neurology & Djavadf Mowafaghian Centre for Brain Health, University of British Columbia, British Columbia, Canada. · Vancouver Coastal Health, Vancouver, British Columbia, Canada. · Pubmed 28887905
  • Motac Neuroscience Ltd, Manchester, United Kingdom. Electronic address: · Motac Neuroscience Ltd, Manchester, United Kingdom; Univ. de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France; CNRS, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France. · Pubmed 28764902
  • Department of Psychiatry and Behavioural and Clinical Neurosciences Institute, University of Cambridge, Cambridge, UK; Cambridgeshire and Peterborough NHS Foundation Trust, Cambridge, UK. Electronic address: · Departments of Pharmacology and Psychiatry, Center for Compulsive Behavior and Addiction, Rush University Medical Center, Chicago, IL, USA. · Department of Cognitive, Linguistic and Psychological Sciences and Department of Psychiatry and Human Behavior, Brown Institute for Brain Science, Providence, RI, USA. · Institut des Sciences Cognitives Marc Jeannerod, CNRS, Bron, France; Université Claude Bernard Lyon 1, Villeurbanne, France. · Departments of Neuroscience, Psychiatry and Psychology, University of Pittsburgh, Pittsburgh, PA, USA. · Biodonostia Health Research Institute, University Hospital Donostia, and Basque Center on Cognition, Brain and Language, San Sebastián, Spain; Ikerbasque-Basque Foundation for Science, Bilbao, Spain; Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas, Instituto Carlos III, Spain. · Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas, Instituto Carlos III, Spain; HM Centro Integral de Neurociencias, HM Puerta del Sur, Mostoles and Centro de Estudios Universitarios-San Pablo University, Madrid, Spain. · Université de Bordeaux, Institut des Maladies Neurodégénératives, Bordeaux, France; Centre National de la Recherche Scientifique, Institut des Maladies Neurodégénératives, Bordeaux, France. · Pubmed 28229895
  • Université de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, Bordeaux, France; CNRS, Institut des Maladies Neurodégénératives, UMR 5293, Bordeaux, France. · GAIA Research Center, Bioanalytical Department, The Goulandris Natural History Museum, Kifissia 14562, Greece. · National and Kapodistrian University of Athens Medical School, Department of Internal Medicine, 75 Mikras Asias Street, Athens 11527, Greece. · Université de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, Bordeaux, France; CNRS, Institut des Maladies Neurodégénératives, UMR 5293, Bordeaux, France. Electronic address: · GAIA Research Center, Bioanalytical Department, The Goulandris Natural History Museum, Kifissia 14562, Greece; National and Kapodistrian University of Athens Medical School, Department of Pharmacology, 75 Mikras Asias Street, Athens 11527, Greece. Electronic address: · Pubmed 26209472
  • University de Bordeaux, Institut des Maladies Neurodégénératives Bordeaux, France. · CNRS, Institut des Maladies Neurodégénératives, Bordeaux, France. · CHU Bordeaux, Service de Biologie de la reproduction-CECOS, Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France. · University de Bordeaux, Interdisciplinary Institute for Neuroscience, Bordeaux, France. · CNRS, Institut Interdisciplinaire de Neurosciences, Bordeaux, France. · Pubmed 28853717
  • Motac Neuroscience Ltd, Manchester, United Kingdom. Electronic address: · Motac Neuroscience Ltd, Manchester, United Kingdom; Institute of Laboratory Animal Sciences, China Academy of Medical Sciences, Beijing, China. · Department of Biomedical Sciences, Section of Toxicology, University of Cagliari, University Campus, SS554 km 4.5, 09042 Monserrato, Italy. · Department of Biomedical Sciences, Section of Physiology, University of Cagliari, University Campus, SS554 km 4.5, 09042 Monserrato, Italy. · Motac Neuroscience Ltd, Manchester, United Kingdom; Institute of Laboratory Animal Sciences, China Academy of Medical Sciences, Beijing, China; Univ. de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France; CNRS, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France. · Pubmed 28739086
  • Department of Anatomy and Neurosciences, VU University Medical Center, Amsterdam Neuroscience, 1081 BT Amsterdam, The Netherlands. · Ernst Strüngmann Institut for Neuroscience in Cooperation with Max Planck Society, 60528 Frankfurt am Main, Germany. · Université de Bordeaux, Institut des Maladies Neurodégénératives, Unité Mixte de Recherche 5293, F-33000 Bordeaux, France. · Centre National de la Recherche Scientifique, Institut des Maladies Neurodégénératives, Unité Mixte de Recherche 5293, F-33000 Bordeaux, France, and. · Department of Neurology, VU University Medical Center, Amsterdam Neuroscience, 1081 HV Amsterdam, The Netherlands. · Department of Anatomy and Neurosciences, VU University Medical Center, Amsterdam Neuroscience, 1081 BT Amsterdam, The Netherlands, · Pubmed 28687605
  • Univ. de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, F-33000, Bordeaux, France. · CNRS, Institut des Maladies Neurodégénératives, UMR 5293, F-33000, Bordeaux, France. · Motac neuroscience Ltd, Manchester, UK. · Institute of Lab Animal Sciences, China Academy of Medical Sciences, Beijing, China. · Department of Biomedical and Molecular Sciences, Queen's University, Kingston, Canada. · Univ. de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, F-33000, Bordeaux, France. · CNRS, Institut des Maladies Neurodégénératives, UMR 5293, F-33000, Bordeaux, France. · Motac neuroscience Ltd, Manchester, UK. · Institute of Lab Animal Sciences, China Academy of Medical Sciences, Beijing, China. · Pubmed 28539659
  • UMR 5293, Institut des Maladies Neurodégénératives, Université de Bordeaux, 33076 Bordeaux, France. · CNRS, UMR 5293, Institut des Maladies Neurodégénératives, 33076 Bordeaux, France. · Vall d'Hebron Research Institute, CIBERNED and Catalan Institution for Research and Advanced Studies (ICREA), Autonomous University of Barcelona (UAB), Barcelona, Spain. · UMR 5297, Interdisciplinary Institute of Neurosciences, Université de Bordeaux, 33076 Bordeaux, France. · CNRS, UMR 5297, Interdisciplinary Institute of Neurosciences, 33076 Bordeaux, France. · Neurodegenerative Disease Department, Merck Serono Institute, Geneva, Switzerland. · Pubmed 28520872
  • Departamento de Neurociencias, Achucarro Basque Center for Neuroscience, Universidad del País Vasco (UPV/EHU) and Centro de Investigación Biomédica en Red en Enfermedades Neurodegenerativas (CIBERNED), S-48940 Leioa, Spain. · ImmuSmol, F-33600 Pessac, France. · Univ. de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France; CNRS, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France. · Univ. de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France; CNRS, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France; INSERM U1084 Laboratoire de Neurosciences Experimentales et Cliniques, F-86000 Poitiers, France. · HM Centro Integral de Neurociencias A.C. (CINAC), HM Puerta del Sur and CIBERNED and CEU-San Pablo University Madrid, E-28938 Mostoles, Spain. · Univ. de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France; CNRS, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France; Motac Neuroscience, UK-M15 6WE Manchester, UK. Electronic address: · Pubmed 28411117
  • Neuroscience Therapeutic Area, New Medicines, UCB Biopharma SPRL, 1420 Braine l'Alleud, Belgium. · Univ. de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, Bordeaux, 33000, France. · CNRS, Institut des Maladies Neurodégénératives, UMR 5293, Bordeaux, 33000, France. · Pubmed 28407359
  • Univ. de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France. · CNRS, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France. · Pubmed 28374864
  • Department of Medicinal Chemistry and Molecular Pharmacology, Purdue University, West Lafayette, IN, USA. · Purdue Institute for Integrative Neuroscience, Purdue University, West Lafayette, IN, USA. · Université de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, Bordeaux, France. · CNRS, Institut des Maladies Neurodégénératives, UMR 5293, Bordeaux, France. · Department of Neurology, Massachusetts Alzheimer's Disease Research Center, Massachusetts General Hospital, Charlestown, MA, USA. · Department of Statistics, Purdue University, West Lafayette, IN, USA. · Department of Biological and Experimental Psychology, School of Biological and Chemical Sciences, Queen Mary University of London, London, UK. · Department of Medicinal Chemistry and Molecular Pharmacology, Purdue University, West Lafayette, IN, USA. · Purdue Institute for Integrative Neuroscience, Purdue University, West Lafayette, IN, USA. · Pubmed 28069058
2016
  • Université de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, Bordeaux, France. · CNRS, Institut des Maladies Neurodégénératives, UMR 5293, Bordeaux, France. · Telethon Institute of Genetics and Medicine, Pozzuoli, Italy. · Department of Neurology, University Hospital Bordeaux, Bordeaux, France. · Pubmed 26926119
  • Université de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, Bordeaux, France. · CNRS, Institut des Maladies Neurodégénératives, UMR 5293, Bordeaux, France. · Neurodegenerative Diseases Research Group, Vall d'Hebron Research Institute, Centro Investigación Biomédica en Red Enfermedades Neurodegenerativas, Barcelona, Spain. · Department of Biochemistry and Molecular Biology, Autonomous University of Barcelona, Bellaterra, Barcelona, Spain. · Catalan Institution for Research and Advanced Studies, Barcelona, Spain. · Laboratory for Translational Parkinson's Disease Research, Center for Neurodegenerative Science, Van Andel Research Institute, Grand Rapids, Michigan, USA. · Department of Neurological Sciences, The Graduate College, Rush University, Chicago, Illinois, USA. · Pubmed 26347034
  • Université de Bordeaux, Institut des Maladies Neurodégénératives, Bordeaux, France. · CNRS, Institut des Maladies Neurodégénératives, UMR 5293, Bordeaux, France. · Service de Neurologie, CHU de Bordeaux, Bordeaux, France. · NS-Park/FCRIN Network, UMS 015, Toulouse, France. · Addex Pharma SA, Plan Les Ouates, Switzerland. · NS-Park/FCRIN Network, UMS 015, Toulouse, France. · Neurology Service, A, Hôpital Gabriel Montpied, Clermont Ferrand, France. · Sorbonne Universités and UPMC Univ Paris 06, INSERM UMRS-1127 and CIC-1422; CNRS UMR-7225; AP-HP; and ICM, Hôpital Pitié-Salpêtrière, Paris, France. · Universitätsklinikum Giessen und Marburg, Klinik für Neurologie, Marburg, Germany. · Department of Neurology USC/Keck School of Medicine, Los Angeles, California, USA. · Parkinson's Disease and Movement Disorders Center of Boca Raton, Boca Raton, Florida, USA. · Université de Bordeaux, Institut des Maladies Neurodégénératives, Bordeaux, France. · CNRS, Institut des Maladies Neurodégénératives, UMR 5293, Bordeaux, France. · Rush University Medical Center, Dept. of Neurological Sciences, Movement Disorder Section, Chicago, Illinois, USA. · Paracelsus Elena Klinik, centre for Parkinson's Disease & Movement Disorders, Kassel, Germany. · CIC9302, Departments of Clinical Pharmacology and Neurosciences and NeuroToul COEN Center; INSERM, University Hospital of Toulouse and University of Toulouse 3, Toulouse, France. · Pubmed 27214664
  • Motac Neuroscience Ltd, Manchester, United Kingdom. Electronic address: · Motac Neuroscience Ltd, Manchester, United Kingdom. · Motac Neuroscience Ltd, Manchester, United Kingdom; Univ. de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France; CNRS, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France. · Pubmed 27424102
  • Univ. de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, F-33000, Bordeaux, France; CNRS, Institut des Maladies Neurodégénératives, UMR 5293, F-33000, Bordeaux, France. · Service de neurologie de l'hôpital de Poitiers, F-86021, Poitiers, France; Université de Poitiers, F-86000, Poitiers, France; CIC INSERM 1402, CHU de Poitiers, Poitiers, France. · Université de Poitiers, F-86000, Poitiers, France; CIC INSERM 1402, CHU de Poitiers, Poitiers, France; INSERM U1084 Laboratoire de Neurosciences Experimentales et Cliniques, F-86000, Poitiers, France. · INSERM U1084 Laboratoire de Neurosciences Experimentales et Cliniques, F-86000, Poitiers, France; Department of Pharmacology, University of Cambridge, CB2 1PD, Cambridge, UK; Behavioural and Clinical Neuroscience Institute of the University of Cambridge, CB2 3ED, Cambridge, UK. · Univ. de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, F-33000, Bordeaux, France; CNRS, Institut des Maladies Neurodégénératives, UMR 5293, F-33000, Bordeaux, France. Electronic address: · Pubmed 27216859
  • Department of Medical Sciences, Section of Pharmacology, University of Ferrara, via Fossato di Mortara 17-19, 44121 Ferrara, Italy; Neuroscience Center and National Institute of Neuroscience, University of Ferrara, via Fossato di Mortara 17-19, 44121 Ferrara, Italy. · Department of Biomedical and Specialty Surgical Sciences, Section of Human Physiology, University of Ferrara, via Fossato di Mortara 19, 44121 Ferrara, Italy. · Université de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France; CNRS, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France. · Astraea Therapeutics, 320 Logue Avenue, Mountain View, CA 94040, USA. · Department of Medical Sciences, Section of Pharmacology, University of Ferrara, via Fossato di Mortara 17-19, 44121 Ferrara, Italy; Neuroscience Center and National Institute of Neuroscience, University of Ferrara, via Fossato di Mortara 17-19, 44121 Ferrara, Italy. Electronic address: · Pubmed 26804029
  • Cynbiose, Marcy l'Etoile, France. · Univ. de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, 33000, Bordeaux, France. · CNRS, Institut des Maladies Neurodégénératives, UMR 5293, 33000, Bordeaux, France. · Institute of Materia Medica, Chinese Academy of Medical Sciences, Beijing, People's Republic of China, 100050. · Motac Neuroscience, Manchester, United Kingdom. · Institute of Laboratory Animal Sciences, China Academy of Medical Sciences, Beijing, People's Republic of China. · Pubmed 26799359
  • a University de Bordeaux, Institut des Maladies Neurodégénératives , UMR 5293, Bordeaux , France. · b CNRS, Institut des Maladies Neurodégénératives , UMR 5293, Bordeaux , France. · c University de Bordeaux, Institut des Sciences Moléculaires , UMR 5255, Talence , France. · Pubmed 26761717
  • Neuroscience Therapeutic Area, New Medicines, UCB Biopharma SPRL, 1420 Braine L'alleud, Belgium. · University De Bordeaux, Institut Des Maladies Neurodégénératives, UMR 5293, Bordeaux, 33000, France. · CNRS, Institut Des Maladies Neurodégénératives, UMR 5293, Bordeaux, 33000, France. · Pubmed 26695835
  • Univ. De Bordeaux, Institut Des Maladies Neurodégénératives, Bordeaux, France. · Institut Des Maladies Neurodégénératives, CNRS, Bordeaux, France. · Pubmed 26583879
  • Univ. de Bordeaux, Institut des Maladies Neurodégénératives,UMR 5293,33000 Bordeaux,France; CNRS,Institut des Maladies Neurodégénératives,UMR 5293,33000 Bordeaux,France. · Pubmed 26480869
2015
  • Univ. de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, 33000 Bordeaux, France; CNRS, Institut des Maladies Neurodégénératives, UMR 5293, 33000 Bordeaux, France. · Univ. de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, 33000 Bordeaux, France; CNRS, Institut des Maladies Neurodégénératives, UMR 5293, 33000 Bordeaux, France; Department of Neurology, University Hospital Bordeaux, France. · Laboratory of Neurophysiology, Fondazione Santa Lucia, IRCCS, Rome, Italy. · Division of Neuroscience, Institute of Experimental Neurology, San Raffaele Scientific Institute, 20132 Milan, Italy. · Department of Neuroscience, Karolinska Institutet, Stockholm, Sweden. · Basal Ganglia Pathophysiology Unit, Department of Experimental Medical Science, Lund University, Lund, Sweden. · Department of Neurology, Columbia University, New York, USA. · Pacific Parkinson's Research Centre and National Parkinson Foundation Centre of Excellence, University of British Columbia, Vancouver, Canada. · Department of Biomedical Sciences, Section of Neuropsychopharmacology, Cagliari University, 09124 Cagliari, Italy. · Univ. de Bordeaux, Institut Interdisciplinaire de neurosciences, UMR 5297, 33000 Bordeaux, France; CNRS, Institut Interdisciplinaire de neurosciences, UMR 5297, 33000 Bordeaux, France. · Department of Neurology, Hospital Universitario Donostia and Neuroscience Unit, Bio Donostia Research Institute, San Sebastian, Spain. · Department of Pharmacology, Vanderbilt University Medical Center, Nashville, TN 37232, USA. · Center for Health Sciences, SRI International, CA 94025, USA. · Department of Medical Sciences, Section of Pharmacology, University of Ferrara, Ferrara, Italy. · Dipartimento di Scienze Farmacologiche e Biomolecolari, Università degli Studi di Milano, 20133 Milano, Italy. · Department of Biomedical Sciences, Physiology Section, Cagliari University, Cagliari, Italy. · Motac Neuroscience Ltd, Manchester, UK. · Michigan State University, College of Human Medicine, Department of Translational Science and Molecular Medicine & The Udall Center of Excellence in Parkinson's Disease Research, 333 Bostwick Ave NE, Grand Rapids, MI 49503, USA. · Morton & Gloria Shulman Movement Disorders Center, Toronto Western Hospital, Toronto, Ontario M4T 2S8, Canada. · Univ. de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, 33000 Bordeaux, France; CNRS, Institut des Maladies Neurodégénératives, UMR 5293, 33000 Bordeaux, France; Motac Neuroscience Ltd, Manchester, UK. Electronic address: · Pubmed 26209473
  • Motac Neuroscience Ltd, Manchester, United Kingdom. · Motac Neuroscience Ltd, Manchester, United Kingdom; Univ. de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France; CNRS, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France. · Pubmed 26135120
  • Institute of Neurodegenerative Diseases, University of Bordeaux, Centre National de la Recherche Scientifique Unité Mixte de Recherche 5293, 33076 Bordeaux, France. · Research Unit of Theoretical & Applied Economics, University of Bordeaux, Centre National de la Recherche Scientifique Unité Mixte de Recherche 5113, 33608 Pessac, France. · Departments of Neurology, Pathology and Cell Biology, and the Center for Motor Neuron Biology and Disease, Columbia University, New York, NY 10032, USA. · Neurodegenerative Diseases Research Group, Vall d'Hebron Research Institute, Centro Investigación Biomédica en Red Enfermedades Neurodegenerativas, 08035 Barcelona, Spain. · Department of Biochemistry and Molecular Biology, Autonomous University of Barcelona, 08193 Bellaterra, Barcelona, Spain. · Catalan Institution for Research and Advanced Studies, 08010 Barcelona, Spain. · ICM, Paris, France; Sorbonne Universités. · UPMC Université Paris 06, UM 75, ICM, Paris, France. · CNRS, UMR 7225, ICM, Paris, France. · Inserm, U 1127, ICM, Paris, France. · Molecular Genetics Section and Laboratory of Neurogenetics, NIA, NIH, Bethesda, MD20892, USA. · Departments of Neurology and Neuroscience, Mount Sinai School of Medicine, New York, NY 10032, USA. · TransThera Consulting Co., Zionsville, IN, 46077, USA. · Department of Neurology and Feil Family Brain and Mind research Institute, Weill Cornell Medical College, New York NY 10021, USA. · Pubmed 26050140
  • Departments of Cell Biology, · Institut des Maladies Neurodégénératives, UMR 5293, Université de Bordeaux, 33000 Bordeaux, France; Institut des Maladies Neurodégénératives, UMR 5293, CNRS, 33000 Bordeaux, France; · Departments of Cell Biology. · Department of Pharmacology and Toxicology, University at Buffalo, The State Uiversity of New York, Buffalo, NY 14260; and. · Departments of Cell Biology, Institute of Translational Biomedicine, St. Petersburg State University, St. Petersburg, 199034, Russia. · Departments of Cell Biology, Medicine, and Neurobiology, Duke University Medical Center, Durham NC 27710; · Pubmed 25918399
  • Department of Biomedical Sciences, Section of Physiology, University of Cagliari, University Campus, SS554 km 4.5, 09042 Monserrato, Italy. · Univ. de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France; CNRS, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France; Motac Neuroscience, Manchester, UK. · Motac Neuroscience, Manchester, UK; Institute of Lab Animal Sciences, China Academy of Medical Sciences, Beijing, China. · Institute of Lab Animal Sciences, China Academy of Medical Sciences, Beijing, China. · Univ. de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France; CNRS, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France; Motac Neuroscience, Manchester, UK; Institute of Lab Animal Sciences, China Academy of Medical Sciences, Beijing, China. · Department of Biomedical Sciences, Section of Physiology, University of Cagliari, University Campus, SS554 km 4.5, 09042 Monserrato, Italy. Electronic address: · Pubmed 25907446
  • 1 Univ. de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France 2 CNRS, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France · 3 Department of Biomedical Sciences, Section of Physiology, University of Cagliari, University Campus, SS554 km 4.5, 09042 Monserrato, Italy. · Pubmed 25669729
  • Univ. de Bordeaux, UMR 5293, F-33000 Bordeaux, France CNRS, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France. · Institute of Lab Animal Sciences, China Academy of Medical Sciences, Beijing 100101, China. · Univ. de Bordeaux, UMR 5293, F-33000 Bordeaux, France CNRS, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France Institute of Lab Animal Sciences, China Academy of Medical Sciences, Beijing 100101, China. · Pubmed 24770706
2014
  • Institut des Maladies Neurodégénératives, Université de Bordeaux, UMR 5293 Bordeaux, France ; CNRS, Institut des Maladies Neurodégénératives, UMR 5293 Bordeaux, France. · Pubmed 25177278
  • Department of Clinical Neurosciences, UCL Institute of Neurology, London, UK. Electronic address: · Departments of Neurology and Neuroscience, Mount Sinai School of Medicine, New York, NY, USA. · Pittsburgh Institute for Neurodegenerative Diseases, University of Pittsburgh, Pittsburgh, PA 15260, USA. · Université de Bordeaux, Institut des Maladies Neurodégénératives, 33000 Bordeaux, France; CNRS, Institut des Maladies Neurodégénératives, 33000 Bordeaux, France. · Pubmed 24954676
  • Univ. de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France; CNRS, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France. · CHU de Bordeaux, Unité de Soutien Méthodologique à la Recherche Clinique (USMR), Pôle de santé publique, Bordeaux, France. · Univ. de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France; CNRS, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France; Service de Neurologie, CHU de Bordeaux, F-33604 Pessac, France. · Centre de référence atrophie multisystématisée, CHU de Toulouse, Toulouse, France. · Centre de référence atrophie multisystématisée, CHU de Toulouse, Toulouse, France; Department of Clinical Pharmacology, University Hospital and University of Toulouse 3, Toulouse, France; Department of Neurosciences, University Hospital and University of Toulouse 3, Toulouse, France; INSERM UMR825 and CIC9302, Toulouse, France. · Univ. de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France; CNRS, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France; Service de Neurologie, CHU de Bordeaux, F-33604 Pessac, France; Centre de référence atrophie multisystématisée, CHU de Bordeaux, Pessac, France. · Univ. de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France; CNRS, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France; Service de Neurologie, CHU de Bordeaux, F-33604 Pessac, France; Centre de référence atrophie multisystématisée, CHU de Bordeaux, Pessac, France. Electronic address: · Pubmed 24727096
  • Faculty of Life Sciences, University of Manchester, Manchester, UK; Univ. de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France; CNRS, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France. Electronic address: · Univ. de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France; CNRS, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France. · Faculty of Life Sciences, University of Manchester, Manchester, UK. · Pubmed 24969021
  • Motac Neuroscience Ltd., Manchester, United Kingdom; Université de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, Bordeaux F-33000, France; CNRS, Institut des Maladies Neurodégénératives, UMR 5293, Bordeaux F-33000, France. · Institute of Laboratory Animal Sciences, China Academy of Medical Sciences, Beijing, China. · Motac Neuroscience Ltd., Manchester, United Kingdom; Université de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, Bordeaux F-33000, France; CNRS, Institut des Maladies Neurodégénératives, UMR 5293, Bordeaux F-33000, France; Institute of Laboratory Animal Sciences, China Academy of Medical Sciences, Beijing, China. Electronic address: · Pubmed 24572591
  • 1] Univ. de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, 33000 Bordeaux, France [2] CNRS, Institut des Maladies Neurodégénératives, UMR 5293, 33000 Bordeaux, France [3] Motac neuroscience, Manchester, UK. · 1] Univ. de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, 33000 Bordeaux, France [2] CNRS, Institut des Maladies Neurodégénératives, UMR 5293, 33000 Bordeaux, France. · 1] Motac neuroscience, Manchester, UK [2] Institute of Laboratory Animal Sciences, China Academy of Medical Sciences, Beijing, China. · Department of Life Sciences and Biotechnology (SVeB), University of Ferrara, Ferrara, Italy. · Institute of Pharmacology and Toxicology, Charité Campus Mitte, Humboldt University, 10117 Berlin, Germany. · 1] Univ. de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, 33000 Bordeaux, France [2] CNRS, Institut des Maladies Neurodégénératives, UMR 5293, 33000 Bordeaux, France [3] Motac neuroscience, Manchester, UK [4] Institute of Laboratory Animal Sciences, China Academy of Medical Sciences, Beijing, China [5] Service de Neurologie, Centre Expert Parkinson, CHU de Bordeaux, 33076 Bordeaux, France. · Department of Medical Sciences, Section of Pharmacology, University of Ferrara, Ferrara, Italy. · 1] Univ. de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, 33000 Bordeaux, France [2] CNRS, Institut des Maladies Neurodégénératives, UMR 5293, 33000 Bordeaux, France [3] Service de Neurologie, Centre Expert Parkinson, CHU de Bordeaux, 33076 Bordeaux, France [4] Centre de référence AMS, CHU de Bordeaux, 33076 Bordeaux, France. · Pubmed 24429495
  • Université de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, Bordeaux, France; CNRS, Institut des Maladies Neurodégénératives, UMR 5293, Bordeaux, France. Electronic address: · Université de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, Bordeaux, France; CNRS, Institut des Maladies Neurodégénératives, UMR 5293, Bordeaux, France. Electronic address: · Université de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, Bordeaux, France; CNRS, Institut des Maladies Neurodégénératives, UMR 5293, Bordeaux, France; Service de Neurologie, CHU de Bordeaux Haut-Lévêque, Pessac, France. Electronic address: · Université de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, Bordeaux, France; CNRS, Institut des Maladies Neurodégénératives, UMR 5293, Bordeaux, France; Institute of Laboratory Animal Sciences, China Academy of Medical Sciences, Beijing, China. Electronic address: · Université de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, Bordeaux, France; CNRS, Institut des Maladies Neurodégénératives, UMR 5293, Bordeaux, France; Département de Neurophysiologie Clinique, CHU de Bordeaux Pellegrin, Bordeaux, France. Electronic address: · Pubmed 24211719
  • Université de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, Bordeaux, France; CNRS, Institut des Maladies Neurodégénératives, UMR 5293, Bordeaux, France. · Department of Pharmaceutical Biosciences, Biomolecular Imaging and Proteomics, Uppsala University, Box 591, SE-75124 Uppsala, Sweden. · Motac Neuroscience, Manchester, UK; Institute of Laboratory Animal Sciences, China Academy of Medical Sciences, Beijing, China. · Motac Neuroscience, Manchester, UK. · Université de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, Bordeaux, France; CNRS, Institut des Maladies Neurodégénératives, UMR 5293, Bordeaux, France; Motac Neuroscience, Manchester, UK; Institute of Laboratory Animal Sciences, China Academy of Medical Sciences, Beijing, China. Electronic address: · Pubmed 24148855
2013
  • Univ. de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France; CNRS, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France; Institute of Lab Animal Sciences, China Academy of Medical Sciences, Beijing, China. · Pubmed 24135129
  • Univ. de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France; CNRS, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France. · Univ. de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France; CNRS, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France; Service de Neurologie, CHU de Bordeaux, F-33604 Pessac, France. · Univ. de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France; CNRS, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France. Electronic address: · Pubmed 22940424
2011
  • Insitute of Neurodegenerative Diseases, Université Victor Ségalen-Bordeaux II, Centre National de la Recherche Scientifique, Bordeaux, France. · Pubmed 21626544
2010
  • Universite Victor Segalen-Bordeaux 2, Centre National de la Recherche Scientifique, Bordeaux Institute of Neuroscience, UMR 5227 Bordeaux, France. · Pubmed 20105227
2019
  • Service de Neurologie, Hôpital Pellegrin, CHU de Bordeaux, 33000, Bordeaux, France. · Institut des Maladies Neurodégénératives, Université de Bordeaux, UMR 5293, 146 rue Léo Saignat, 33000, Bordeaux Cedex, France. · CNRS, Institut des Maladies Neurodégénératives, UMR 5293, 33000, Bordeaux, France. · Institute of Laboratory Animal Sciences, China Academy of Medical Sciences, Beijing, China. · Motac Neuroscience, Manchester, UK. · CIC Toulouse, Toulouse, France. · Départements de Pharmacologie Clinique et Neurosciences, INSERM CIC9302, CHU de Toulouse, Toulouse, France. · Service de Pharmacologie, Faculté de Médecine, CHU de Toulouse, Université de Toulouse, Toulouse, France. · Service de Neurologie, Hôpital Pellegrin, CHU de Bordeaux, 33000, Bordeaux, France. · Institut des Maladies Neurodégénératives, Université de Bordeaux, UMR 5293, 146 rue Léo Saignat, 33000, Bordeaux Cedex, France. · CNRS, Institut des Maladies Neurodégénératives, UMR 5293, 33000, Bordeaux, France. · Department Medicine, University of Otago, Christchurch, New Zealand. · New Zealand Brain Research Institute, Christchurch, New Zealand. · Pubmed 31098725
2017
  • Ceinge Biotecnologie Avanzate, Naples, Italy. · Department of Molecular Medicine and Medical Biotechnology, University of Naples Federico II, Naples, Italy. · Department of Pharmacology, Vanderbilt University, Nashville, TN, United States of America. · Department of Biology Unit of Cell and Developmental Biology, University of Pisa, Pisa, Italy. · Department of Environmental, Biological and Pharmaceutical Sciences and Technologies, University of Campania, Luigi Vanvitelli, Italy. · Motac Neuroscience, UK-M15 6WE, Manchester, United Kingdom. · Institute of Lab Animal Sciences, China Academy of Medical Sciences, Beijing, China. · Université de Bordeaux, Institut des Maladies Neurodégénératives,Bordeaux, France. · Centre National de la Recherche Scientifique Unité Mixte de Recherche 5293, Institut des Maladies Neurodégénératives, Bordeaux, France. · IRCSS Casa Sollievo della Sofferenza, ISBReMIT-Institute for Stem Cell Biology, Regenerative Medicine and Innovative Therapies, San Giovanni Rotondo, Italy. · Department of Medicine, University of Perugia and Clinica Neurologica, Santa Maria della Misericordia Hospital, Perugia, Italy. · National Research Council of Italy (CNR), Neuroscience Institute, Cagliari, Italy. · Department of Biomedical Sciences, section of Neuropsychopharmacology, University of Cagliari, Cagliari, Italy. · Center for Neuroscience and Cognitive Systems, Istituto Italiano di Tecnologia, Rovereto, TN, Italy. · Neuroscience Institute, National Research Council (CNR), Pisa, Italy. · Pubmed 28742811
  • Department of Clinical Neurosciences, Institute of Neurology, University College London, NW3 2PF, United Kingdom. · Motac Neuroscience, Manchester, United Kingdom. · Institute of Laboratory Animal Sciences, China Academy of Medical Sciences, Beijing City, People's Republic of China. · University de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, Bordeaux, F-33000, France. · CNRS, Institut des Maladies Neurodégénératives, UMR 5293, Bordeaux, F-33000, France. · Pubmed 28295625
2016
  • National Research Council of Italy, Neuroscience Institute, Cagliari, Italy. · Motac Neuroscience Ltd, Manchester, UK. · Institute of Laboratory Animal Sciences, China Academy of Medical Sciences, Beijing, China. · Department of Biomedical Sciences, section of Neuropsychopharmacology, University of Cagliari, Cagliari, Italy. · Department of Biomedical Sciences, section of Physiology, University of Cagliari, Cagliari, Italy. · Department of Chemical and Pharmaceutical Sciences, University of Ferrara, Ferrara, Italy. · Université de Bordeaux, Institut des Maladies Neurodégénératives, Bordeaux, France. · CNRS, Institut des Maladies Neurodégénératives, Bordeaux, France. · Pubmed 26871939
2014
  • Institute of Neurodegenerative Diseases, University of Bordeaux, Centre National de la Recherche Scientifique Unité Mixte de Recherche, Bordeaux, France. · Pubmed 25214445
  • Université Bordeaux; CNRS, Institut des Maladies Neurodégénératives, Bordeaux, France; Department of Pathology, Bordeaux University Hospital, Bordeaux, France. · Pubmed 24494664
2012
  • Institut des Maladies Neurodégénératives, Université de Bordeaux, CNRS UMR 5293, Bordeaux, France. · Pubmed 22885599
  • Insitute of Neurodegenerative Diseases, University of Bordeaux Segalen, Centre National de la Recherche Scientifique Unité Mixte de Recherche 5293, 33076 Bordeaux, France. · Pubmed 22647602
  • University de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293 Bordeaux, France; CNRS, Institut des Maladiesw Neurodégénératives, UMR 5293 Bordeaux, France. · Pubmed 22393538
2011
  • Université Victor Ségalen-Bordeaux II, Centre National de la Recherche Scientifique, Institute of Neurodegenerative Diseases, Bordeaux, France. · Pubmed 22046592
2010
  • Centre National de la Recherche Scientifique UMR 5227, Bordeaux Institute of Neuroscience, Université Victor-Segalen Bordeaux 2 Bordeaux, France. · Pubmed 20890450
Universite de Bordeaux
2020
  • Centre National de la Recherche Scientifique, Université de Strasbourg, Institut des Neurosciences Cellulaires et Intégratives, F-67000 Strasbourg, France. · Centre National de la Recherche Scientifique, Université de Strasbourg, Institut des Neurosciences Cellulaires et Intégratives, F-67000 Strasbourg, France; Unitat Predepartemental de Medicina, Universitat Jaume I Castelló de la Plana, Spain. · Université de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France; Centre National de la Recherche Scientifique, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France. · Centre National de la Recherche Scientifique, Université de Strasbourg, Institut des Neurosciences Cellulaires et Intégratives, F-67000 Strasbourg, France; Department of Endocrinology and Metabolism, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, Netherlands. · Centre National de la Recherche Scientifique, Université de Strasbourg, Institut des Neurosciences Cellulaires et Intégratives, F-67000 Strasbourg, France. Electronic address: · Pubmed 32087289
  • Medical Mass Spectrometry Imaging, Department of Pharmaceutical Biosciences, Uppsala University, Uppsala, Sweden; Science for Life Laboratory, National Resource for Mass Spectrometry Imaging, Uppsala University, Uppsala, Sweden. · Medical Mass Spectrometry Imaging, Department of Pharmaceutical Biosciences, Uppsala University, Uppsala, Sweden. · Section of Neurology, Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden. · Université de Bordeaux, Institut des Maladies Neurodégénératives, Bordeaux, France; Centre National de la Recherche Scientifique, Institut des Maladies Neurodégénératives, Bordeaux, France. · Medical Mass Spectrometry Imaging, Department of Pharmaceutical Biosciences, Uppsala University, Uppsala, Sweden; Science for Life Laboratory, National Resource for Mass Spectrometry Imaging, Uppsala University, Uppsala, Sweden. Electronic address: · Pubmed 31927144
2019
  • Centre National de la Recherche Scientifique, Université de Strasbourg, Institut des Neurosciences Cellulaires et Intégratives, F-67000 Strasbourg, France. · Université de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France; Centre National de la Recherche Scientifique, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France. · Centre National de la Recherche Scientifique, Université de Strasbourg, Institut des Neurosciences Cellulaires et Intégratives, F-67000 Strasbourg, France. Electronic address: · Pubmed 30365972
  • Medical Mass Spectrometry Imaging, Department of Pharmaceutical Biosciences, Uppsala University, Uppsala, Sweden. · Science for Life Laboratory, National Resource for Mass Spectrometry Imaging, Uppsala University, Uppsala, Sweden. · Department of Medicinal Chemistry, Uppsala University, Uppsala, Sweden. · Section of Neurology, Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden. · Institut des Maladies Neurodégénératives, Université de Bordeaux, Bordeaux, France. · Institut des Maladies Neurodégénératives, CNRS, Bordeaux, France. · Department of Medicinal Chemistry, Uppsala University, Uppsala, Sweden. · Medical Mass Spectrometry Imaging, Department of Pharmaceutical Biosciences, Uppsala University, Uppsala, Sweden. · Science for Life Laboratory, National Resource for Mass Spectrometry Imaging, Uppsala University, Uppsala, Sweden. · Pubmed 31548706
  • Université de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France. · CNRS, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France. · Telethon Institute of Genetics and Medicine (TIGEM), Pozzuoli (Naples), Italy. · Department of Translational Medicine, Federico II University, Naples, Italy. · Department of Molecular and Human Genetics, Ian and Dan Duncan Neurological Research Institute, Baylor College of Medicine, Houston, Texas, USA. · Laboratoire de Neurosciences Expérimentales et Cliniques, INSERM U-1084, Université de Poitiers, Poitiers, France. · Service de Neurologie, Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France. · Pubmed 31434803
  • Département des Sciences de l'Activité Physique, Université du Québec à Montréal, Montréal, QC, Canada. · Centre de Recherche de l'Institut Universitaire de Gériatrie de Montréal, Montréal, QC, Canada. · Département de Stomatologie, Faculté de Médecine Dentaire, Université de Montréal, Montréal, QC, Canada. · Département de Médecine, CHU Montréal, Montréal, QC, Canada. · Laboratoire de Neurophysiologie, Université de Bordeaux, Institut des Maladies Neurodégénératives, Bordeaux, France. · Unité Mixte de Recherche 5293, Centre National de la Recherche Scientifique, Institut des Maladies Neurodégénératives, Bordeaux, France. · Département de Réadaptation, Faculté de Médecine, Université Laval, Quebec, QC, Canada. · Department of Clinical Neurosciences, Hotchkiss Brain Institute, University of Calgary, Calgary, AB, Canada. · Pubmed 30967832
  • Dipartimento di Scienze Farmacologiche e Biomolecolari (DiSFeB), Università degli Studi di Milano - La Statale, 20133 Milano, Italy. · Laboratory of Neurophysiology, Santa Lucia Foundation, IRCCS, 00100 Rome, Italy. · Laboratory of Neurophysiology, Santa Lucia Foundation, IRCCS, 00100 Rome, Italy; Department of Philosophy, Human, Social and Educational Sciences, University of Perugia, 06100 Perugia, Italy. · Université de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France; CNRS, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France. · Motac Neuroscience Ltd, Manchester, United Kingdom; Institute of Laboratory Animal Sciences, China Academy of Medical Sciences, Beijing, China. · Laboratory of Neurophysiology, Santa Lucia Foundation, IRCCS, 00100 Rome, Italy; Clinica Neurologica, Università degli studi di Perugia, Ospedale Santa Maria della Misericordia, S. Andrea delle Fratte, 06156 Perugia, Italy. · Université de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France; CNRS, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France; Motac Neuroscience Ltd, Manchester, United Kingdom; Institute of Laboratory Animal Sciences, China Academy of Medical Sciences, Beijing, China. · Experimental Neurophysiology Laboratory, IRCCS San Raffaele Pisana, University San Raffaele, Rome, Italy. · Dipartimento di Scienze Farmacologiche e Biomolecolari (DiSFeB), Università degli Studi di Milano - La Statale, 20133 Milano, Italy. Electronic address: · Pubmed 30261285
2018
  • UC Gardner Neuroscience Institute and Gardner Family Center for Parkinson's Disease and Movement Disorders, Department of Neurology, University of Cincinnati, Cincinnati, OH. · Institute of Molecular and Clinical Sciences, St George's University of London, London, United Kingdom. · Edmond J. Safra Program in Parkinson's Disease, Morton and Gloria Shulman Movement Disorders Clinic, Toronto Western Hospital, University Health Network, Division of Neurology, University of Toronto, Toronto, Ontario, Canada. · Krembil Brain Institute, Toronto, Ontario, Canada. · University of Bordeaux, Institute of Neurodegenerative Diseases, Bordeaux, France. · National Center for Scientific Research, Institute of Neurodegenerative Diseases, Bordeaux, France. · Experimental Neurophysiology Laboratory, IRCCS University San Raffaele Pisana, University San Raffaele, Rome, Italy. · Neurological Clinic, University of Perugia, Santa Maria della Misericordia Hospital, Perugia, Italy. · Pubmed 30357892
  • Research Statistics, Pfizer Worldwide Research and Development, Cambridge, United Kingdom. · Motac Neuroscience, Manchester, United Kingdom. · Internal Medicine Research Unit, Pfizer Worldwide Research and Development, Cambridge, Massachusetts, USA. · Université de Bordeaux, Institut des Maladies Neurodégénératives, Bordeaux, France. · Centre National de la Recherche Scientifique Unité Mixte de Recherche 5293, Institut des Maladies Neurodégénératives, Bordeaux, France. · Pubmed 30288778
  • Department of Medical Sciences, Section of Pharmacology, University of Ferrara, National Institute of Neuroscience, Ferrara, Italy. · Université de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France; CNRS, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France. · Department of Neuroscience, Novartis Institutes for BioMedical Research, Novartis Pharma AG, 4002 Basel, Switzerland. · Department of Medical Sciences, Section of Pharmacology, University of Ferrara, National Institute of Neuroscience, Ferrara, Italy. Electronic address: · Pubmed 30172844
  • Département des Sciences de l'activité physique, Université du Québec à Montréal, Montréal, Québec, Canada. · Centre de Recherche de l'Institut universitaire de gériatrie de Montréal, Montréal, Québec, Canada. · Département de stomatologie, Faculté de médecine dentaire, Université de Montréal, Montréal, QC, Canada. · Département de médecine, CHU Montréal, Montréal, QC, Canada. · Université de Bordeaux, Institut des Maladies Neurodégénératives, F-33000 Bordeaux, France. · Centre National de la Recherche Scientifique Unité Mixte de Recherche 5293, Institut des Maladies Neurodégénératives, F-33000 Bordeaux, France. · Département de réadaptation, Faculté de médecine, Université Laval, Québec, Québec, Canada. · Département de médecine, Faculté de médecine, Université Laval, Québec, Québec, Canada. · Pubmed 29843253
  • Division of Neuroscience, San Raffaele Scientific Institute, 20132 Milan, Italy. · Molecular Neurogenetics Unit, IRCCS Foundation C. Besta Neurological Institute, 20126 Milan, Italy. · IRCCS Institute of Neurological Sciences of Bologna, Bellaria Hospital, Bologna, Italy. · University of Milano-Bicocca, Department of Medicine and Surgery, Monza, Italy. · Division of Neuroscience, San Raffaele Scientific Institute, 20132 Milan, Italy; National Research Council (CNR), Institute of Neuroscience, 20129 Milan, Italy. · Division of Neuroscience, San Raffaele Scientific Institute, 20132 Milan, Italy; University of Milano-Bicocca, Milan, Italy. · Department of Neuroscience, University of Messina, Messina, Italy. · Division of Clinical Haematology-Oncology, European Institute of Oncology, Milan, Italy. · Université de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France. · IRCCS Institute of Neurological Sciences of Bologna, Bellaria Hospital, Bologna, Italy; Neurology Unit, Department of Biomedical and Neuromotor Sciences, University of Bologna, Bologna, Italy. · Division of Neuroscience, San Raffaele Scientific Institute, 20132 Milan, Italy; National Research Council (CNR), Institute of Neuroscience, 20129 Milan, Italy. Electronic address: · Pubmed 29466734
2017
  • HM CINAC, Hospital Universitario HM Puerta del Sur, Mostoles, Madrid, Spain. · Universidad CEU San Pablo, Madrid, Spain. · CIBERNED, Madrid, Spain. · Department of Neurology, Philipps University, Marburg, Germany. · Parkinson's Disease and Movement Disorders Department, HYGEIA Hospital and Attikon Hospital, University of Athens, Athens, Greece. · Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois, USA. · Department of Neurology, Medical University Innsbruck, Innsbruck, Austria. · Morton and Gloria Shulman Movement Disorders Clinic and the Edmond J Safra Program in Parkinson's Disease, Toronto Western Hospital, Toronto, Canada. · Department of Medicine, University of Toronto, Toronto, Canada. · Department of Psychiatry, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA. · Parkinson's Disease and Mental Illness Research, Education and Clinical Centers (PADRECC and MIRECC), Corporal Michael J. Crescenz Veteran's Affairs Medical Center, Philadelphia, Pennsylvania, USA. · Medical Sciences, Newcastle University, Newcastle, UK. · Brain and Mind Centre, Sydney Medical School, The University of Sydney, Sydney, Australia. · School of Medical Sciences, University of New South Wales and Neuroscience Research Australia, Sydney, Australia. · Université de Bordeaux, Institut des Maladies Neurodégénératives, Centre National de la Recherche Scientifique Unité Mixte de Recherche 5293, Institut des Maladies Neurodégénératives, Bordeaux, France. · China Academy of Medical Sciences, Institute of Lab Animal Sciences, Beijing, China. · Departments of Neurology, Pathology, and Cell Biology, the Center for Motor Neuron Biology and Disease, Columbia University, New York, New York, USA. · Columbia Translational Neuroscience Initiative, Columbia University, New York, New York, USA. · Institut du Cerveau et de la Moelle épinière - ICM, Centre de NeuroImagerie de Recherche - CENIR, Sorbonne Universités, UPMC Univ Paris 06, Inserm U1127, CNRS UMR 7225, Paris, France. · Groupe Hospitalier Pitié-Salpêtrière, Paris, France. · Clinical Sciences Department, Newcastle University, Newcastle, UK. · Department of Nuclear Medicine, Aarhus University, Aarhus, Denmark. · Human Neurophysiology, Sobell Department, UCL Institute of Neurology, London, UK. · Human Motor Control Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland, USA. · Department of Neurology, Emory University School of Medicine, Atlanta, Georgia, USA. · Morton and Gloria Shulman Movement Disorders Centre and the Edmond J Safra Program in Parkinson's disease, Toronto Western Hospital, University of Toronto, Toronto, Canada. · Movement Disorders and Neuromodulation Center, Department of Neurology, University of California-San Francisco, San Francisco, California, USA. · Parkinson's Disease Research, Education and Clinical Center, San Francisco Veterans Affairs Medical Center, San Francisco, California, USA. · Veterans Affairs Pacific Islands Health Care System, Honolulu, Hawaii, USA. · Parkinson's Institute, Sunnyvale, California, USA. · Institute of Neurogenetics, University of Luebeck, Luebeck, Germany. · Department of Clinical Genetics, Erasmus University Medical Center, Rotterdam, The Netherlands. · Parkinson's Disease Center and Movement Disorders Clinic, Department of Neurology, Baylor College of Medicine, Houston, Texas, USA. · Department of Neurosurgery, Toronto Western Hospital, University of Toronto, Toronto, Canada. · Department of Neurology, Universitätsklinikum Schleswig-Holstein, Christian Albrechts University Kiel, Kiel, Germany. · Department of Medical Neurobiology, Institute of Medical Research Israel-Canada, Jerusalem, Israel. · Edmond and Lily Safra Center for Brain Sciences, The Hebrew University, Jerusalem, Israel. · Department of Neurosurgery, Hadassah University Hospital, Jerusalem, Israel. · Parkinson's Disease and Movement Disorders Unit, Neurology Service, Institut Clínic de Neurociències, Hospital Clínic de Barcelona, Barcelona, Spain. · Department of Medicine, Universitat de Barcelona, IDIBAPS, Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED) Barcelona, Spain. · Movement Disorders Clinic, Clinical Neurodegenerative Research Unit, Mexico City, Mexico. · Instituto Nacional de Neurología y Neurocirugía, Mexico City, Mexico. · Department of Neurology, Columbia University Medical Center, New York, New York, USA. · Department of Neurology, McGill University, Montreal General Hospital, Montreal, Quebec, Canada. · Klinik für Neurologie, UKSH, Campus Kiel, Christian-Albrechts-Universität, Kiel, Germany. · Institute for Neurodegenerative Disorders, New Haven, Connecticut, USA. · Department of Neurology, University of Alabama at Birmingham, Birmingham, Alabama, USA. · Department of Physiology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA. · Departments of Neurology and Neuroscience, Mount Sinai School of Medicine, New York, New York, USA. · Research Center for Brain Repair, Rush University Medical Center, Chicago, Illinois, USA. · Neuroscience Graduate Program, Rush University Medical Center, Chicago, Illinois, USA. · Neurological Clinic, Department of Medicine, Hospital Santa Maria della Misericordia, University of Perugia, Perugia, Italy. · Laboratory of Neurophysiology, Santa Lucia Foundation, IRCCS, Rome, Italy. · University Department of Clinical Neurosciences, UCL Institute of Neurology, University College London, London, UK. · Pacific Parkinson's Research Centre, Division of Neurology & Djavadf Mowafaghian Centre for Brain Health, University of British Columbia, British Columbia, Canada. · Vancouver Coastal Health, Vancouver, British Columbia, Canada. · Pubmed 28887905
  • Department of Psychiatry and Behavioural and Clinical Neurosciences Institute, University of Cambridge, Cambridge, UK; Cambridgeshire and Peterborough NHS Foundation Trust, Cambridge, UK. Electronic address: · Departments of Pharmacology and Psychiatry, Center for Compulsive Behavior and Addiction, Rush University Medical Center, Chicago, IL, USA. · Department of Cognitive, Linguistic and Psychological Sciences and Department of Psychiatry and Human Behavior, Brown Institute for Brain Science, Providence, RI, USA. · Institut des Sciences Cognitives Marc Jeannerod, CNRS, Bron, France; Université Claude Bernard Lyon 1, Villeurbanne, France. · Departments of Neuroscience, Psychiatry and Psychology, University of Pittsburgh, Pittsburgh, PA, USA. · Biodonostia Health Research Institute, University Hospital Donostia, and Basque Center on Cognition, Brain and Language, San Sebastián, Spain; Ikerbasque-Basque Foundation for Science, Bilbao, Spain; Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas, Instituto Carlos III, Spain. · Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas, Instituto Carlos III, Spain; HM Centro Integral de Neurociencias, HM Puerta del Sur, Mostoles and Centro de Estudios Universitarios-San Pablo University, Madrid, Spain. · Université de Bordeaux, Institut des Maladies Neurodégénératives, Bordeaux, France; Centre National de la Recherche Scientifique, Institut des Maladies Neurodégénératives, Bordeaux, France. · Pubmed 28229895
  • Université de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, Bordeaux, France; CNRS, Institut des Maladies Neurodégénératives, UMR 5293, Bordeaux, France. · GAIA Research Center, Bioanalytical Department, The Goulandris Natural History Museum, Kifissia 14562, Greece. · National and Kapodistrian University of Athens Medical School, Department of Internal Medicine, 75 Mikras Asias Street, Athens 11527, Greece. · Université de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, Bordeaux, France; CNRS, Institut des Maladies Neurodégénératives, UMR 5293, Bordeaux, France. Electronic address: · GAIA Research Center, Bioanalytical Department, The Goulandris Natural History Museum, Kifissia 14562, Greece; National and Kapodistrian University of Athens Medical School, Department of Pharmacology, 75 Mikras Asias Street, Athens 11527, Greece. Electronic address: · Pubmed 26209472
  • Department of Anatomy and Neurosciences, VU University Medical Center, Amsterdam Neuroscience, 1081 BT Amsterdam, The Netherlands. · Ernst Strüngmann Institut for Neuroscience in Cooperation with Max Planck Society, 60528 Frankfurt am Main, Germany. · Université de Bordeaux, Institut des Maladies Neurodégénératives, Unité Mixte de Recherche 5293, F-33000 Bordeaux, France. · Centre National de la Recherche Scientifique, Institut des Maladies Neurodégénératives, Unité Mixte de Recherche 5293, F-33000 Bordeaux, France, and. · Department of Neurology, VU University Medical Center, Amsterdam Neuroscience, 1081 HV Amsterdam, The Netherlands. · Department of Anatomy and Neurosciences, VU University Medical Center, Amsterdam Neuroscience, 1081 BT Amsterdam, The Netherlands, · Pubmed 28687605
  • Univ. de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, F-33000, Bordeaux, France. · CNRS, Institut des Maladies Neurodégénératives, UMR 5293, F-33000, Bordeaux, France. · Motac neuroscience Ltd, Manchester, UK. · Institute of Lab Animal Sciences, China Academy of Medical Sciences, Beijing, China. · Department of Biomedical and Molecular Sciences, Queen's University, Kingston, Canada. · Univ. de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, F-33000, Bordeaux, France. · CNRS, Institut des Maladies Neurodégénératives, UMR 5293, F-33000, Bordeaux, France. · Motac neuroscience Ltd, Manchester, UK. · Institute of Lab Animal Sciences, China Academy of Medical Sciences, Beijing, China. · Pubmed 28539659
  • UMR 5293, Institut des Maladies Neurodégénératives, Université de Bordeaux, 33076 Bordeaux, France. · CNRS, UMR 5293, Institut des Maladies Neurodégénératives, 33076 Bordeaux, France. · Vall d'Hebron Research Institute, CIBERNED and Catalan Institution for Research and Advanced Studies (ICREA), Autonomous University of Barcelona (UAB), Barcelona, Spain. · UMR 5297, Interdisciplinary Institute of Neurosciences, Université de Bordeaux, 33076 Bordeaux, France. · CNRS, UMR 5297, Interdisciplinary Institute of Neurosciences, 33076 Bordeaux, France. · Neurodegenerative Disease Department, Merck Serono Institute, Geneva, Switzerland. · Pubmed 28520872
  • Departamento de Neurociencias, Achucarro Basque Center for Neuroscience, Universidad del País Vasco (UPV/EHU) and Centro de Investigación Biomédica en Red en Enfermedades Neurodegenerativas (CIBERNED), S-48940 Leioa, Spain. · ImmuSmol, F-33600 Pessac, France. · Univ. de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France; CNRS, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France. · Univ. de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France; CNRS, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France; INSERM U1084 Laboratoire de Neurosciences Experimentales et Cliniques, F-86000 Poitiers, France. · HM Centro Integral de Neurociencias A.C. (CINAC), HM Puerta del Sur and CIBERNED and CEU-San Pablo University Madrid, E-28938 Mostoles, Spain. · Univ. de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France; CNRS, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France; Motac Neuroscience, UK-M15 6WE Manchester, UK. Electronic address: · Pubmed 28411117
  • Department of Medicinal Chemistry and Molecular Pharmacology, Purdue University, West Lafayette, IN, USA. · Purdue Institute for Integrative Neuroscience, Purdue University, West Lafayette, IN, USA. · Université de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, Bordeaux, France. · CNRS, Institut des Maladies Neurodégénératives, UMR 5293, Bordeaux, France. · Department of Neurology, Massachusetts Alzheimer's Disease Research Center, Massachusetts General Hospital, Charlestown, MA, USA. · Department of Statistics, Purdue University, West Lafayette, IN, USA. · Department of Biological and Experimental Psychology, School of Biological and Chemical Sciences, Queen Mary University of London, London, UK. · Department of Medicinal Chemistry and Molecular Pharmacology, Purdue University, West Lafayette, IN, USA. · Purdue Institute for Integrative Neuroscience, Purdue University, West Lafayette, IN, USA. · Pubmed 28069058
2016
  • Université de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, Bordeaux, France. · CNRS, Institut des Maladies Neurodégénératives, UMR 5293, Bordeaux, France. · Telethon Institute of Genetics and Medicine, Pozzuoli, Italy. · Department of Neurology, University Hospital Bordeaux, Bordeaux, France. · Pubmed 26926119
  • Université de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, Bordeaux, France. · CNRS, Institut des Maladies Neurodégénératives, UMR 5293, Bordeaux, France. · Neurodegenerative Diseases Research Group, Vall d'Hebron Research Institute, Centro Investigación Biomédica en Red Enfermedades Neurodegenerativas, Barcelona, Spain. · Department of Biochemistry and Molecular Biology, Autonomous University of Barcelona, Bellaterra, Barcelona, Spain. · Catalan Institution for Research and Advanced Studies, Barcelona, Spain. · Laboratory for Translational Parkinson's Disease Research, Center for Neurodegenerative Science, Van Andel Research Institute, Grand Rapids, Michigan, USA. · Department of Neurological Sciences, The Graduate College, Rush University, Chicago, Illinois, USA. · Pubmed 26347034
  • Université de Bordeaux, Institut des Maladies Neurodégénératives, Bordeaux, France. · CNRS, Institut des Maladies Neurodégénératives, UMR 5293, Bordeaux, France. · Service de Neurologie, CHU de Bordeaux, Bordeaux, France. · NS-Park/FCRIN Network, UMS 015, Toulouse, France. · Addex Pharma SA, Plan Les Ouates, Switzerland. · NS-Park/FCRIN Network, UMS 015, Toulouse, France. · Neurology Service, A, Hôpital Gabriel Montpied, Clermont Ferrand, France. · Sorbonne Universités and UPMC Univ Paris 06, INSERM UMRS-1127 and CIC-1422; CNRS UMR-7225; AP-HP; and ICM, Hôpital Pitié-Salpêtrière, Paris, France. · Universitätsklinikum Giessen und Marburg, Klinik für Neurologie, Marburg, Germany. · Department of Neurology USC/Keck School of Medicine, Los Angeles, California, USA. · Parkinson's Disease and Movement Disorders Center of Boca Raton, Boca Raton, Florida, USA. · Université de Bordeaux, Institut des Maladies Neurodégénératives, Bordeaux, France. · CNRS, Institut des Maladies Neurodégénératives, UMR 5293, Bordeaux, France. · Rush University Medical Center, Dept. of Neurological Sciences, Movement Disorder Section, Chicago, Illinois, USA. · Paracelsus Elena Klinik, centre for Parkinson's Disease & Movement Disorders, Kassel, Germany. · CIC9302, Departments of Clinical Pharmacology and Neurosciences and NeuroToul COEN Center; INSERM, University Hospital of Toulouse and University of Toulouse 3, Toulouse, France. · Pubmed 27214664
  • Department of Clinical Neurosciences, Institute of Neurology, University College London, London, United Kingdom. · Neurodegenerative Diseases Institute, University of Bordeaux, Mixed Unit of Research 5293, Bordeaux, France. · Neurodegenerative Diseases Institute, National Center for Scientific Research, Mixed Unit of Research 5293, Bordeaux, France. · Pubmed 27859541
  • Department of Medical Sciences, Section of Pharmacology, University of Ferrara, via Fossato di Mortara 17-19, 44121 Ferrara, Italy; Neuroscience Center and National Institute of Neuroscience, University of Ferrara, via Fossato di Mortara 17-19, 44121 Ferrara, Italy. · Department of Biomedical and Specialty Surgical Sciences, Section of Human Physiology, University of Ferrara, via Fossato di Mortara 19, 44121 Ferrara, Italy. · Université de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France; CNRS, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France. · Astraea Therapeutics, 320 Logue Avenue, Mountain View, CA 94040, USA. · Department of Medical Sciences, Section of Pharmacology, University of Ferrara, via Fossato di Mortara 17-19, 44121 Ferrara, Italy; Neuroscience Center and National Institute of Neuroscience, University of Ferrara, via Fossato di Mortara 17-19, 44121 Ferrara, Italy. Electronic address: · Pubmed 26804029
  • Université de Bordeaux, Institut des Maladies Neurodégénératives, Bordeaux, France; National Centre for Scientific Research, Institut des Maladies Neurodégénératives, Bordeaux, France. · Université de Bordeaux, Institut des Maladies Neurodégénératives, Bordeaux, France; National Centre for Scientific Research, Institut des Maladies Neurodégénératives, Bordeaux, France; Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France. · Université de Bordeaux, Institut des Maladies Neurodégénératives, Bordeaux, France; National Centre for Scientific Research, Institut des Maladies Neurodégénératives, Bordeaux, France. Electronic address: · Pubmed 25442003
  • Institute of Neurodegenerative Diseases, University of Bordeaux and National Center for Scientific Research, Bordeaux, France. · Pubmed 27273753
2015
  • Univ. de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, 33000 Bordeaux, France; CNRS, Institut des Maladies Neurodégénératives, UMR 5293, 33000 Bordeaux, France. · Univ. de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, 33000 Bordeaux, France; CNRS, Institut des Maladies Neurodégénératives, UMR 5293, 33000 Bordeaux, France; Department of Neurology, University Hospital Bordeaux, France. · Laboratory of Neurophysiology, Fondazione Santa Lucia, IRCCS, Rome, Italy. · Division of Neuroscience, Institute of Experimental Neurology, San Raffaele Scientific Institute, 20132 Milan, Italy. · Department of Neuroscience, Karolinska Institutet, Stockholm, Sweden. · Basal Ganglia Pathophysiology Unit, Department of Experimental Medical Science, Lund University, Lund, Sweden. · Department of Neurology, Columbia University, New York, USA. · Pacific Parkinson's Research Centre and National Parkinson Foundation Centre of Excellence, University of British Columbia, Vancouver, Canada. · Department of Biomedical Sciences, Section of Neuropsychopharmacology, Cagliari University, 09124 Cagliari, Italy. · Univ. de Bordeaux, Institut Interdisciplinaire de neurosciences, UMR 5297, 33000 Bordeaux, France; CNRS, Institut Interdisciplinaire de neurosciences, UMR 5297, 33000 Bordeaux, France. · Department of Neurology, Hospital Universitario Donostia and Neuroscience Unit, Bio Donostia Research Institute, San Sebastian, Spain. · Department of Pharmacology, Vanderbilt University Medical Center, Nashville, TN 37232, USA. · Center for Health Sciences, SRI International, CA 94025, USA. · Department of Medical Sciences, Section of Pharmacology, University of Ferrara, Ferrara, Italy. · Dipartimento di Scienze Farmacologiche e Biomolecolari, Università degli Studi di Milano, 20133 Milano, Italy. · Department of Biomedical Sciences, Physiology Section, Cagliari University, Cagliari, Italy. · Motac Neuroscience Ltd, Manchester, UK. · Michigan State University, College of Human Medicine, Department of Translational Science and Molecular Medicine & The Udall Center of Excellence in Parkinson's Disease Research, 333 Bostwick Ave NE, Grand Rapids, MI 49503, USA. · Morton & Gloria Shulman Movement Disorders Center, Toronto Western Hospital, Toronto, Ontario M4T 2S8, Canada. · Univ. de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, 33000 Bordeaux, France; CNRS, Institut des Maladies Neurodégénératives, UMR 5293, 33000 Bordeaux, France; Motac Neuroscience Ltd, Manchester, UK. Electronic address: · Pubmed 26209473
  • Institute of Neurodegenerative Diseases, University of Bordeaux, Centre National de la Recherche Scientifique Unité Mixte de Recherche 5293, 33076 Bordeaux, France. · Research Unit of Theoretical & Applied Economics, University of Bordeaux, Centre National de la Recherche Scientifique Unité Mixte de Recherche 5113, 33608 Pessac, France. · Departments of Neurology, Pathology and Cell Biology, and the Center for Motor Neuron Biology and Disease, Columbia University, New York, NY 10032, USA. · Neurodegenerative Diseases Research Group, Vall d'Hebron Research Institute, Centro Investigación Biomédica en Red Enfermedades Neurodegenerativas, 08035 Barcelona, Spain. · Department of Biochemistry and Molecular Biology, Autonomous University of Barcelona, 08193 Bellaterra, Barcelona, Spain. · Catalan Institution for Research and Advanced Studies, 08010 Barcelona, Spain. · ICM, Paris, France; Sorbonne Universités. · UPMC Université Paris 06, UM 75, ICM, Paris, France. · CNRS, UMR 7225, ICM, Paris, France. · Inserm, U 1127, ICM, Paris, France. · Molecular Genetics Section and Laboratory of Neurogenetics, NIA, NIH, Bethesda, MD20892, USA. · Departments of Neurology and Neuroscience, Mount Sinai School of Medicine, New York, NY 10032, USA. · TransThera Consulting Co., Zionsville, IN, 46077, USA. · Department of Neurology and Feil Family Brain and Mind research Institute, Weill Cornell Medical College, New York NY 10021, USA. · Pubmed 26050140
  • Departments of Cell Biology, · Institut des Maladies Neurodégénératives, UMR 5293, Université de Bordeaux, 33000 Bordeaux, France; Institut des Maladies Neurodégénératives, UMR 5293, CNRS, 33000 Bordeaux, France; · Departments of Cell Biology. · Department of Pharmacology and Toxicology, University at Buffalo, The State Uiversity of New York, Buffalo, NY 14260; and. · Departments of Cell Biology, Institute of Translational Biomedicine, St. Petersburg State University, St. Petersburg, 199034, Russia. · Departments of Cell Biology, Medicine, and Neurobiology, Duke University Medical Center, Durham NC 27710; · Pubmed 25918399
  • 1 Univ. de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France 2 CNRS, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France · 3 Department of Biomedical Sciences, Section of Physiology, University of Cagliari, University Campus, SS554 km 4.5, 09042 Monserrato, Italy. · Pubmed 25669729
2014
  • Institut des Maladies Neurodégénératives, Université de Bordeaux, UMR 5293 Bordeaux, France ; CNRS, Institut des Maladies Neurodégénératives, UMR 5293 Bordeaux, France. · Pubmed 25177278
  • Department of Clinical Neurosciences, UCL Institute of Neurology, London, UK. Electronic address: · Departments of Neurology and Neuroscience, Mount Sinai School of Medicine, New York, NY, USA. · Pittsburgh Institute for Neurodegenerative Diseases, University of Pittsburgh, Pittsburgh, PA 15260, USA. · Université de Bordeaux, Institut des Maladies Neurodégénératives, 33000 Bordeaux, France; CNRS, Institut des Maladies Neurodégénératives, 33000 Bordeaux, France. · Pubmed 24954676
  • Motac Neuroscience Ltd., Manchester, United Kingdom; Université de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, Bordeaux F-33000, France; CNRS, Institut des Maladies Neurodégénératives, UMR 5293, Bordeaux F-33000, France. · Institute of Laboratory Animal Sciences, China Academy of Medical Sciences, Beijing, China. · Motac Neuroscience Ltd., Manchester, United Kingdom; Université de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, Bordeaux F-33000, France; CNRS, Institut des Maladies Neurodégénératives, UMR 5293, Bordeaux F-33000, France; Institute of Laboratory Animal Sciences, China Academy of Medical Sciences, Beijing, China. Electronic address: · Pubmed 24572591
  • Université de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, Bordeaux, France; CNRS, Institut des Maladies Neurodégénératives, UMR 5293, Bordeaux, France. Electronic address: · Université de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, Bordeaux, France; CNRS, Institut des Maladies Neurodégénératives, UMR 5293, Bordeaux, France. Electronic address: · Université de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, Bordeaux, France; CNRS, Institut des Maladies Neurodégénératives, UMR 5293, Bordeaux, France; Service de Neurologie, CHU de Bordeaux Haut-Lévêque, Pessac, France. Electronic address: · Université de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, Bordeaux, France; CNRS, Institut des Maladies Neurodégénératives, UMR 5293, Bordeaux, France; Institute of Laboratory Animal Sciences, China Academy of Medical Sciences, Beijing, China. Electronic address: · Université de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, Bordeaux, France; CNRS, Institut des Maladies Neurodégénératives, UMR 5293, Bordeaux, France; Département de Neurophysiologie Clinique, CHU de Bordeaux Pellegrin, Bordeaux, France. Electronic address: · Pubmed 24211719
  • Université de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, Bordeaux, France; CNRS, Institut des Maladies Neurodégénératives, UMR 5293, Bordeaux, France. · Department of Pharmaceutical Biosciences, Biomolecular Imaging and Proteomics, Uppsala University, Box 591, SE-75124 Uppsala, Sweden. · Motac Neuroscience, Manchester, UK; Institute of Laboratory Animal Sciences, China Academy of Medical Sciences, Beijing, China. · Motac Neuroscience, Manchester, UK. · Université de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, Bordeaux, France; CNRS, Institut des Maladies Neurodégénératives, UMR 5293, Bordeaux, France; Motac Neuroscience, Manchester, UK; Institute of Laboratory Animal Sciences, China Academy of Medical Sciences, Beijing, China. Electronic address: · Pubmed 24148855
2013
  • University de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, Bordeaux, France. · Pubmed 22753348
2011
  • Insitute of Neurodegenerative Diseases, Université Victor Ségalen-Bordeaux II, Centre National de la Recherche Scientifique, Bordeaux, France. · Pubmed 21626544
2010
  • Universite Victor Segalen-Bordeaux 2, Centre National de la Recherche Scientifique, Bordeaux Institute of Neuroscience, UMR 5227 Bordeaux, France. · Pubmed 20105227
2019
  • Service de Neurologie, Hôpital Pellegrin, CHU de Bordeaux, 33000, Bordeaux, France. · Institut des Maladies Neurodégénératives, Université de Bordeaux, UMR 5293, 146 rue Léo Saignat, 33000, Bordeaux Cedex, France. · CNRS, Institut des Maladies Neurodégénératives, UMR 5293, 33000, Bordeaux, France. · Institute of Laboratory Animal Sciences, China Academy of Medical Sciences, Beijing, China. · Motac Neuroscience, Manchester, UK. · CIC Toulouse, Toulouse, France. · Départements de Pharmacologie Clinique et Neurosciences, INSERM CIC9302, CHU de Toulouse, Toulouse, France. · Service de Pharmacologie, Faculté de Médecine, CHU de Toulouse, Université de Toulouse, Toulouse, France. · Service de Neurologie, Hôpital Pellegrin, CHU de Bordeaux, 33000, Bordeaux, France. · Institut des Maladies Neurodégénératives, Université de Bordeaux, UMR 5293, 146 rue Léo Saignat, 33000, Bordeaux Cedex, France. · CNRS, Institut des Maladies Neurodégénératives, UMR 5293, 33000, Bordeaux, France. · Department Medicine, University of Otago, Christchurch, New Zealand. · New Zealand Brain Research Institute, Christchurch, New Zealand. · Pubmed 31098725
2017
  • Ceinge Biotecnologie Avanzate, Naples, Italy. · Department of Molecular Medicine and Medical Biotechnology, University of Naples Federico II, Naples, Italy. · Department of Pharmacology, Vanderbilt University, Nashville, TN, United States of America. · Department of Biology Unit of Cell and Developmental Biology, University of Pisa, Pisa, Italy. · Department of Environmental, Biological and Pharmaceutical Sciences and Technologies, University of Campania, Luigi Vanvitelli, Italy. · Motac Neuroscience, UK-M15 6WE, Manchester, United Kingdom. · Institute of Lab Animal Sciences, China Academy of Medical Sciences, Beijing, China. · Université de Bordeaux, Institut des Maladies Neurodégénératives,Bordeaux, France. · Centre National de la Recherche Scientifique Unité Mixte de Recherche 5293, Institut des Maladies Neurodégénératives, Bordeaux, France. · IRCSS Casa Sollievo della Sofferenza, ISBReMIT-Institute for Stem Cell Biology, Regenerative Medicine and Innovative Therapies, San Giovanni Rotondo, Italy. · Department of Medicine, University of Perugia and Clinica Neurologica, Santa Maria della Misericordia Hospital, Perugia, Italy. · National Research Council of Italy (CNR), Neuroscience Institute, Cagliari, Italy. · Department of Biomedical Sciences, section of Neuropsychopharmacology, University of Cagliari, Cagliari, Italy. · Center for Neuroscience and Cognitive Systems, Istituto Italiano di Tecnologia, Rovereto, TN, Italy. · Neuroscience Institute, National Research Council (CNR), Pisa, Italy. · Pubmed 28742811
2016
  • National Research Council of Italy, Neuroscience Institute, Cagliari, Italy. · Motac Neuroscience Ltd, Manchester, UK. · Institute of Laboratory Animal Sciences, China Academy of Medical Sciences, Beijing, China. · Department of Biomedical Sciences, section of Neuropsychopharmacology, University of Cagliari, Cagliari, Italy. · Department of Biomedical Sciences, section of Physiology, University of Cagliari, Cagliari, Italy. · Department of Chemical and Pharmaceutical Sciences, University of Ferrara, Ferrara, Italy. · Université de Bordeaux, Institut des Maladies Neurodégénératives, Bordeaux, France. · CNRS, Institut des Maladies Neurodégénératives, Bordeaux, France. · Pubmed 26871939
2014
  • Institute of Neurodegenerative Diseases, University of Bordeaux, Centre National de la Recherche Scientifique Unité Mixte de Recherche, Bordeaux, France. · Pubmed 25214445
2013
  • Institute of Neurodegenerative Diseases, University of Bordeaux Segalen, Centre National de Recherche Scientifique Unité Mixte de Recherche 5293, Bordeaux, France. · Pubmed 23580333
  • Institute of Neurodegenerative Diseases, UMR 5293, F-33000 Bordeaux, France, University of Bordeaux, Bordeaux, France; Institute of Neurodegenerative Diseases, UMR 5293, F-33000 Bordeaux, France, National Center for Scientific Research, Bordeaux, France. · Pubmed 23494678
  • Université de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, Bordeaux, France. · Pubmed 23283428
2012
  • Université de Bordeaux, Institut des Maladies Neurodégénératives, Bordeaux, France. · Pubmed 23041629
  • Institut des Maladies Neurodégénératives, Université de Bordeaux, CNRS UMR 5293, Bordeaux, France. · Pubmed 22885599
  • Insitute of Neurodegenerative Diseases, University of Bordeaux Segalen, Centre National de la Recherche Scientifique Unité Mixte de Recherche 5293, 33076 Bordeaux, France. · Pubmed 22647602
2011
  • Université Victor Ségalen-Bordeaux II, Centre National de la Recherche Scientifique, Institute of Neurodegenerative Diseases, Bordeaux, France. · Pubmed 22046592
2010
  • Centre National de la Recherche Scientifique UMR 5227, Bordeaux Institute of Neuroscience, Université Victor-Segalen Bordeaux 2 Bordeaux, France. · Pubmed 20890450
Miscellaneous institutions in Bordeaux
2020
  • Univ. de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France. · CNRS, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France. · Pubmed 32138193
2018
  • UC Gardner Neuroscience Institute and Gardner Family Center for Parkinson's Disease and Movement Disorders, Department of Neurology, University of Cincinnati, Cincinnati, OH. · Institute of Molecular and Clinical Sciences, St George's University of London, London, United Kingdom. · Edmond J. Safra Program in Parkinson's Disease, Morton and Gloria Shulman Movement Disorders Clinic, Toronto Western Hospital, University Health Network, Division of Neurology, University of Toronto, Toronto, Ontario, Canada. · Krembil Brain Institute, Toronto, Ontario, Canada. · University of Bordeaux, Institute of Neurodegenerative Diseases, Bordeaux, France. · National Center for Scientific Research, Institute of Neurodegenerative Diseases, Bordeaux, France. · Experimental Neurophysiology Laboratory, IRCCS University San Raffaele Pisana, University San Raffaele, Rome, Italy. · Neurological Clinic, University of Perugia, Santa Maria della Misericordia Hospital, Perugia, Italy. · Pubmed 30357892
2017
  • University de Bordeaux, Institut des Maladies Neurodégénératives Bordeaux, France. · CNRS, Institut des Maladies Neurodégénératives, Bordeaux, France. · CHU Bordeaux, Service de Biologie de la reproduction-CECOS, Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France. · University de Bordeaux, Interdisciplinary Institute for Neuroscience, Bordeaux, France. · CNRS, Institut Interdisciplinaire de Neurosciences, Bordeaux, France. · Pubmed 28853717
  • Neuroscience Therapeutic Area, New Medicines, UCB Biopharma SPRL, 1420 Braine l'Alleud, Belgium. · Univ. de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, Bordeaux, 33000, France. · CNRS, Institut des Maladies Neurodégénératives, UMR 5293, Bordeaux, 33000, France. · Pubmed 28407359
  • Univ. de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France. · CNRS, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France. · Pubmed 28374864
2016
  • Department of Clinical Neurosciences, Institute of Neurology, University College London, London, United Kingdom. · Neurodegenerative Diseases Institute, University of Bordeaux, Mixed Unit of Research 5293, Bordeaux, France. · Neurodegenerative Diseases Institute, National Center for Scientific Research, Mixed Unit of Research 5293, Bordeaux, France. · Pubmed 27859541
  • Cynbiose, Marcy l'Etoile, France. · Univ. de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, 33000, Bordeaux, France. · CNRS, Institut des Maladies Neurodégénératives, UMR 5293, 33000, Bordeaux, France. · Institute of Materia Medica, Chinese Academy of Medical Sciences, Beijing, People's Republic of China, 100050. · Motac Neuroscience, Manchester, United Kingdom. · Institute of Laboratory Animal Sciences, China Academy of Medical Sciences, Beijing, People's Republic of China. · Pubmed 26799359
  • a University de Bordeaux, Institut des Maladies Neurodégénératives , UMR 5293, Bordeaux , France. · b CNRS, Institut des Maladies Neurodégénératives , UMR 5293, Bordeaux , France. · c University de Bordeaux, Institut des Sciences Moléculaires , UMR 5255, Talence , France. · Pubmed 26761717
  • Neuroscience Therapeutic Area, New Medicines, UCB Biopharma SPRL, 1420 Braine L'alleud, Belgium. · University De Bordeaux, Institut Des Maladies Neurodégénératives, UMR 5293, Bordeaux, 33000, France. · CNRS, Institut Des Maladies Neurodégénératives, UMR 5293, Bordeaux, 33000, France. · Pubmed 26695835
  • Univ. De Bordeaux, Institut Des Maladies Neurodégénératives, Bordeaux, France. · Institut Des Maladies Neurodégénératives, CNRS, Bordeaux, France. · Pubmed 26583879
  • University de Bordeaux, Institut des Maladies Neurodégénératives, Bordeaux, France; National Centre for Scientific Research, Institut des Maladies Neurodégénératives, Bordeaux, France. · China Academy of Medical Sciences, Institute of Laboratory Animal Sciences, Beijing, China. · Laboratory of Neurophysiology and Plasticity, Fondazione Santa Lucia, Istituto di Ricovero e Cura a Carattere Scientifico, Rome, Italy. · University de Bordeaux, Institut des Maladies Neurodégénératives, Bordeaux, France; National Centre for Scientific Research, Institut des Maladies Neurodégénératives, Bordeaux, France. Electronic address: · Pubmed 25146322
2013
  • Institute for Neurodegenerative Diseases, Bordeaux University, Bordeaux, France. · Pubmed 23389842
2017
  • Department of Clinical Neurosciences, Institute of Neurology, University College London, NW3 2PF, United Kingdom. · Motac Neuroscience, Manchester, United Kingdom. · Institute of Laboratory Animal Sciences, China Academy of Medical Sciences, Beijing City, People's Republic of China. · University de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, Bordeaux, F-33000, France. · CNRS, Institut des Maladies Neurodégénératives, UMR 5293, Bordeaux, F-33000, France. · Pubmed 28295625
2012
  • Univ. de Bordeaux, Institut des Maladies Neurodégénératives , UMR 5293, F-33000 Bordeaux, France. · Pubmed 23205271
Miscellaneous institutions in Manchester, UK
2018
  • Research Statistics, Pfizer Worldwide Research and Development, Cambridge, United Kingdom. · Motac Neuroscience, Manchester, United Kingdom. · Internal Medicine Research Unit, Pfizer Worldwide Research and Development, Cambridge, Massachusetts, USA. · Université de Bordeaux, Institut des Maladies Neurodégénératives, Bordeaux, France. · Centre National de la Recherche Scientifique Unité Mixte de Recherche 5293, Institut des Maladies Neurodégénératives, Bordeaux, France. · Pubmed 30288778
  • Prexton Therapeutics SA, 1228 Plan-les-Ouates, Geneva, Switzerland. · Neuroscience Research Unit CHU de Québec, CHUL Pavillon and Faculty of Pharmacy, Laval University, Quebec City, Quebec, Canada. · Motac Neuroscience Ltd, Manchester, United Kingdom. · Karolinska Institutet, Centre for Psychiatry Research, Department of Clinical Neuroscience, Stockholm, Sweden. · Pubmed 30216534
2019
  • Service de Neurologie, Hôpital Pellegrin, CHU de Bordeaux, 33000, Bordeaux, France. · Institut des Maladies Neurodégénératives, Université de Bordeaux, UMR 5293, 146 rue Léo Saignat, 33000, Bordeaux Cedex, France. · CNRS, Institut des Maladies Neurodégénératives, UMR 5293, 33000, Bordeaux, France. · Institute of Laboratory Animal Sciences, China Academy of Medical Sciences, Beijing, China. · Motac Neuroscience, Manchester, UK. · CIC Toulouse, Toulouse, France. · Départements de Pharmacologie Clinique et Neurosciences, INSERM CIC9302, CHU de Toulouse, Toulouse, France. · Service de Pharmacologie, Faculté de Médecine, CHU de Toulouse, Université de Toulouse, Toulouse, France. · Service de Neurologie, Hôpital Pellegrin, CHU de Bordeaux, 33000, Bordeaux, France. · Institut des Maladies Neurodégénératives, Université de Bordeaux, UMR 5293, 146 rue Léo Saignat, 33000, Bordeaux Cedex, France. · CNRS, Institut des Maladies Neurodégénératives, UMR 5293, 33000, Bordeaux, France. · Department Medicine, University of Otago, Christchurch, New Zealand. · New Zealand Brain Research Institute, Christchurch, New Zealand. · Pubmed 31098725
2017
  • Ceinge Biotecnologie Avanzate, Naples, Italy. · Department of Molecular Medicine and Medical Biotechnology, University of Naples Federico II, Naples, Italy. · Department of Pharmacology, Vanderbilt University, Nashville, TN, United States of America. · Department of Biology Unit of Cell and Developmental Biology, University of Pisa, Pisa, Italy. · Department of Environmental, Biological and Pharmaceutical Sciences and Technologies, University of Campania, Luigi Vanvitelli, Italy. · Motac Neuroscience, UK-M15 6WE, Manchester, United Kingdom. · Institute of Lab Animal Sciences, China Academy of Medical Sciences, Beijing, China. · Université de Bordeaux, Institut des Maladies Neurodégénératives,Bordeaux, France. · Centre National de la Recherche Scientifique Unité Mixte de Recherche 5293, Institut des Maladies Neurodégénératives, Bordeaux, France. · IRCSS Casa Sollievo della Sofferenza, ISBReMIT-Institute for Stem Cell Biology, Regenerative Medicine and Innovative Therapies, San Giovanni Rotondo, Italy. · Department of Medicine, University of Perugia and Clinica Neurologica, Santa Maria della Misericordia Hospital, Perugia, Italy. · National Research Council of Italy (CNR), Neuroscience Institute, Cagliari, Italy. · Department of Biomedical Sciences, section of Neuropsychopharmacology, University of Cagliari, Cagliari, Italy. · Center for Neuroscience and Cognitive Systems, Istituto Italiano di Tecnologia, Rovereto, TN, Italy. · Neuroscience Institute, National Research Council (CNR), Pisa, Italy. · Pubmed 28742811
  • Department of Clinical Neurosciences, Institute of Neurology, University College London, NW3 2PF, United Kingdom. · Motac Neuroscience, Manchester, United Kingdom. · Institute of Laboratory Animal Sciences, China Academy of Medical Sciences, Beijing City, People's Republic of China. · University de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, Bordeaux, F-33000, France. · CNRS, Institut des Maladies Neurodégénératives, UMR 5293, Bordeaux, F-33000, France. · Pubmed 28295625
2016
  • National Research Council of Italy, Neuroscience Institute, Cagliari, Italy. · Motac Neuroscience Ltd, Manchester, UK. · Institute of Laboratory Animal Sciences, China Academy of Medical Sciences, Beijing, China. · Department of Biomedical Sciences, section of Neuropsychopharmacology, University of Cagliari, Cagliari, Italy. · Department of Biomedical Sciences, section of Physiology, University of Cagliari, Cagliari, Italy. · Department of Chemical and Pharmaceutical Sciences, University of Ferrara, Ferrara, Italy. · Université de Bordeaux, Institut des Maladies Neurodégénératives, Bordeaux, France. · CNRS, Institut des Maladies Neurodégénératives, Bordeaux, France. · Pubmed 26871939
Miscellaneous institutions in Beijing
2017
  • HM CINAC, Hospital Universitario HM Puerta del Sur, Mostoles, Madrid, Spain. · Universidad CEU San Pablo, Madrid, Spain. · CIBERNED, Madrid, Spain. · Department of Neurology, Philipps University, Marburg, Germany. · Parkinson's Disease and Movement Disorders Department, HYGEIA Hospital and Attikon Hospital, University of Athens, Athens, Greece. · Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois, USA. · Department of Neurology, Medical University Innsbruck, Innsbruck, Austria. · Morton and Gloria Shulman Movement Disorders Clinic and the Edmond J Safra Program in Parkinson's Disease, Toronto Western Hospital, Toronto, Canada. · Department of Medicine, University of Toronto, Toronto, Canada. · Department of Psychiatry, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA. · Parkinson's Disease and Mental Illness Research, Education and Clinical Centers (PADRECC and MIRECC), Corporal Michael J. Crescenz Veteran's Affairs Medical Center, Philadelphia, Pennsylvania, USA. · Medical Sciences, Newcastle University, Newcastle, UK. · Brain and Mind Centre, Sydney Medical School, The University of Sydney, Sydney, Australia. · School of Medical Sciences, University of New South Wales and Neuroscience Research Australia, Sydney, Australia. · Université de Bordeaux, Institut des Maladies Neurodégénératives, Centre National de la Recherche Scientifique Unité Mixte de Recherche 5293, Institut des Maladies Neurodégénératives, Bordeaux, France. · China Academy of Medical Sciences, Institute of Lab Animal Sciences, Beijing, China. · Departments of Neurology, Pathology, and Cell Biology, the Center for Motor Neuron Biology and Disease, Columbia University, New York, New York, USA. · Columbia Translational Neuroscience Initiative, Columbia University, New York, New York, USA. · Institut du Cerveau et de la Moelle épinière - ICM, Centre de NeuroImagerie de Recherche - CENIR, Sorbonne Universités, UPMC Univ Paris 06, Inserm U1127, CNRS UMR 7225, Paris, France. · Groupe Hospitalier Pitié-Salpêtrière, Paris, France. · Clinical Sciences Department, Newcastle University, Newcastle, UK. · Department of Nuclear Medicine, Aarhus University, Aarhus, Denmark. · Human Neurophysiology, Sobell Department, UCL Institute of Neurology, London, UK. · Human Motor Control Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland, USA. · Department of Neurology, Emory University School of Medicine, Atlanta, Georgia, USA. · Morton and Gloria Shulman Movement Disorders Centre and the Edmond J Safra Program in Parkinson's disease, Toronto Western Hospital, University of Toronto, Toronto, Canada. · Movement Disorders and Neuromodulation Center, Department of Neurology, University of California-San Francisco, San Francisco, California, USA. · Parkinson's Disease Research, Education and Clinical Center, San Francisco Veterans Affairs Medical Center, San Francisco, California, USA. · Veterans Affairs Pacific Islands Health Care System, Honolulu, Hawaii, USA. · Parkinson's Institute, Sunnyvale, California, USA. · Institute of Neurogenetics, University of Luebeck, Luebeck, Germany. · Department of Clinical Genetics, Erasmus University Medical Center, Rotterdam, The Netherlands. · Parkinson's Disease Center and Movement Disorders Clinic, Department of Neurology, Baylor College of Medicine, Houston, Texas, USA. · Department of Neurosurgery, Toronto Western Hospital, University of Toronto, Toronto, Canada. · Department of Neurology, Universitätsklinikum Schleswig-Holstein, Christian Albrechts University Kiel, Kiel, Germany. · Department of Medical Neurobiology, Institute of Medical Research Israel-Canada, Jerusalem, Israel. · Edmond and Lily Safra Center for Brain Sciences, The Hebrew University, Jerusalem, Israel. · Department of Neurosurgery, Hadassah University Hospital, Jerusalem, Israel. · Parkinson's Disease and Movement Disorders Unit, Neurology Service, Institut Clínic de Neurociències, Hospital Clínic de Barcelona, Barcelona, Spain. · Department of Medicine, Universitat de Barcelona, IDIBAPS, Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED) Barcelona, Spain. · Movement Disorders Clinic, Clinical Neurodegenerative Research Unit, Mexico City, Mexico. · Instituto Nacional de Neurología y Neurocirugía, Mexico City, Mexico. · Department of Neurology, Columbia University Medical Center, New York, New York, USA. · Department of Neurology, McGill University, Montreal General Hospital, Montreal, Quebec, Canada. · Klinik für Neurologie, UKSH, Campus Kiel, Christian-Albrechts-Universität, Kiel, Germany. · Institute for Neurodegenerative Disorders, New Haven, Connecticut, USA. · Department of Neurology, University of Alabama at Birmingham, Birmingham, Alabama, USA. · Department of Physiology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA. · Departments of Neurology and Neuroscience, Mount Sinai School of Medicine, New York, New York, USA. · Research Center for Brain Repair, Rush University Medical Center, Chicago, Illinois, USA. · Neuroscience Graduate Program, Rush University Medical Center, Chicago, Illinois, USA. · Neurological Clinic, Department of Medicine, Hospital Santa Maria della Misericordia, University of Perugia, Perugia, Italy. · Laboratory of Neurophysiology, Santa Lucia Foundation, IRCCS, Rome, Italy. · University Department of Clinical Neurosciences, UCL Institute of Neurology, University College London, London, UK. · Pacific Parkinson's Research Centre, Division of Neurology & Djavadf Mowafaghian Centre for Brain Health, University of British Columbia, British Columbia, Canada. · Vancouver Coastal Health, Vancouver, British Columbia, Canada. · Pubmed 28887905
2016
  • Cynbiose, Marcy l'Etoile, France. · Univ. de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, 33000, Bordeaux, France. · CNRS, Institut des Maladies Neurodégénératives, UMR 5293, 33000, Bordeaux, France. · Institute of Materia Medica, Chinese Academy of Medical Sciences, Beijing, People's Republic of China, 100050. · Motac Neuroscience, Manchester, United Kingdom. · Institute of Laboratory Animal Sciences, China Academy of Medical Sciences, Beijing, People's Republic of China. · Pubmed 26799359
2019
  • Service de Neurologie, Hôpital Pellegrin, CHU de Bordeaux, 33000, Bordeaux, France. · Institut des Maladies Neurodégénératives, Université de Bordeaux, UMR 5293, 146 rue Léo Saignat, 33000, Bordeaux Cedex, France. · CNRS, Institut des Maladies Neurodégénératives, UMR 5293, 33000, Bordeaux, France. · Institute of Laboratory Animal Sciences, China Academy of Medical Sciences, Beijing, China. · Motac Neuroscience, Manchester, UK. · CIC Toulouse, Toulouse, France. · Départements de Pharmacologie Clinique et Neurosciences, INSERM CIC9302, CHU de Toulouse, Toulouse, France. · Service de Pharmacologie, Faculté de Médecine, CHU de Toulouse, Université de Toulouse, Toulouse, France. · Service de Neurologie, Hôpital Pellegrin, CHU de Bordeaux, 33000, Bordeaux, France. · Institut des Maladies Neurodégénératives, Université de Bordeaux, UMR 5293, 146 rue Léo Saignat, 33000, Bordeaux Cedex, France. · CNRS, Institut des Maladies Neurodégénératives, UMR 5293, 33000, Bordeaux, France. · Department Medicine, University of Otago, Christchurch, New Zealand. · New Zealand Brain Research Institute, Christchurch, New Zealand. · Pubmed 31098725
2017
  • Ceinge Biotecnologie Avanzate, Naples, Italy. · Department of Molecular Medicine and Medical Biotechnology, University of Naples Federico II, Naples, Italy. · Department of Pharmacology, Vanderbilt University, Nashville, TN, United States of America. · Department of Biology Unit of Cell and Developmental Biology, University of Pisa, Pisa, Italy. · Department of Environmental, Biological and Pharmaceutical Sciences and Technologies, University of Campania, Luigi Vanvitelli, Italy. · Motac Neuroscience, UK-M15 6WE, Manchester, United Kingdom. · Institute of Lab Animal Sciences, China Academy of Medical Sciences, Beijing, China. · Université de Bordeaux, Institut des Maladies Neurodégénératives,Bordeaux, France. · Centre National de la Recherche Scientifique Unité Mixte de Recherche 5293, Institut des Maladies Neurodégénératives, Bordeaux, France. · IRCSS Casa Sollievo della Sofferenza, ISBReMIT-Institute for Stem Cell Biology, Regenerative Medicine and Innovative Therapies, San Giovanni Rotondo, Italy. · Department of Medicine, University of Perugia and Clinica Neurologica, Santa Maria della Misericordia Hospital, Perugia, Italy. · National Research Council of Italy (CNR), Neuroscience Institute, Cagliari, Italy. · Department of Biomedical Sciences, section of Neuropsychopharmacology, University of Cagliari, Cagliari, Italy. · Center for Neuroscience and Cognitive Systems, Istituto Italiano di Tecnologia, Rovereto, TN, Italy. · Neuroscience Institute, National Research Council (CNR), Pisa, Italy. · Pubmed 28742811
  • Department of Clinical Neurosciences, Institute of Neurology, University College London, NW3 2PF, United Kingdom. · Motac Neuroscience, Manchester, United Kingdom. · Institute of Laboratory Animal Sciences, China Academy of Medical Sciences, Beijing City, People's Republic of China. · University de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, Bordeaux, F-33000, France. · CNRS, Institut des Maladies Neurodégénératives, UMR 5293, Bordeaux, F-33000, France. · Pubmed 28295625
2016
  • National Research Council of Italy, Neuroscience Institute, Cagliari, Italy. · Motac Neuroscience Ltd, Manchester, UK. · Institute of Laboratory Animal Sciences, China Academy of Medical Sciences, Beijing, China. · Department of Biomedical Sciences, section of Neuropsychopharmacology, University of Cagliari, Cagliari, Italy. · Department of Biomedical Sciences, section of Physiology, University of Cagliari, Cagliari, Italy. · Department of Chemical and Pharmaceutical Sciences, University of Ferrara, Ferrara, Italy. · Université de Bordeaux, Institut des Maladies Neurodégénératives, Bordeaux, France. · CNRS, Institut des Maladies Neurodégénératives, Bordeaux, France. · Pubmed 26871939
CHU Bordeaux
2014
  • Univ. de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France; CNRS, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France. · CHU de Bordeaux, Unité de Soutien Méthodologique à la Recherche Clinique (USMR), Pôle de santé publique, Bordeaux, France. · Univ. de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France; CNRS, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France; Service de Neurologie, CHU de Bordeaux, F-33604 Pessac, France. · Centre de référence atrophie multisystématisée, CHU de Toulouse, Toulouse, France. · Centre de référence atrophie multisystématisée, CHU de Toulouse, Toulouse, France; Department of Clinical Pharmacology, University Hospital and University of Toulouse 3, Toulouse, France; Department of Neurosciences, University Hospital and University of Toulouse 3, Toulouse, France; INSERM UMR825 and CIC9302, Toulouse, France. · Univ. de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France; CNRS, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France; Service de Neurologie, CHU de Bordeaux, F-33604 Pessac, France; Centre de référence atrophie multisystématisée, CHU de Bordeaux, Pessac, France. · Univ. de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France; CNRS, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France; Service de Neurologie, CHU de Bordeaux, F-33604 Pessac, France; Centre de référence atrophie multisystématisée, CHU de Bordeaux, Pessac, France. Electronic address: · Pubmed 24727096
  • 1] Univ. de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, 33000 Bordeaux, France [2] CNRS, Institut des Maladies Neurodégénératives, UMR 5293, 33000 Bordeaux, France [3] Motac neuroscience, Manchester, UK. · 1] Univ. de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, 33000 Bordeaux, France [2] CNRS, Institut des Maladies Neurodégénératives, UMR 5293, 33000 Bordeaux, France. · 1] Motac neuroscience, Manchester, UK [2] Institute of Laboratory Animal Sciences, China Academy of Medical Sciences, Beijing, China. · Department of Life Sciences and Biotechnology (SVeB), University of Ferrara, Ferrara, Italy. · Institute of Pharmacology and Toxicology, Charité Campus Mitte, Humboldt University, 10117 Berlin, Germany. · 1] Univ. de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, 33000 Bordeaux, France [2] CNRS, Institut des Maladies Neurodégénératives, UMR 5293, 33000 Bordeaux, France [3] Motac neuroscience, Manchester, UK [4] Institute of Laboratory Animal Sciences, China Academy of Medical Sciences, Beijing, China [5] Service de Neurologie, Centre Expert Parkinson, CHU de Bordeaux, 33076 Bordeaux, France. · Department of Medical Sciences, Section of Pharmacology, University of Ferrara, Ferrara, Italy. · 1] Univ. de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, 33000 Bordeaux, France [2] CNRS, Institut des Maladies Neurodégénératives, UMR 5293, 33000 Bordeaux, France [3] Service de Neurologie, Centre Expert Parkinson, CHU de Bordeaux, 33076 Bordeaux, France [4] Centre de référence AMS, CHU de Bordeaux, 33076 Bordeaux, France. · Pubmed 24429495
2013
  • Univ. de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France; CNRS, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France. · Univ. de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France; CNRS, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France; Service de Neurologie, CHU de Bordeaux, F-33604 Pessac, France. · Univ. de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France; CNRS, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France. Electronic address: · Pubmed 22940424
2019
  • Service de Neurologie, Hôpital Pellegrin, CHU de Bordeaux, 33000, Bordeaux, France. · Institut des Maladies Neurodégénératives, Université de Bordeaux, UMR 5293, 146 rue Léo Saignat, 33000, Bordeaux Cedex, France. · CNRS, Institut des Maladies Neurodégénératives, UMR 5293, 33000, Bordeaux, France. · Institute of Laboratory Animal Sciences, China Academy of Medical Sciences, Beijing, China. · Motac Neuroscience, Manchester, UK. · CIC Toulouse, Toulouse, France. · Départements de Pharmacologie Clinique et Neurosciences, INSERM CIC9302, CHU de Toulouse, Toulouse, France. · Service de Pharmacologie, Faculté de Médecine, CHU de Toulouse, Université de Toulouse, Toulouse, France. · Service de Neurologie, Hôpital Pellegrin, CHU de Bordeaux, 33000, Bordeaux, France. · Institut des Maladies Neurodégénératives, Université de Bordeaux, UMR 5293, 146 rue Léo Saignat, 33000, Bordeaux Cedex, France. · CNRS, Institut des Maladies Neurodégénératives, UMR 5293, 33000, Bordeaux, France. · Department Medicine, University of Otago, Christchurch, New Zealand. · New Zealand Brain Research Institute, Christchurch, New Zealand. · Pubmed 31098725
2014
  • Université Bordeaux; CNRS, Institut des Maladies Neurodégénératives, Bordeaux, France; Department of Pathology, Bordeaux University Hospital, Bordeaux, France. · Pubmed 24494664
2013
  • Université de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, Bordeaux, France. · Pubmed 23283428
2011
  • Service de Neurologie et Centre de référence atrophie multisystématisée, CHU de Bordeaux, Avenue Magellan F-33604 Pessac France. · Pubmed 21532567
5 Other Locations Show
Yearly article counts 36715168119554
 
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.